data_1l3y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1l3y _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 42.3 t . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.844 0.354 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.71 172.76 13.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.6 p -84.63 62.93 7.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -155.84 164.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 -178.173 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.477 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -154.9 151.49 28.62 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.68 -178.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 58.8 m -29.2 133.25 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.278 -0.873 . . . . 0.0 113.343 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 15' ' ' CYS . 4.0 mt-10 -95.65 113.02 24.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.37 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 3.3 mtp180 -84.8 134.1 34.32 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.556 0.693 . . . . 0.0 110.673 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.856 ' HE1' ' HB2' ' A' ' 13' ' ' GLN . 1.2 p90 -92.65 -27.38 17.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.339 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -155.45 -86.14 0.05 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.393 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.95 -2.83 9.23 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.851 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.856 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 2.4 mp0 -106.58 -116.11 0.26 Allowed 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -168.65 111.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.633 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.8 OUTLIER 71.7 40.08 0.81 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.03 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.654 ' HA2' ' CD2' ' A' ' 10' ' ' TYR . . . 59.56 39.75 95.43 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.504 -1.331 . . . . 0.0 111.089 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 62.54 141.11 0.01 OUTLIER Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.203 -0.499 . . . . 0.0 112.444 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.25 -30.94 92.43 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.569 2.18 . . . . 0.0 112.36 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.55 -37.21 40.77 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.916 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.419 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -97.08 -43.86 7.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.718 0.294 . . . . 0.0 110.924 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -154.73 137.3 5.6 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.033 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mp -101.75 138.57 38.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.923 0.392 . . . . 0.0 111.867 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.81 147.24 26.94 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 26' ' ' GLY . 19.8 m-85 -153.91 -173.86 4.74 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 122.017 0.913 . . . . 0.0 112.484 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -32.27 90.53 0.0 OUTLIER 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 113.089 -1.869 . . . . 0.0 111.292 178.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 54.34 22.28 22.36 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.761 -0.654 . . . . 0.0 113.282 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -155.11 -167.37 2.54 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.0 t -152.91 104.24 2.83 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.691 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.76 94.92 8.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.158 0.504 . . . . 0.0 111.009 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.53 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -96.03 166.22 11.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.836 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -85.39 159.6 55.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.971 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.56 114.07 2.22 Favored 'Trans proline' 0 CA--C 1.512 -0.589 0 C-N-CA 122.725 2.283 . . . . 0.0 112.402 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.78 26.72 3.23 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.626 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 20' ' ' ARG . 24.3 m-85 -134.64 150.84 50.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.302 . . . . 0.0 110.774 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 38' ' ' ALA . 0.9 OUTLIER -155.07 -83.11 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.062 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA3' ' HG2' ' A' ' 40' ' ' GLN . . . 48.96 -155.22 1.73 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.259 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.02 -10.54 59.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.633 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -143.71 -80.46 0.19 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.712 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 4.9 m -155.96 41.37 0.39 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.731 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.505 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -98.58 -32.28 11.52 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.505 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.32 -0.848 . . . . 0.0 111.72 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.756 0.312 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.58 ' O ' HD11 ' A' ' 5' ' ' ILE . 6.9 t70 -175.28 -124.79 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.691 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.85 93.43 8.51 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.58 HD11 ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -156.3 80.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.851 0.834 . . . . 0.0 109.178 -179.32 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -84.26 137.79 33.29 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.425 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.406 ' HB2' ' CG1' ' A' ' 14' ' ' VAL . 2.7 m -52.9 157.94 1.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.313 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 15' ' ' CYS . 4.8 mm-40 -84.24 129.56 34.88 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.346 178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 47.0 mtm180 -84.37 131.03 34.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.932 0.872 . . . . 0.0 110.905 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.873 ' HE1' ' HB2' ' A' ' 13' ' ' GLN . 0.9 OUTLIER -84.99 -60.66 1.98 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.833 -178.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.441 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 28.0 p30 -156.05 49.76 0.51 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.037 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.39 -45.96 1.08 Allowed Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.908 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.873 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 2.5 mp0 -105.05 -165.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -113.35 112.85 42.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.16 0.505 . . . . 0.0 111.354 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.617 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 74.7 46.15 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.388 178.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.619 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 54.32 33.53 52.92 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.631 -1.271 . . . . 0.0 111.34 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.84 145.25 0.02 OUTLIER Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.245 -0.477 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.52 -25.03 47.26 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.555 2.17 . . . . 0.0 112.024 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.8 -26.14 32.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.996 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.491 ' NE ' ' CE1' ' A' ' 34' ' ' PHE . 4.4 mmm180 -114.74 -51.42 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 110.307 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -139.94 139.77 10.16 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.597 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.1 tp -133.91 130.27 37.51 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 120.73 0.3 . . . . 0.0 110.913 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.827 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 1.7 p -104.0 157.94 16.76 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.624 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -156.06 -97.43 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.285 -0.966 . . . . 0.0 113.113 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.5 t -76.46 67.36 2.63 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.223 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.529 ' HA2' HG13 ' A' ' 5' ' ' ILE . . . 92.2 -6.97 78.7 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.97 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -155.63 163.15 40.31 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -178.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.827 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 7.8 t -103.19 100.47 10.38 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.052 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -84.54 96.19 9.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.998 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.61 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -87.58 151.99 22.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.236 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -70.26 153.62 95.09 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.487 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.15 116.9 3.59 Favored 'Trans proline' 0 CA--C 1.513 -0.555 0 C-N-CA 122.705 2.27 . . . . 0.0 112.851 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . 106.82 44.8 1.26 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.902 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.491 ' CE1' ' NE ' ' A' ' 20' ' ' ARG . 17.2 m-85 -145.42 154.74 42.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.383 . . . . 0.0 111.106 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -155.14 -83.53 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.111 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 47.63 -154.7 1.23 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.31 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.18 -9.16 59.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.617 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -145.18 -80.35 0.17 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.52 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 1.9 m -155.99 40.67 0.38 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.884 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.504 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -97.16 -32.91 11.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.504 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.742 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 3' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.378 0 CA-C-O 120.471 0.177 . . . . 0.0 110.864 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.433 ' O ' HD11 ' A' ' 5' ' ' ILE . 24.1 t70 80.02 -118.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.266 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 p -84.13 90.67 7.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.235 0.541 . . . . 0.0 110.042 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.442 HD11 ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -155.55 178.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.03 134.8 10.86 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.149 -1.021 . . . . 0.0 112.155 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.5 m -60.73 140.52 57.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.5 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -83.06 127.05 33.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.696 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.6 OUTLIER -104.71 131.96 51.52 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.573 0.702 . . . . 0.0 111.949 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.843 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 1.3 p90 -88.37 -149.26 0.17 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.435 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.456 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 3.4 p-10 -91.31 77.46 5.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.496 ' C ' ' HG2' ' A' ' 13' ' ' GLN . . . 138.29 -28.99 2.65 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 119.963 -1.113 . . . . 0.0 114.87 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.732 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -152.23 -162.64 1.55 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.718 0.759 . . . . 0.0 110.372 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 34.4 m -106.06 108.13 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.283 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . 0.5 OUTLIER 84.36 43.69 0.02 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.969 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.843 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 59.97 30.0 69.07 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.217 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.484 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 76.03 134.74 0.51 Allowed Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.259 -0.471 . . . . 0.0 112.654 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -51.93 -33.91 53.88 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.631 2.221 . . . . 0.0 112.678 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.69 -22.57 11.92 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.857 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 40' ' ' GLN . 38.4 mtm-85 -110.13 -36.7 5.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.604 0.24 . . . . 0.0 111.304 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 30' ' ' CYS . . . -171.33 139.87 5.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.139 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -91.71 -179.52 5.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.233 0.54 . . . . 0.0 112.15 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.849 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 16.0 p -121.26 143.16 49.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 27' ' ' LYS . 5.3 m-85 -143.93 179.28 7.28 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -37.46 102.51 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 112.718 -2.037 . . . . 0.0 111.04 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.61 -44.37 2.42 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.312 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 24' ' ' PHE . 26.6 mtmm -155.04 -179.28 7.91 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.849 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -84.44 160.69 20.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.833 179.425 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 95.54 2.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.898 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.403 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 2.2 p -100.37 162.02 13.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.949 0.404 . . . . 0.0 111.102 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -64.16 157.68 68.59 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.498 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.08 112.08 1.43 Allowed 'Trans proline' 0 CA--C 1.513 -0.57 0 C-N-CA 122.531 2.154 . . . . 0.0 112.476 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.46 32.79 2.65 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.93 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -125.52 150.53 47.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.003 0.43 . . . . 0.0 111.11 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 40' ' ' GLN . 45.7 mt-10 -155.4 -152.98 0.42 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.304 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.88 -161.22 12.89 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.291 -0.956 . . . . 0.0 111.892 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.3 m -62.25 -21.48 65.21 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.628 ' HB2' ' HA ' ' A' ' 15' ' ' CYS . . . -140.84 -81.39 0.25 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.026 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.5 m -157.1 39.33 0.31 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.121 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -85.94 -31.29 22.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.934 -179.135 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.633 -178.828 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.558 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 52.3 t . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.554 0.216 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.54 162.87 40.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.381 . . . . 0.0 111.346 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.407 ' O ' HG12 ' A' ' 5' ' ' ILE . 28.5 p -84.88 63.48 8.08 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.614 HG23 ' HA2' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -155.5 169.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -177.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.503 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -153.65 163.34 40.16 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.494 -0.883 . . . . 0.0 112.525 -179.038 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.548 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 8.7 m -18.85 136.61 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.649 -1.159 . . . . 0.0 114.029 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 15' ' ' CYS . 24.6 mt-10 -95.24 128.17 41.87 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.477 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 24.0 mtm105 -103.02 130.97 50.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.835 0.826 . . . . 0.0 111.456 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.624 ' CE2' ' HA2' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -92.42 -32.9 14.76 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.584 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.423 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.4 m-20 -156.14 -79.96 0.08 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.003 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.05 26.86 1.27 Allowed Glycine 0 C--N 1.331 0.306 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.566 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.492 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 37.4 mm-40 -136.0 11.73 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.466 0.174 . . . . 0.0 110.854 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.669 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 1.5 p 43.59 106.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.876 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.669 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 77.1 m 80.28 40.13 0.08 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.746 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.624 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 44.15 52.65 6.95 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.118 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.06 146.75 2.94 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.986 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.3 -35.65 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.81 2.34 . . . . 0.0 112.727 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.94 -21.17 29.71 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.892 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.459 ' CD ' ' CE1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -99.71 -31.56 11.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.95 0.405 . . . . 0.0 110.832 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . -175.45 158.43 25.71 Favored Glycine 0 N--CA 1.453 -0.189 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.716 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -104.1 -150.08 0.42 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 117.33 0.565 . . . . 0.0 111.629 -179.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.554 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 11.4 p -155.69 125.58 6.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.873 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.618 ' CZ ' ' HB3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -156.45 -102.72 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.453 177.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 8.3 t -56.08 77.31 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.148 0.499 . . . . 0.0 110.227 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.614 ' HA2' HG23 ' A' ' 5' ' ' ILE . . . 46.42 21.49 0.77 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.968 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.16 168.16 28.16 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 14.7 m -105.11 125.12 50.63 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.452 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.74 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -84.45 88.43 7.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.629 0.728 . . . . 0.0 109.481 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -92.81 160.01 15.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.906 -178.041 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.26 163.62 24.33 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.495 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.84 115.1 2.31 Favored 'Trans proline' 0 CA--C 1.512 -0.62 0 C-N-CA 122.753 2.302 . . . . 0.0 112.762 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . 116.26 36.9 1.06 Allowed Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 114.704 -1.134 . . . . 0.0 112.913 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.459 ' CE1' ' CD ' ' A' ' 20' ' ' ARG . 30.0 m-85 -148.03 156.12 42.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.739 0.304 . . . . 0.0 110.935 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -154.33 -90.28 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.23 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 47.95 -162.86 0.34 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.419 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -16.83 62.45 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.577 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -136.84 -81.96 0.37 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.079 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -156.13 42.4 0.39 Allowed 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.014 178.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.499 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -92.82 -31.24 15.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.886 -179.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.471 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.468 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 25' ' ' CYS . 42.0 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.818 0.342 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 t0 178.72 -148.81 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.687 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.6 p -84.75 94.56 8.71 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.478 HG21 ' CA ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -155.45 67.22 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 121.89 0.852 . . . . 0.0 108.983 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.38 135.73 34.16 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.503 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 23' ' ' CYS . 22.6 m -40.47 146.42 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.033 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 44.4 mm-40 -93.67 178.74 5.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 14.0 mtt85 -133.15 131.79 40.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.131 0.967 . . . . 0.0 113.233 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.951 ' HE1' ' HB2' ' A' ' 13' ' ' GLN . 5.6 p90 -92.16 -146.19 0.22 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.301 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -91.46 68.57 5.78 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 145.37 -32.5 1.63 Allowed Glycine 0 C--N 1.338 0.69 0 C-N-CA 119.818 -1.182 . . . . 0.0 114.868 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.951 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 3.1 mm100 -149.57 -156.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.528 0.664 . . . . 0.0 110.489 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 23.0 m -104.89 115.05 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.978 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.584 ' O ' ' HB3' ' A' ' 39' ' ' CYS . 0.5 OUTLIER 64.63 53.58 1.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.3 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.644 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 51.33 31.95 28.72 Favored Glycine 0 C--N 1.318 -0.442 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.954 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.404 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 64.25 158.0 0.24 Allowed Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.498 -0.351 . . . . 0.0 112.855 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.3 -13.02 35.71 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.75 2.3 . . . . 0.0 112.902 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.74 27.58 4.26 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.792 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.487 ' C ' ' SG ' ' A' ' 39' ' ' CYS . 26.3 mtp85 -155.13 -42.45 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 30' ' ' CYS . . . 179.19 176.0 46.59 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.15 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.434 ' CD1' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -143.08 -175.04 4.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.931 0.396 . . . . 0.0 110.82 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.871 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 8.2 p -101.43 143.2 31.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.47 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.571 ' O ' ' N ' ' A' ' 26' ' ' GLY . 7.3 m-85 -126.42 -179.05 4.57 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.923 0.868 . . . . 0.0 112.977 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 2' ' ' CYS . 1.7 t -55.04 72.76 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.801 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 141.66 -55.84 0.6 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.482 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.57 -177.6 6.67 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.871 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -84.33 128.84 34.82 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.913 178.491 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -113.24 103.96 11.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.366 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.609 ' SG ' ' CB ' ' A' ' 34' ' ' PHE . 7.7 t -85.08 156.14 21.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.819 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.457 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 9.5 m-70 -65.48 157.13 79.78 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.882 0.372 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.85 116.46 3.37 Favored 'Trans proline' 0 CA--C 1.512 -0.584 0 C-N-CA 122.804 2.336 . . . . 0.0 112.696 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.12 29.08 5.01 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.756 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.609 ' CB ' ' SG ' ' A' ' 30' ' ' CYS . 5.4 m-85 -125.1 170.92 10.71 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.908 -0.172 . . . . 0.0 110.811 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.41 ' N ' ' OXT' ' A' ' 41' ' ' ALA . 6.2 mm-40 -155.44 -102.65 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.063 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.412 ' N ' ' CB ' ' A' ' 41' ' ' ALA . . . 63.51 -157.19 41.54 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.367 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.508 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 0.5 OUTLIER -94.87 -18.1 21.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.04 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.48 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -138.56 -73.62 0.4 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.433 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 53.4 t -157.35 20.21 0.29 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.938 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.71 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -77.62 -33.33 53.68 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.7 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.412 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 117.961 -1.019 . . . . 0.0 111.36 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 10.8 t . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 120.587 0.232 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.56 -155.61 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.67 0.271 . . . . 0.0 110.807 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 48.0 p -84.08 113.93 21.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.456 ' CG2' ' CA ' ' A' ' 26' ' ' GLY . 0.4 OUTLIER -147.78 74.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-O 121.799 0.809 . . . . 0.0 111.141 -177.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 7' ' ' CYS . 6.2 p30 -93.89 53.52 1.81 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.486 -1.233 . . . . 0.0 108.55 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' ASN . 21.4 m -7.77 135.16 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 113.448 -1.706 . . . . 0.0 114.813 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -89.96 128.77 36.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.985 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 4.7 mpp_? -92.33 134.0 35.32 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.331 0.586 . . . . 0.0 111.809 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 1.134 ' CE1' ' HB2' ' A' ' 13' ' ' GLN . 9.7 p90 -85.59 -134.83 0.06 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.806 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -83.26 72.18 10.19 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.03 -18.52 45.95 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 1.134 ' HB2' ' CE1' ' A' ' 10' ' ' TYR . 2.7 mp0 -115.21 -133.51 0.34 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.889 0.844 . . . . 0.0 111.317 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.598 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.9 m -147.4 114.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 121.079 0.466 . . . . 0.0 111.739 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.568 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 66.43 44.41 2.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.379 178.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.717 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 60.29 18.08 48.42 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.769 -1.205 . . . . 0.0 111.83 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.637 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 66.2 144.98 0.06 OUTLIER Glycine 0 C--N 1.338 0.655 0 C-N-CA 121.79 -0.243 . . . . 0.0 113.076 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.68 -31.81 52.04 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.69 2.26 . . . . 0.0 112.449 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -48.29 -28.71 6.46 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.927 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.427 ' HD2' ' CE2' ' A' ' 34' ' ' PHE . 6.6 mmm-85 -118.25 -31.47 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 110.636 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.448 ' CA ' ' HA ' ' A' ' 30' ' ' CYS . . . -168.43 149.69 14.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.738 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.45 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -128.8 166.27 19.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.097 0.475 . . . . 0.0 111.208 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -84.75 134.88 34.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.105 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 27' ' ' LYS . 1.1 m-85 -130.16 -177.56 4.36 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.702 0.763 . . . . 0.0 112.111 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.467 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 0.1 OUTLIER -41.95 86.25 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.224 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 70.47 6.31 57.9 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.731 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -156.3 142.03 17.85 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -90.43 115.46 27.61 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -99.66 102.43 13.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.135 0.493 . . . . 0.0 111.726 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.448 ' HA ' ' CA ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -96.32 144.07 26.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.375 179.163 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.459 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 12.3 m-70 -53.76 149.82 15.51 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.22 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.67 117.48 4.37 Favored 'Trans proline' 0 CA--C 1.514 -0.51 0 C-N-CA 122.698 2.265 . . . . 0.0 112.834 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.421 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . 109.03 31.49 3.32 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.84 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.459 ' CE2' ' HB2' ' A' ' 31' ' ' HIS . 17.9 m-85 -136.46 146.66 46.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.921 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 18.9 pt-20 -142.44 -140.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.076 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.406 ' N ' ' HG3' ' A' ' 35' ' ' GLU . . . 102.1 -162.38 17.16 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.517 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.471 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 0.7 OUTLIER -69.36 -16.15 63.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.568 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -145.77 -79.88 0.17 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.694 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -155.9 26.56 0.37 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.027 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.712 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -69.46 -31.02 69.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.449 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.156 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.301 0.096 . . . . 0.0 110.773 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 13.0 t70 -177.19 -4.04 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.6 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -84.42 57.41 4.27 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.562 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -84.73 92.88 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.862 -177.138 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.76 37.99 0.37 Allowed 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.474 -1.693 . . . . 0.0 108.925 -177.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.463 ' CB ' HG11 ' A' ' 14' ' ' VAL . 13.6 m -35.51 147.77 0.02 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 113.811 -1.541 . . . . 0.0 112.896 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.24 121.47 33.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.928 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.601 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 17.4 mtm180 -95.73 131.36 42.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.639 0.733 . . . . 0.0 112.133 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.771 ' CD2' ' HA2' ' A' ' 16' ' ' GLY . 1.6 p90 -84.97 -33.08 22.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.495 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.71 -77.86 0.09 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.007 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -148.06 16.41 1.35 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.19 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.491 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 47.2 mm-40 -118.68 -19.04 8.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.972 0.415 . . . . 0.0 110.577 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.636 ' O ' ' CB ' ' A' ' 15' ' ' CYS . 1.6 t 70.67 92.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.662 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.636 ' CB ' ' O ' ' A' ' 14' ' ' VAL . 8.2 t 104.96 34.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.765 0.666 . . . . 0.0 112.123 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.771 ' HA2' ' CD2' ' A' ' 10' ' ' TYR . . . 56.48 41.23 88.18 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.051 -1.071 . . . . 0.0 113.109 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.35 148.95 4.03 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.188 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.67 -44.8 15.84 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.71 2.274 . . . . 0.0 112.087 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.46 -31.65 14.22 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.341 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.433 ' HG3' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -95.51 -30.44 13.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.771 0.32 . . . . 0.0 110.712 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.464 ' CA ' ' HA ' ' A' ' 30' ' ' CYS . . . 179.68 156.02 16.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.879 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -122.43 -166.16 1.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.726 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 5.3 t -145.2 145.56 31.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.622 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.614 ' O ' ' N ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -155.78 -101.21 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.573 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.542 ' HA ' ' CB ' ' A' ' 2' ' ' CYS . 0.8 OUTLIER -55.61 80.3 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 41.38 26.35 0.21 Allowed Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.616 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.61 142.3 18.83 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.726 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -87.92 111.1 21.08 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.923 178.582 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.586 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 7.3 ttp85 -97.63 100.45 11.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.916 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.464 ' HA ' ' CA ' ' A' ' 21' ' ' GLY . 1.8 p -95.87 165.04 12.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.074 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -73.37 159.15 85.53 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.498 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.17 112.66 1.61 Allowed 'Trans proline' 0 CA--C 1.513 -0.551 0 C-N-CA 122.609 2.206 . . . . 0.0 112.527 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.36 22.53 4.07 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.046 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.457 ' HA ' ' OXT' ' A' ' 41' ' ' ALA . 40.5 m-85 -125.49 148.82 48.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.659 0.266 . . . . 0.0 110.842 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 39' ' ' CYS . 1.2 mt-10 -155.54 -96.6 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' ' HB3' ' A' ' 41' ' ' ALA . . . 67.21 -144.36 44.44 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.174 -1.013 . . . . 0.0 111.883 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.42 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 40.3 t -90.46 -3.06 57.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.457 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -148.68 -79.96 0.14 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.29 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 35' ' ' GLU . 9.0 m -157.17 39.37 0.3 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.635 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.566 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 17.6 pm0 -106.11 -33.49 7.84 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.537 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.346 -0.835 . . . . 0.0 112.121 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 25' ' ' CYS . 46.0 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.737 0.303 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.418 ' O ' HD12 ' A' ' 5' ' ' ILE . 14.9 p-10 -167.17 -160.24 0.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.858 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.75 86.33 7.37 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.532 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -156.34 79.35 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-O 121.981 0.896 . . . . 0.0 108.92 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 7' ' ' CYS . 6.9 p30 -84.22 72.88 10.5 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.867 -177.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.556 ' HB3' ' HB ' ' A' ' 14' ' ' VAL . 69.9 m 47.73 149.35 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.433 -1.258 . . . . 0.0 113.457 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.684 ' O ' ' N ' ' A' ' 15' ' ' CYS . 15.1 mm-40 -94.93 131.43 40.86 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.558 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.624 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 4.0 mtp85 -100.08 131.36 46.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.794 0.807 . . . . 0.0 111.347 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.666 ' CD2' ' HA2' ' A' ' 16' ' ' GLY . 1.2 p90 -91.37 -30.4 16.56 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.842 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -155.79 -85.33 0.05 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.825 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.56 -16.39 10.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.255 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.551 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -110.76 -159.96 0.7 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.624 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 28.2 m -124.4 104.09 13.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.137 0.494 . . . . 0.0 111.267 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.684 ' N ' ' O ' ' A' ' 8' ' ' GLU . 0.5 OUTLIER 86.21 48.15 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.501 179.504 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.666 ' HA2' ' CD2' ' A' ' 10' ' ' TYR . . . 53.64 30.39 42.88 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.352 -1.404 . . . . 0.0 111.726 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.21 143.81 0.82 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.602 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.0 -35.33 98.87 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.521 2.147 . . . . 0.0 112.27 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -48.17 -28.95 6.42 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.845 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.46 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.1 OUTLIER -101.48 -36.43 8.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.104 0.478 . . . . 0.0 109.778 179.165 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 30' ' ' CYS . . . 177.02 152.39 9.83 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.634 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.45 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -113.7 175.73 5.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.784 0.326 . . . . 0.0 110.721 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -98.71 156.07 17.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.295 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.601 ' O ' ' N ' ' A' ' 26' ' ' GLY . 6.2 m-85 -139.29 -175.23 4.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.875 0.845 . . . . 0.0 112.26 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 1.5 t -47.27 77.36 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 113.406 -1.725 . . . . 0.0 110.874 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 80.7 19.26 68.53 Favored Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.316 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -155.18 -164.86 1.87 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 117.388 0.594 . . . . 0.0 112.246 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -145.49 115.59 7.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.625 179.439 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.39 88.0 7.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.12 0.486 . . . . 0.0 110.913 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.96 ' SG ' ' HB2' ' A' ' 34' ' ' PHE . 18.2 t -85.03 155.47 21.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.931 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.46 ' CD2' ' O ' ' A' ' 20' ' ' ARG . 11.6 m-70 -78.46 154.5 79.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.959 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.04 112.73 1.61 Allowed 'Trans proline' 0 CA--C 1.513 -0.54 0 C-N-CA 122.481 2.121 . . . . 0.0 112.883 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.5 28.53 2.52 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.356 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.96 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 12.4 m-85 -130.86 164.04 26.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.81 0.305 . . . . 0.0 110.955 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -153.39 -91.61 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.98 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 48.6 -152.21 2.66 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.07 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.45 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 27.7 p -92.18 1.04 57.46 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.635 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -155.21 -79.31 0.09 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.092 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 43.2 t -156.55 36.95 0.32 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.682 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.577 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -92.46 -34.85 13.94 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.464 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.655 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.748 0.309 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -178.75 -138.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.903 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.9 90.01 6.91 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.527 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -155.23 72.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.243 -177.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -84.15 -179.51 7.24 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.891 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 m -78.88 140.88 38.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.567 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 15' ' ' CYS . 2.4 mt-10 -94.81 124.8 39.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -84.52 132.11 34.57 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.832 0.825 . . . . 0.0 112.863 -177.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 1.069 ' CE1' ' HB2' ' A' ' 13' ' ' GLN . 4.2 p90 -84.91 -125.51 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.574 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -83.71 51.58 2.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.89 -28.48 6.12 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 119.965 -1.112 . . . . 0.0 115.641 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 1.069 ' HB2' ' CE1' ' A' ' 10' ' ' TYR . 2.8 mp0 -101.75 -125.95 0.19 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.942 0.871 . . . . 0.0 111.439 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -150.37 110.52 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 120.998 0.428 . . . . 0.0 111.495 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.565 ' N ' ' O ' ' A' ' 8' ' ' GLU . 0.1 OUTLIER 65.87 44.13 2.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.657 179.014 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.713 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 60.58 22.72 59.68 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.315 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.545 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 69.45 144.87 0.19 Allowed Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.407 -0.397 . . . . 0.0 112.739 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -50.61 -30.26 27.85 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.701 2.268 . . . . 0.0 112.441 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.7 -26.7 54.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.435 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.93 -28.49 9.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.612 0.244 . . . . 0.0 111.109 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.515 ' HA3' ' HB3' ' A' ' 30' ' ' CYS . . . -179.86 158.34 21.91 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.843 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 29' ' ' ARG . 5.7 mp -124.56 142.26 51.48 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 111.697 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -84.73 127.76 34.27 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.53 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.529 ' O ' ' N ' ' A' ' 26' ' ' GLY . 16.2 m-85 -141.71 175.83 9.39 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -177.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -34.46 83.57 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 111.814 -2.448 . . . . 0.0 111.031 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 120.77 -57.94 0.58 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.234 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -155.79 -178.29 7.19 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 4.8 t -89.16 107.58 19.13 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.348 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 22' ' ' LEU . 5.2 tpt85 -84.81 88.57 7.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.989 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.515 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 1.0 OUTLIER -95.01 156.77 16.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -63.13 153.39 81.5 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.647 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.14 113.05 1.58 Allowed 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 122.591 2.194 . . . . 0.0 112.564 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.4 23.03 4.6 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.932 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -124.49 148.98 47.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.871 0.367 . . . . 0.0 111.089 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.422 ' HB2' ' OXT' ' A' ' 41' ' ' ALA . 4.5 mm-40 -155.4 -88.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.218 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.427 ' HA3' ' HG2' ' A' ' 40' ' ' GLN . . . 61.45 -147.89 47.39 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.044 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.427 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 1.1 m -87.22 -5.04 59.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -144.09 -82.89 0.16 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.232 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 7.3 m -157.47 42.88 0.32 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.057 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.517 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 9.9 pm0 -108.56 -33.77 6.93 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.471 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.115 -0.945 . . . . 0.0 111.983 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 33.8 m . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.438 0.161 . . . . 0.0 110.714 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.469 ' CB ' ' O ' ' A' ' 2' ' ' CYS . 0.8 OUTLIER 82.23 -141.68 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.0 p -84.4 117.15 23.44 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.541 0.686 . . . . 0.0 109.896 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.619 HG13 ' H ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -155.31 74.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.4 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -84.85 140.67 31.0 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.281 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 75.8 m -100.16 -177.98 3.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.272 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -67.82 144.89 55.13 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.322 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.479 ' HB3' ' C ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -105.12 160.69 14.86 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.501 0.667 . . . . 0.0 111.619 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.764 ' CD2' ' HA3' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -127.69 -16.67 4.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.79 179.197 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.422 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -155.66 62.43 0.6 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.302 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.78 26.4 57.58 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.479 ' C ' ' HB3' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -155.14 127.43 7.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.197 -0.501 . . . . 0.0 110.545 -178.442 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 12.9 m -51.17 118.67 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.67 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 95.3 m 64.52 49.95 2.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -176.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.764 ' HA3' ' CD2' ' A' ' 10' ' ' TYR . . . 17.87 48.29 0.01 OUTLIER Glycine 0 C--N 1.341 0.845 0 CA-C-N 114.467 -1.242 . . . . 0.0 115.047 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 15' ' ' CYS . . . 96.94 147.84 23.25 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.823 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.415 ' HA ' ' HB3' ' A' ' 22' ' ' LEU . 26.3 Cg_exo -61.66 -15.72 43.74 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.531 2.154 . . . . 0.0 113.039 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -46.59 -45.63 17.58 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.088 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -102.96 -44.1 5.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.186 0.517 . . . . 0.0 110.033 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -157.87 144.84 10.95 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.502 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -132.62 135.91 46.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.988 0.394 . . . . 0.0 111.764 -179.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.926 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 11.8 t -97.55 128.78 44.56 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.406 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.623 ' CE1' ' HB2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -156.89 -157.8 0.72 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.783 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.519 ' C ' ' O ' ' A' ' 24' ' ' PHE . 39.9 t -24.87 94.21 0.01 OUTLIER 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.105 0.478 . . . . 0.0 110.393 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.619 ' H ' HG13 ' A' ' 5' ' ' ILE . . . 102.83 -76.12 0.3 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.386 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -154.27 -160.65 1.11 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.926 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 50.5 t -92.39 112.65 24.68 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.881 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.623 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -84.74 94.15 8.61 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -93.55 156.72 16.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.07 -178.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -83.01 157.16 66.62 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.772 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -57.68 122.58 11.99 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 122.89 2.393 . . . . 0.0 113.197 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.54 49.23 2.59 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.719 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.466 ' CZ ' ' HG3' ' A' ' 20' ' ' ARG . 7.1 m-85 -139.99 150.09 44.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.965 0.412 . . . . 0.0 111.702 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 38' ' ' ALA . 1.9 mm-40 -155.33 -90.3 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.384 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.94 -145.52 43.55 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.994 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.449 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -91.36 -1.72 57.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.129 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.67 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -146.27 -83.2 0.13 Allowed 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.639 -1.618 . . . . 0.0 109.088 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 69.5 m -156.48 45.05 0.42 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.518 178.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.571 HE22 ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -97.83 -36.05 10.32 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.521 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.963 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.482 ' CB ' ' HA ' ' A' ' 25' ' ' CYS . 4.9 t . . . . . 0 CA--C 1.53 0.19 0 CA-C-O 120.551 0.215 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.99 -161.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.685 0.278 . . . . 0.0 111.089 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 5' ' ' ILE . 12.4 p -84.49 91.27 7.81 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.557 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -155.75 79.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.134 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.2 151.3 25.73 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.886 -177.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.51 ' HB3' ' CG1' ' A' ' 14' ' ' VAL . 5.2 m -50.0 135.88 19.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.043 -0.981 . . . . 0.0 113.333 -177.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -96.01 148.6 22.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.989 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.1 154.93 23.57 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 122.069 0.938 . . . . 0.0 111.248 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.83 ' CZ ' ' HA2' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -112.68 -27.63 8.1 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.421 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -156.24 -38.07 0.08 Allowed 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.16 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.74 1.27 0.05 OUTLIER Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.891 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.413 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -101.05 -17.64 16.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.346 0.573 . . . . 0.0 110.22 179.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 7' ' ' CYS . 3.5 t 84.96 98.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.514 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.768 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 1.0 OUTLIER 69.43 47.37 0.69 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.53 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.83 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 45.51 61.25 3.8 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.521 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 54.96 168.48 0.05 OUTLIER Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.953 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.489 ' CB ' HD13 ' A' ' 22' ' ' LEU . 95.6 Cg_endo -80.98 -26.82 3.32 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.663 2.242 . . . . 0.0 112.763 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.6 -25.62 6.78 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.696 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.97 -51.64 3.0 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 30' ' ' CYS . . . -165.18 144.76 9.56 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.668 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.512 ' O ' ' CA ' ' A' ' 28' ' ' CYS . 0.7 OUTLIER -96.51 -177.76 4.05 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 122.651 0.38 . . . . 0.0 111.434 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 29.3 p -126.51 116.18 20.69 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.553 ' CZ ' ' HB3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -157.6 -162.94 1.25 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.191 -1.003 . . . . 0.0 112.533 177.262 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.482 ' HA ' ' CB ' ' A' ' 2' ' ' CYS . 9.2 t -24.04 122.19 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.236 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.532 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 80.02 -73.01 2.51 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.169 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.532 ' HG2' ' C ' ' A' ' 26' ' ' GLY . 5.5 mmmm -155.84 -157.93 0.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.613 0.721 . . . . 0.0 112.39 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.1 m -85.5 124.58 32.24 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.049 178.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.553 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . 10.2 ttt-85 -84.72 84.57 7.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.932 0.396 . . . . 0.0 110.279 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.416 ' HA ' ' CA ' ' A' ' 21' ' ' GLY . 0.8 OUTLIER -96.99 141.76 29.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.169 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -61.68 158.6 40.08 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.45 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.65 114.98 2.29 Favored 'Trans proline' 0 CA--C 1.512 -0.597 0 C-N-CA 122.539 2.159 . . . . 0.0 112.755 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.1 34.71 1.76 Allowed Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.754 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -135.09 147.55 49.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.874 0.368 . . . . 0.0 111.111 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.488 ' O ' ' C ' ' A' ' 38' ' ' ALA . 2.4 mt-10 -155.08 -83.69 0.07 Allowed 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.03 -155.42 4.46 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.234 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.1 m -75.73 -12.35 60.17 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.768 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -138.53 -81.84 0.31 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.286 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.0 m -156.93 44.21 0.38 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.456 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.519 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -100.1 -33.44 10.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.305 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.519 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.777 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.948 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 121.595 0.712 . . . . 0.0 111.479 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.544 ' O ' ' O ' ' A' ' 2' ' ' CYS . 7.7 t70 -47.1 -123.36 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.761 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.9 p -84.89 92.79 8.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.457 . . . . 0.0 109.935 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.487 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -156.16 71.77 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-O 122.191 0.996 . . . . 0.0 108.719 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.57 136.57 33.73 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.27 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -58.13 159.1 6.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.38 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' CYS . 2.4 mt-10 -95.22 169.6 9.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 3.0 mtp180 -123.9 127.84 48.59 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 122.2 1.0 . . . . 0.0 112.244 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.605 ' CE2' ' HA2' ' A' ' 16' ' ' GLY . 1.2 p90 -92.15 -32.86 14.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.069 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -155.89 -74.4 0.1 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.027 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.9 24.58 0.62 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.797 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.469 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 37.9 mm-40 -135.3 14.32 3.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.627 0.251 . . . . 0.0 110.966 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 8.2 m 43.53 105.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.451 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.623 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER 80.98 36.62 0.09 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 178.274 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.605 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 49.69 48.71 35.72 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.991 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.7 150.77 0.01 OUTLIER Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.301 -0.476 . . . . 0.0 113.15 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 45.1 Cg_endo -68.57 -29.26 30.61 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.571 2.181 . . . . 0.0 112.017 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.425 ' O ' ' CD2' ' A' ' 31' ' ' HIS . . . -49.04 -38.36 24.5 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.861 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.495 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -97.11 -45.02 6.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.058 0.456 . . . . 0.0 110.195 179.33 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -156.47 142.6 8.89 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.961 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.29 132.86 15.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.866 0.365 . . . . 0.0 111.351 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.735 ' CA ' ' HA ' ' A' ' 28' ' ' CYS . 20.8 p -98.44 157.15 16.39 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.111 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -155.82 -95.47 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.586 -0.845 . . . . 0.0 112.123 179.328 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.948 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 24.0 t -93.66 73.19 4.32 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 121.37 0.605 . . . . 0.0 110.338 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.44 ' H ' HG13 ' A' ' 5' ' ' ILE . . . 133.58 -65.49 0.58 Allowed Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.854 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 6.6 mttt -156.58 -174.49 4.96 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.735 ' HA ' ' CA ' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -85.01 109.11 17.96 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.453 178.182 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -84.39 91.11 7.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.398 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.536 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -92.93 134.4 35.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.582 -179.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.425 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 1.2 m-70 -67.16 159.73 75.17 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.817 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.23 118.07 4.9 Favored 'Trans proline' 0 CA--C 1.511 -0.633 0 C-N-CA 122.696 2.264 . . . . 0.0 112.832 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.3 47.66 0.98 Allowed Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.678 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.495 ' CE2' ' HA ' ' A' ' 20' ' ' ARG . 26.4 m-85 -146.13 149.29 33.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 111.264 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 38' ' ' ALA . 22.0 mt-10 -154.4 -82.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.819 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 47.25 -156.88 0.69 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.631 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.01 -13.28 60.49 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.623 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -137.84 -82.74 0.33 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.24 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 97.3 m -156.5 44.19 0.4 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.634 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.499 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -98.38 -32.9 11.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.828 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 121.007 0.432 . . . . 0.0 110.279 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -148.1 -135.28 0.07 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.307 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 p -84.12 107.08 16.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -155.63 66.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.132 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -84.35 85.73 7.35 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.833 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.5 m -44.66 173.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.732 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -69.98 132.21 45.57 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.504 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -100.58 132.25 46.07 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.58 0.705 . . . . 0.0 111.955 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 1.04 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -84.0 -31.37 25.53 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.688 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.401 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 9.0 m120 -156.21 -85.72 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.24 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.63 -18.15 11.23 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.56 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 25.3 mm100 -106.98 156.75 18.4 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 3.1 m -92.28 29.53 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 23' ' ' CYS . 66.2 m -166.0 49.25 0.08 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.705 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 1.04 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 58.37 16.97 30.3 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 118.191 -1.957 . . . . 0.0 111.404 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.531 ' HA2' ' HG3' ' A' ' 13' ' ' GLN . . . 90.07 145.44 13.13 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 121.433 -0.413 . . . . 0.0 112.453 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.423 ' CD ' ' HG3' ' A' ' 13' ' ' GLN . 15.1 Cg_endo -57.37 -41.81 68.7 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.913 2.409 . . . . 0.0 112.628 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -45.38 -36.85 6.0 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.679 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.469 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 1.1 mpp_? -106.96 -22.82 12.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.721 -0.239 . . . . 0.0 111.098 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . 177.7 148.11 7.16 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.018 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -140.19 143.62 36.17 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.194 0.521 . . . . 0.0 112.283 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 9.5 t -101.36 143.22 31.66 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.346 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -155.84 -108.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 118.753 -1.179 . . . . 0.0 113.255 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 43.6 t -72.26 68.41 0.74 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -177.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.93 -38.72 3.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.279 -0.962 . . . . 0.0 115.167 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -155.82 -165.98 2.09 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -177.172 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.7 m -83.09 -175.19 5.71 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.22 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 20.8 ttt180 -155.17 64.67 0.63 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -89.64 138.9 31.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.402 -178.488 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -80.65 162.9 58.82 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.692 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.71 117.16 3.81 Favored 'Trans proline' 0 CA--C 1.512 -0.606 0 C-N-CA 122.669 2.246 . . . . 0.0 112.738 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.18 46.98 0.97 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.75 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.469 ' CE2' ' HA ' ' A' ' 20' ' ' ARG . 24.3 m-85 -146.04 147.49 31.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.691 0.282 . . . . 0.0 111.126 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 -87.25 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.48 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.45 ' HA3' ' HG2' ' A' ' 40' ' ' GLN . . . 50.85 -154.91 3.37 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.343 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.8 t -78.3 -20.46 51.47 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.408 ' O ' ' SG ' ' A' ' 39' ' ' CYS . . . -127.86 -83.65 0.59 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.582 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 93.9 m -156.36 43.45 0.4 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.931 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.541 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 15.5 pm0 -102.92 -33.18 9.41 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.492 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.484 -0.77 . . . . 0.0 111.649 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.997 0.427 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.473 ' O ' HD13 ' A' ' 5' ' ' ILE . 64.5 m-20 -158.2 -124.76 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.429 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.85 87.87 7.36 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.514 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -156.23 69.51 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-O 122.126 0.965 . . . . 0.0 108.787 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.55 153.86 23.0 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.963 -177.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.8 m -40.63 145.41 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.194 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 15' ' ' CYS . 76.0 mt-10 -87.76 179.15 6.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.671 178.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.574 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -137.95 128.25 26.17 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.093 0.949 . . . . 0.0 112.251 178.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.776 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 1.0 OUTLIER -95.12 -147.09 0.27 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.572 178.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.452 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 3.0 t-20 -91.41 71.47 6.05 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.98 -24.83 2.25 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 119.673 -1.251 . . . . 0.0 115.216 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.761 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 9.5 mt-30 -155.56 -156.33 0.64 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.941 0.871 . . . . 0.0 110.386 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 32.9 m -107.23 115.01 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.195 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.598 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 1.2 m 68.87 47.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.71 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.776 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 54.47 29.77 48.19 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.19 -1.481 . . . . 0.0 111.227 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.14 150.69 0.27 Allowed Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.405 -0.398 . . . . 0.0 112.358 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.0 -31.55 95.94 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.72 2.28 . . . . 0.0 112.672 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.28 -21.96 13.58 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.625 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -107.74 -33.49 7.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.358 . . . . 0.0 110.987 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.32 161.54 29.06 Favored Glycine 0 CA--C 1.517 0.198 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.069 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.649 ' O ' ' N ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -125.93 -175.18 3.28 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 120.672 0.273 . . . . 0.0 110.41 179.387 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.745 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 14.6 p -137.42 148.24 46.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.386 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -156.61 -169.41 2.99 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.496 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.444 ' C ' ' O ' ' A' ' 24' ' ' PHE . 4.7 t -24.71 85.94 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.314 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 120.39 -68.42 0.4 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.382 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.52 -163.69 1.5 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.745 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 3.6 t -84.34 169.5 14.58 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.679 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.649 ' N ' ' O ' ' A' ' 22' ' ' LEU . 2.0 tpp85 -145.47 94.55 2.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.944 ' SG ' ' HB2' ' A' ' 34' ' ' PHE . 30.5 t -85.61 157.12 20.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.842 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 20' ' ' ARG . 9.5 m-70 -77.88 158.21 78.15 Favored Pre-proline 0 C--O 1.231 0.124 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.348 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -64.71 113.54 2.37 Favored 'Trans proline' 0 CA--C 1.515 -0.434 0 C-N-CA 122.712 2.274 . . . . 0.0 112.665 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.91 -24.88 5.94 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.922 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.944 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.8 m-85 -85.53 164.68 17.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.719 0.295 . . . . 0.0 110.846 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -155.0 -90.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.134 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 49.23 -153.52 2.61 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.129 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.45 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 0.3 OUTLIER -88.63 -0.11 56.94 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.598 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -154.92 -78.61 0.09 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.051 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.455 ' SG ' ' CB ' ' A' ' 34' ' ' PHE . 23.2 t -156.29 35.67 0.33 Allowed 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.858 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.6 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -91.81 -35.28 14.19 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.473 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.659 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.425 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.684 0.278 . . . . 0.0 110.746 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.7 -170.59 0.14 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.032 0.444 . . . . 0.0 111.493 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.0 p -84.42 76.8 10.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.596 HG23 ' HA2' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -98.15 -20.21 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.387 -178.065 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.46 94.63 2.71 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.296 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.41 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 4.7 m -134.06 134.91 42.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.155 0.502 . . . . 0.0 111.145 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 15' ' ' CYS . 9.1 mm-40 -95.41 154.58 17.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.412 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 24.8 mtt180 -129.78 130.14 44.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.716 0.77 . . . . 0.0 111.209 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.847 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 1.5 p90 -96.28 -33.6 11.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.445 -1.252 . . . . 0.0 112.908 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -155.62 44.71 0.46 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.253 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.75 -13.4 56.36 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.285 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.715 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 32.4 mm-40 -84.59 -77.74 0.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.516 ' CB ' ' O ' ' A' ' 13' ' ' GLN . 3.7 p 145.72 108.29 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.553 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.629 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER 67.81 42.55 1.93 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 178.16 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.847 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 62.78 33.65 87.49 Favored Glycine 0 C--N 1.316 -0.554 0 C-N-CA 119.162 -1.495 . . . . 0.0 111.784 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.459 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 73.52 163.39 8.36 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.434 -0.412 . . . . 0.0 112.742 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.86 -42.36 2.32 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.774 2.316 . . . . 0.0 112.809 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -47.42 -27.95 4.44 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.858 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.481 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -106.11 -49.55 3.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.71 0.29 . . . . 0.0 110.925 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.19 132.91 3.47 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.342 -0.933 . . . . 0.0 113.018 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.405 ' HB2' ' CG ' ' A' ' 29' ' ' ARG . 2.6 mm? -96.21 170.98 8.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.21 0.529 . . . . 0.0 112.226 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -112.75 131.66 55.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.068 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -135.08 -173.25 3.27 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.425 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -31.74 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.464 -1.698 . . . . 0.0 111.446 179.03 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.596 ' HA2' HG23 ' A' ' 5' ' ' ILE . . . 56.56 4.87 1.0 Allowed Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.829 -0.623 . . . . 0.0 114.042 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' A' ' 24' ' ' PHE . 15.0 mttt -156.16 152.65 28.15 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 118.064 0.932 . . . . 0.0 112.995 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -84.45 175.76 9.11 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.004 178.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.405 ' CG ' ' HB2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -148.79 86.0 1.5 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.825 0.345 . . . . 0.0 111.421 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.909 ' SG ' ' HB2' ' A' ' 34' ' ' PHE . 19.2 t -85.03 154.79 21.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.368 . . . . 0.0 110.916 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 20' ' ' ARG . 2.9 m-70 -78.21 153.97 79.65 Favored Pre-proline 0 N--CA 1.455 -0.194 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.36 111.62 1.51 Allowed 'Trans proline' 0 CA--C 1.514 -0.524 0 C-N-CA 122.434 2.09 . . . . 0.0 112.743 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.08 31.67 2.01 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.349 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.909 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 6.3 m-85 -131.12 158.5 40.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -148.17 -88.22 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.036 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 47.99 -154.85 1.37 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.118 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 m -79.31 -8.24 58.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.629 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -155.18 -74.67 0.11 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.377 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.449 ' SG ' ' CB ' ' A' ' 34' ' ' PHE . 45.3 t -155.74 33.54 0.36 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.21 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.55 -29.74 13.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.725 0.297 . . . . 0.0 111.742 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.207 -0.901 . . . . 0.0 111.146 -179.852 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.902 0.382 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 42.3 t -94.12 -31.13 14.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.948 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.71 172.76 13.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.6 p -84.63 62.93 7.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -155.84 164.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 -178.173 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.477 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -154.9 151.49 28.62 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.68 -178.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 58.8 m -29.2 133.25 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.278 -0.873 . . . . 0.0 113.343 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 15' ' ' CYS . 4.0 mt-10 -95.65 113.02 24.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.37 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 3.3 mtp180 -84.8 134.1 34.32 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.556 0.693 . . . . 0.0 110.673 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.856 ' HE1' ' HB2' ' A' ' 13' ' ' GLN . 1.2 p90 -92.65 -27.38 17.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.339 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -155.45 -86.14 0.05 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.393 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.95 -2.83 9.23 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.851 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.856 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 2.4 mp0 -106.58 -116.11 0.26 Allowed 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -168.65 111.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.633 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.8 OUTLIER 71.7 40.08 0.81 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.03 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.654 ' HA2' ' CD2' ' A' ' 10' ' ' TYR . . . 59.56 39.75 95.43 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.504 -1.331 . . . . 0.0 111.089 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 62.54 141.11 0.01 OUTLIER Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.203 -0.499 . . . . 0.0 112.444 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.25 -30.94 92.43 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.569 2.18 . . . . 0.0 112.36 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.55 -37.21 40.77 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.916 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.419 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -97.08 -43.86 7.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.718 0.294 . . . . 0.0 110.924 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -154.73 137.3 5.6 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.033 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mp -101.75 138.57 38.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.923 0.392 . . . . 0.0 111.867 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.81 147.24 26.94 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 26' ' ' GLY . 19.8 m-85 -153.91 -173.86 4.74 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 122.017 0.913 . . . . 0.0 112.484 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -32.27 90.53 0.0 OUTLIER 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 113.089 -1.869 . . . . 0.0 111.292 178.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 54.34 22.28 22.36 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.761 -0.654 . . . . 0.0 113.282 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -155.11 -167.37 2.54 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.0 t -152.91 104.24 2.83 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.691 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.76 94.92 8.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.158 0.504 . . . . 0.0 111.009 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.53 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -96.03 166.22 11.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.836 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -85.39 159.6 55.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.971 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.56 114.07 2.22 Favored 'Trans proline' 0 CA--C 1.512 -0.589 0 C-N-CA 122.725 2.283 . . . . 0.0 112.402 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.78 26.72 3.23 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.626 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 20' ' ' ARG . 24.3 m-85 -134.64 150.84 50.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.302 . . . . 0.0 110.774 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 38' ' ' ALA . 0.9 OUTLIER -155.07 -83.11 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.062 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA3' ' HG2' ' A' ' 40' ' ' GLN . . . 48.96 -155.22 1.73 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.259 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.02 -10.54 59.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.633 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -143.71 -80.46 0.19 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.712 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 4.9 m -155.96 41.37 0.39 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.731 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.505 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -98.58 -32.28 11.52 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.505 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.32 -0.848 . . . . 0.0 111.72 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.793 0.33 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.77 123.87 47.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.245 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.58 ' O ' HD11 ' A' ' 5' ' ' ILE . 6.9 t70 -175.28 -124.79 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.691 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.85 93.43 8.51 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.58 HD11 ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -156.3 80.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.851 0.834 . . . . 0.0 109.178 -179.32 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -84.26 137.79 33.29 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.425 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.406 ' HB2' ' CG1' ' A' ' 14' ' ' VAL . 2.7 m -52.9 157.94 1.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.313 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 15' ' ' CYS . 4.8 mm-40 -84.24 129.56 34.88 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.346 178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 47.0 mtm180 -84.37 131.03 34.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.932 0.872 . . . . 0.0 110.905 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.873 ' HE1' ' HB2' ' A' ' 13' ' ' GLN . 0.9 OUTLIER -84.99 -60.66 1.98 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.833 -178.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.441 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 28.0 p30 -156.05 49.76 0.51 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.037 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.39 -45.96 1.08 Allowed Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.908 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.873 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 2.5 mp0 -105.05 -165.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -113.35 112.85 42.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.16 0.505 . . . . 0.0 111.354 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.617 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 74.7 46.15 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.388 178.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.619 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 54.32 33.53 52.92 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.631 -1.271 . . . . 0.0 111.34 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.84 145.25 0.02 OUTLIER Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.245 -0.477 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.52 -25.03 47.26 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.555 2.17 . . . . 0.0 112.024 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.8 -26.14 32.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.996 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.491 ' NE ' ' CE1' ' A' ' 34' ' ' PHE . 4.4 mmm180 -114.74 -51.42 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 110.307 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -139.94 139.77 10.16 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.597 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.1 tp -133.91 130.27 37.51 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 120.73 0.3 . . . . 0.0 110.913 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.827 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 1.7 p -104.0 157.94 16.76 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.624 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -156.06 -97.43 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.285 -0.966 . . . . 0.0 113.113 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.5 t -76.46 67.36 2.63 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.223 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.529 ' HA2' HG13 ' A' ' 5' ' ' ILE . . . 92.2 -6.97 78.7 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.97 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -155.63 163.15 40.31 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -178.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.827 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 7.8 t -103.19 100.47 10.38 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.052 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -84.54 96.19 9.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.998 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.61 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -87.58 151.99 22.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.236 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -70.26 153.62 95.09 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.487 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.15 116.9 3.59 Favored 'Trans proline' 0 CA--C 1.513 -0.555 0 C-N-CA 122.705 2.27 . . . . 0.0 112.851 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . 106.82 44.8 1.26 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.902 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.491 ' CE1' ' NE ' ' A' ' 20' ' ' ARG . 17.2 m-85 -145.42 154.74 42.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.383 . . . . 0.0 111.106 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -155.14 -83.53 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.111 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 47.63 -154.7 1.23 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.31 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.18 -9.16 59.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.617 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -145.18 -80.35 0.17 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.52 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 1.9 m -155.99 40.67 0.38 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.884 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.504 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -97.16 -32.91 11.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.504 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.742 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.765 0.317 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 43.93 -164.53 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.433 ' O ' HD11 ' A' ' 5' ' ' ILE . 24.1 t70 80.02 -118.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.266 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 p -84.13 90.67 7.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.235 0.541 . . . . 0.0 110.042 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.442 HD11 ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -155.55 178.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.03 134.8 10.86 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.149 -1.021 . . . . 0.0 112.155 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.5 m -60.73 140.52 57.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.5 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -83.06 127.05 33.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.696 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.6 OUTLIER -104.71 131.96 51.52 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.573 0.702 . . . . 0.0 111.949 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.843 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 1.3 p90 -88.37 -149.26 0.17 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.435 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.456 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 3.4 p-10 -91.31 77.46 5.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.496 ' C ' ' HG2' ' A' ' 13' ' ' GLN . . . 138.29 -28.99 2.65 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 119.963 -1.113 . . . . 0.0 114.87 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.732 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -152.23 -162.64 1.55 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.718 0.759 . . . . 0.0 110.372 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 34.4 m -106.06 108.13 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.283 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . 0.5 OUTLIER 84.36 43.69 0.02 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.969 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.843 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 59.97 30.0 69.07 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.217 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.484 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 76.03 134.74 0.51 Allowed Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.259 -0.471 . . . . 0.0 112.654 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -51.93 -33.91 53.88 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.631 2.221 . . . . 0.0 112.678 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.69 -22.57 11.92 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.857 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 40' ' ' GLN . 38.4 mtm-85 -110.13 -36.7 5.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.604 0.24 . . . . 0.0 111.304 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 30' ' ' CYS . . . -171.33 139.87 5.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.139 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -91.71 -179.52 5.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.233 0.54 . . . . 0.0 112.15 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.849 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 16.0 p -121.26 143.16 49.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 27' ' ' LYS . 5.3 m-85 -143.93 179.28 7.28 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -37.46 102.51 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 112.718 -2.037 . . . . 0.0 111.04 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.61 -44.37 2.42 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.312 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 24' ' ' PHE . 26.6 mtmm -155.04 -179.28 7.91 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.849 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -84.44 160.69 20.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.833 179.425 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 95.54 2.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.898 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.403 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 2.2 p -100.37 162.02 13.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.949 0.404 . . . . 0.0 111.102 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -64.16 157.68 68.59 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.498 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.08 112.08 1.43 Allowed 'Trans proline' 0 CA--C 1.513 -0.57 0 C-N-CA 122.531 2.154 . . . . 0.0 112.476 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.46 32.79 2.65 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.93 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -125.52 150.53 47.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.003 0.43 . . . . 0.0 111.11 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 40' ' ' GLN . 45.7 mt-10 -155.4 -152.98 0.42 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.304 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.88 -161.22 12.89 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.291 -0.956 . . . . 0.0 111.892 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.3 m -62.25 -21.48 65.21 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.628 ' HB2' ' HA ' ' A' ' 15' ' ' CYS . . . -140.84 -81.39 0.25 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.026 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.5 m -157.1 39.33 0.31 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.121 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -85.94 -31.29 22.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.934 -179.135 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.633 -178.828 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.859 0.361 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.558 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 52.3 t -177.1 -36.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.277 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.54 162.87 40.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.381 . . . . 0.0 111.346 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.407 ' O ' HG12 ' A' ' 5' ' ' ILE . 28.5 p -84.88 63.48 8.08 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.614 HG23 ' HA2' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -155.5 169.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -177.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.503 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -153.65 163.34 40.16 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.494 -0.883 . . . . 0.0 112.525 -179.038 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.548 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 8.7 m -18.85 136.61 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.649 -1.159 . . . . 0.0 114.029 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 15' ' ' CYS . 24.6 mt-10 -95.24 128.17 41.87 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.477 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 24.0 mtm105 -103.02 130.97 50.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.835 0.826 . . . . 0.0 111.456 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.624 ' CE2' ' HA2' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -92.42 -32.9 14.76 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.584 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.423 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.4 m-20 -156.14 -79.96 0.08 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.003 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.05 26.86 1.27 Allowed Glycine 0 C--N 1.331 0.306 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.566 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.492 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 37.4 mm-40 -136.0 11.73 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.466 0.174 . . . . 0.0 110.854 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.669 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 1.5 p 43.59 106.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.876 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.669 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 77.1 m 80.28 40.13 0.08 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.746 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.624 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 44.15 52.65 6.95 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.118 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.06 146.75 2.94 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.986 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.3 -35.65 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.81 2.34 . . . . 0.0 112.727 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.94 -21.17 29.71 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.892 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.459 ' CD ' ' CE1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -99.71 -31.56 11.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.95 0.405 . . . . 0.0 110.832 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . -175.45 158.43 25.71 Favored Glycine 0 N--CA 1.453 -0.189 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.716 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -104.1 -150.08 0.42 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 117.33 0.565 . . . . 0.0 111.629 -179.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.554 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 11.4 p -155.69 125.58 6.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.873 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.618 ' CZ ' ' HB3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -156.45 -102.72 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.453 177.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 8.3 t -56.08 77.31 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.148 0.499 . . . . 0.0 110.227 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.614 ' HA2' HG23 ' A' ' 5' ' ' ILE . . . 46.42 21.49 0.77 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.968 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.16 168.16 28.16 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 14.7 m -105.11 125.12 50.63 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.452 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.74 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -84.45 88.43 7.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.629 0.728 . . . . 0.0 109.481 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -92.81 160.01 15.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.906 -178.041 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.26 163.62 24.33 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.495 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.84 115.1 2.31 Favored 'Trans proline' 0 CA--C 1.512 -0.62 0 C-N-CA 122.753 2.302 . . . . 0.0 112.762 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . 116.26 36.9 1.06 Allowed Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 114.704 -1.134 . . . . 0.0 112.913 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.459 ' CE1' ' CD ' ' A' ' 20' ' ' ARG . 30.0 m-85 -148.03 156.12 42.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.739 0.304 . . . . 0.0 110.935 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -154.33 -90.28 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.23 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 47.95 -162.86 0.34 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.419 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -16.83 62.45 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.577 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -136.84 -81.96 0.37 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.079 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -156.13 42.4 0.39 Allowed 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.014 178.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.499 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -92.82 -31.24 15.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.886 -179.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.471 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.468 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.824 0.345 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 25' ' ' CYS . 42.0 t -112.83 -55.42 2.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.718 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 t0 178.72 -148.81 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.687 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.6 p -84.75 94.56 8.71 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.478 HG21 ' CA ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -155.45 67.22 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 121.89 0.852 . . . . 0.0 108.983 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.38 135.73 34.16 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.503 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 23' ' ' CYS . 22.6 m -40.47 146.42 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.033 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 44.4 mm-40 -93.67 178.74 5.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 14.0 mtt85 -133.15 131.79 40.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.131 0.967 . . . . 0.0 113.233 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.951 ' HE1' ' HB2' ' A' ' 13' ' ' GLN . 5.6 p90 -92.16 -146.19 0.22 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.301 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -91.46 68.57 5.78 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 145.37 -32.5 1.63 Allowed Glycine 0 C--N 1.338 0.69 0 C-N-CA 119.818 -1.182 . . . . 0.0 114.868 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.951 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 3.1 mm100 -149.57 -156.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.528 0.664 . . . . 0.0 110.489 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 23.0 m -104.89 115.05 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.978 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.584 ' O ' ' HB3' ' A' ' 39' ' ' CYS . 0.5 OUTLIER 64.63 53.58 1.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.3 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.644 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 51.33 31.95 28.72 Favored Glycine 0 C--N 1.318 -0.442 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.954 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.404 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 64.25 158.0 0.24 Allowed Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.498 -0.351 . . . . 0.0 112.855 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.3 -13.02 35.71 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.75 2.3 . . . . 0.0 112.902 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.74 27.58 4.26 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.792 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.487 ' C ' ' SG ' ' A' ' 39' ' ' CYS . 26.3 mtp85 -155.13 -42.45 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 30' ' ' CYS . . . 179.19 176.0 46.59 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.15 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.434 ' CD1' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -143.08 -175.04 4.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.931 0.396 . . . . 0.0 110.82 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.871 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 8.2 p -101.43 143.2 31.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.47 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.571 ' O ' ' N ' ' A' ' 26' ' ' GLY . 7.3 m-85 -126.42 -179.05 4.57 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.923 0.868 . . . . 0.0 112.977 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 2' ' ' CYS . 1.7 t -55.04 72.76 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.801 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 141.66 -55.84 0.6 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.482 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.57 -177.6 6.67 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.871 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -84.33 128.84 34.82 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.913 178.491 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -113.24 103.96 11.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.366 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.609 ' SG ' ' CB ' ' A' ' 34' ' ' PHE . 7.7 t -85.08 156.14 21.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.819 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.457 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 9.5 m-70 -65.48 157.13 79.78 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.882 0.372 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.85 116.46 3.37 Favored 'Trans proline' 0 CA--C 1.512 -0.584 0 C-N-CA 122.804 2.336 . . . . 0.0 112.696 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.12 29.08 5.01 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.756 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.609 ' CB ' ' SG ' ' A' ' 30' ' ' CYS . 5.4 m-85 -125.1 170.92 10.71 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.908 -0.172 . . . . 0.0 110.811 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.41 ' N ' ' OXT' ' A' ' 41' ' ' ALA . 6.2 mm-40 -155.44 -102.65 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.063 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.412 ' N ' ' CB ' ' A' ' 41' ' ' ALA . . . 63.51 -157.19 41.54 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.367 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.508 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 0.5 OUTLIER -94.87 -18.1 21.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.04 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.48 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -138.56 -73.62 0.4 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.433 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 53.4 t -157.35 20.21 0.29 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.938 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.71 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -77.62 -33.33 53.68 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.7 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.412 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 117.961 -1.019 . . . . 0.0 111.36 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.707 0.289 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 10.8 t -177.48 -32.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.505 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.56 -155.61 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.67 0.271 . . . . 0.0 110.807 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 48.0 p -84.08 113.93 21.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.456 ' CG2' ' CA ' ' A' ' 26' ' ' GLY . 0.4 OUTLIER -147.78 74.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-O 121.799 0.809 . . . . 0.0 111.141 -177.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 7' ' ' CYS . 6.2 p30 -93.89 53.52 1.81 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.486 -1.233 . . . . 0.0 108.55 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' ASN . 21.4 m -7.77 135.16 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 113.448 -1.706 . . . . 0.0 114.813 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -89.96 128.77 36.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.985 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 4.7 mpp_? -92.33 134.0 35.32 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.331 0.586 . . . . 0.0 111.809 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 1.134 ' CE1' ' HB2' ' A' ' 13' ' ' GLN . 9.7 p90 -85.59 -134.83 0.06 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.806 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -83.26 72.18 10.19 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.03 -18.52 45.95 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 1.134 ' HB2' ' CE1' ' A' ' 10' ' ' TYR . 2.7 mp0 -115.21 -133.51 0.34 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.889 0.844 . . . . 0.0 111.317 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.598 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.9 m -147.4 114.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 121.079 0.466 . . . . 0.0 111.739 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.568 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 66.43 44.41 2.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.379 178.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.717 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 60.29 18.08 48.42 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.769 -1.205 . . . . 0.0 111.83 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.637 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 66.2 144.98 0.06 OUTLIER Glycine 0 C--N 1.338 0.655 0 C-N-CA 121.79 -0.243 . . . . 0.0 113.076 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.68 -31.81 52.04 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.69 2.26 . . . . 0.0 112.449 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -48.29 -28.71 6.46 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.927 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.427 ' HD2' ' CE2' ' A' ' 34' ' ' PHE . 6.6 mmm-85 -118.25 -31.47 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 110.636 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.448 ' CA ' ' HA ' ' A' ' 30' ' ' CYS . . . -168.43 149.69 14.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.738 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.45 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -128.8 166.27 19.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.097 0.475 . . . . 0.0 111.208 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -84.75 134.88 34.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.105 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 27' ' ' LYS . 1.1 m-85 -130.16 -177.56 4.36 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.702 0.763 . . . . 0.0 112.111 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.467 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 0.1 OUTLIER -41.95 86.25 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.224 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 70.47 6.31 57.9 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.731 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -156.3 142.03 17.85 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -90.43 115.46 27.61 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -99.66 102.43 13.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.135 0.493 . . . . 0.0 111.726 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.448 ' HA ' ' CA ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -96.32 144.07 26.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.375 179.163 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.459 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 12.3 m-70 -53.76 149.82 15.51 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.22 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.67 117.48 4.37 Favored 'Trans proline' 0 CA--C 1.514 -0.51 0 C-N-CA 122.698 2.265 . . . . 0.0 112.834 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.421 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . 109.03 31.49 3.32 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.84 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.459 ' CE2' ' HB2' ' A' ' 31' ' ' HIS . 17.9 m-85 -136.46 146.66 46.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.921 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 18.9 pt-20 -142.44 -140.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.076 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.406 ' N ' ' HG3' ' A' ' 35' ' ' GLU . . . 102.1 -162.38 17.16 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.517 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.471 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 0.7 OUTLIER -69.36 -16.15 63.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.568 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -145.77 -79.88 0.17 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.694 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -155.9 26.56 0.37 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.027 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.712 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -69.46 -31.02 69.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.449 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.156 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -136.82 -166.29 1.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.773 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 13.0 t70 -177.19 -4.04 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.6 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -84.42 57.41 4.27 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.562 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -84.73 92.88 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.862 -177.138 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.76 37.99 0.37 Allowed 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.474 -1.693 . . . . 0.0 108.925 -177.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.463 ' CB ' HG11 ' A' ' 14' ' ' VAL . 13.6 m -35.51 147.77 0.02 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 113.811 -1.541 . . . . 0.0 112.896 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.24 121.47 33.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.928 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.601 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 17.4 mtm180 -95.73 131.36 42.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.639 0.733 . . . . 0.0 112.133 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.771 ' CD2' ' HA2' ' A' ' 16' ' ' GLY . 1.6 p90 -84.97 -33.08 22.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.495 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.71 -77.86 0.09 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.007 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -148.06 16.41 1.35 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.19 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.491 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 47.2 mm-40 -118.68 -19.04 8.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.972 0.415 . . . . 0.0 110.577 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.636 ' O ' ' CB ' ' A' ' 15' ' ' CYS . 1.6 t 70.67 92.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.662 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.636 ' CB ' ' O ' ' A' ' 14' ' ' VAL . 8.2 t 104.96 34.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.765 0.666 . . . . 0.0 112.123 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.771 ' HA2' ' CD2' ' A' ' 10' ' ' TYR . . . 56.48 41.23 88.18 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.051 -1.071 . . . . 0.0 113.109 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.35 148.95 4.03 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.188 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.67 -44.8 15.84 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.71 2.274 . . . . 0.0 112.087 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.46 -31.65 14.22 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.341 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.433 ' HG3' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -95.51 -30.44 13.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.771 0.32 . . . . 0.0 110.712 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.464 ' CA ' ' HA ' ' A' ' 30' ' ' CYS . . . 179.68 156.02 16.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.879 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -122.43 -166.16 1.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.726 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 5.3 t -145.2 145.56 31.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.622 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.614 ' O ' ' N ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -155.78 -101.21 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.573 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.542 ' HA ' ' CB ' ' A' ' 2' ' ' CYS . 0.8 OUTLIER -55.61 80.3 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 41.38 26.35 0.21 Allowed Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.616 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.61 142.3 18.83 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.726 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -87.92 111.1 21.08 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.923 178.582 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.586 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 7.3 ttp85 -97.63 100.45 11.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.916 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.464 ' HA ' ' CA ' ' A' ' 21' ' ' GLY . 1.8 p -95.87 165.04 12.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.074 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -73.37 159.15 85.53 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.498 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.17 112.66 1.61 Allowed 'Trans proline' 0 CA--C 1.513 -0.551 0 C-N-CA 122.609 2.206 . . . . 0.0 112.527 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.36 22.53 4.07 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.046 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.457 ' HA ' ' OXT' ' A' ' 41' ' ' ALA . 40.5 m-85 -125.49 148.82 48.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.659 0.266 . . . . 0.0 110.842 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 39' ' ' CYS . 1.2 mt-10 -155.54 -96.6 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' ' HB3' ' A' ' 41' ' ' ALA . . . 67.21 -144.36 44.44 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.174 -1.013 . . . . 0.0 111.883 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.42 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 40.3 t -90.46 -3.06 57.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.457 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -148.68 -79.96 0.14 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.29 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 35' ' ' GLU . 9.0 m -157.17 39.37 0.3 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.635 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.566 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 17.6 pm0 -106.11 -33.49 7.84 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.537 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.346 -0.835 . . . . 0.0 112.121 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.888 0.375 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 25' ' ' CYS . 46.0 t -145.23 -62.17 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.418 ' O ' HD12 ' A' ' 5' ' ' ILE . 14.9 p-10 -167.17 -160.24 0.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.858 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.75 86.33 7.37 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.532 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -156.34 79.35 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-O 121.981 0.896 . . . . 0.0 108.92 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 7' ' ' CYS . 6.9 p30 -84.22 72.88 10.5 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.867 -177.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.556 ' HB3' ' HB ' ' A' ' 14' ' ' VAL . 69.9 m 47.73 149.35 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.433 -1.258 . . . . 0.0 113.457 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.684 ' O ' ' N ' ' A' ' 15' ' ' CYS . 15.1 mm-40 -94.93 131.43 40.86 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.558 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.624 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 4.0 mtp85 -100.08 131.36 46.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.794 0.807 . . . . 0.0 111.347 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.666 ' CD2' ' HA2' ' A' ' 16' ' ' GLY . 1.2 p90 -91.37 -30.4 16.56 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.842 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -155.79 -85.33 0.05 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.825 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.56 -16.39 10.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.255 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.551 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -110.76 -159.96 0.7 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.624 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 28.2 m -124.4 104.09 13.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.137 0.494 . . . . 0.0 111.267 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.684 ' N ' ' O ' ' A' ' 8' ' ' GLU . 0.5 OUTLIER 86.21 48.15 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.501 179.504 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.666 ' HA2' ' CD2' ' A' ' 10' ' ' TYR . . . 53.64 30.39 42.88 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.352 -1.404 . . . . 0.0 111.726 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.21 143.81 0.82 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.602 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.0 -35.33 98.87 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.521 2.147 . . . . 0.0 112.27 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -48.17 -28.95 6.42 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.845 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.46 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.1 OUTLIER -101.48 -36.43 8.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.104 0.478 . . . . 0.0 109.778 179.165 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 30' ' ' CYS . . . 177.02 152.39 9.83 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.634 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.45 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -113.7 175.73 5.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.784 0.326 . . . . 0.0 110.721 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -98.71 156.07 17.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.295 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.601 ' O ' ' N ' ' A' ' 26' ' ' GLY . 6.2 m-85 -139.29 -175.23 4.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.875 0.845 . . . . 0.0 112.26 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 1.5 t -47.27 77.36 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 113.406 -1.725 . . . . 0.0 110.874 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 80.7 19.26 68.53 Favored Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.316 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -155.18 -164.86 1.87 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 117.388 0.594 . . . . 0.0 112.246 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -145.49 115.59 7.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.625 179.439 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.39 88.0 7.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.12 0.486 . . . . 0.0 110.913 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.96 ' SG ' ' HB2' ' A' ' 34' ' ' PHE . 18.2 t -85.03 155.47 21.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.931 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.46 ' CD2' ' O ' ' A' ' 20' ' ' ARG . 11.6 m-70 -78.46 154.5 79.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.959 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.04 112.73 1.61 Allowed 'Trans proline' 0 CA--C 1.513 -0.54 0 C-N-CA 122.481 2.121 . . . . 0.0 112.883 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.5 28.53 2.52 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.356 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.96 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 12.4 m-85 -130.86 164.04 26.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.81 0.305 . . . . 0.0 110.955 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -153.39 -91.61 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.98 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 48.6 -152.21 2.66 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.07 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.45 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 27.7 p -92.18 1.04 57.46 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.635 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -155.21 -79.31 0.09 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.092 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 43.2 t -156.55 36.95 0.32 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.682 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.577 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -92.46 -34.85 13.94 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.464 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.655 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.668 0.27 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 157.26 16.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.325 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -178.75 -138.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.903 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.9 90.01 6.91 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.527 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -155.23 72.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.243 -177.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -84.15 -179.51 7.24 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.891 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 m -78.88 140.88 38.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.567 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 15' ' ' CYS . 2.4 mt-10 -94.81 124.8 39.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -84.52 132.11 34.57 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.832 0.825 . . . . 0.0 112.863 -177.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 1.069 ' CE1' ' HB2' ' A' ' 13' ' ' GLN . 4.2 p90 -84.91 -125.51 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.574 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -83.71 51.58 2.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.89 -28.48 6.12 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 119.965 -1.112 . . . . 0.0 115.641 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 1.069 ' HB2' ' CE1' ' A' ' 10' ' ' TYR . 2.8 mp0 -101.75 -125.95 0.19 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.942 0.871 . . . . 0.0 111.439 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -150.37 110.52 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 120.998 0.428 . . . . 0.0 111.495 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.565 ' N ' ' O ' ' A' ' 8' ' ' GLU . 0.1 OUTLIER 65.87 44.13 2.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.657 179.014 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.713 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 60.58 22.72 59.68 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.315 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.545 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 69.45 144.87 0.19 Allowed Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.407 -0.397 . . . . 0.0 112.739 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -50.61 -30.26 27.85 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.701 2.268 . . . . 0.0 112.441 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.7 -26.7 54.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.435 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.93 -28.49 9.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.612 0.244 . . . . 0.0 111.109 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.515 ' HA3' ' HB3' ' A' ' 30' ' ' CYS . . . -179.86 158.34 21.91 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.843 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 29' ' ' ARG . 5.7 mp -124.56 142.26 51.48 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 111.697 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -84.73 127.76 34.27 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.53 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.529 ' O ' ' N ' ' A' ' 26' ' ' GLY . 16.2 m-85 -141.71 175.83 9.39 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -177.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -34.46 83.57 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 111.814 -2.448 . . . . 0.0 111.031 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 120.77 -57.94 0.58 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.234 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -155.79 -178.29 7.19 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 4.8 t -89.16 107.58 19.13 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.348 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 22' ' ' LEU . 5.2 tpt85 -84.81 88.57 7.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.989 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.515 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 1.0 OUTLIER -95.01 156.77 16.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -63.13 153.39 81.5 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.647 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.14 113.05 1.58 Allowed 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 122.591 2.194 . . . . 0.0 112.564 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.4 23.03 4.6 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.932 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -124.49 148.98 47.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.871 0.367 . . . . 0.0 111.089 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.422 ' HB2' ' OXT' ' A' ' 41' ' ' ALA . 4.5 mm-40 -155.4 -88.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.218 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.427 ' HA3' ' HG2' ' A' ' 40' ' ' GLN . . . 61.45 -147.89 47.39 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.044 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.427 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 1.1 m -87.22 -5.04 59.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -144.09 -82.89 0.16 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.232 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 7.3 m -157.47 42.88 0.32 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.057 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.517 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 9.9 pm0 -108.56 -33.77 6.93 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.471 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.115 -0.945 . . . . 0.0 111.983 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.782 0.325 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 33.8 m -72.52 -68.86 0.44 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.714 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.469 ' CB ' ' O ' ' A' ' 2' ' ' CYS . 0.8 OUTLIER 82.23 -141.68 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.0 p -84.4 117.15 23.44 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.541 0.686 . . . . 0.0 109.896 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.619 HG13 ' H ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -155.31 74.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.4 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -84.85 140.67 31.0 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.281 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 75.8 m -100.16 -177.98 3.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.272 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -67.82 144.89 55.13 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.322 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.479 ' HB3' ' C ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -105.12 160.69 14.86 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.501 0.667 . . . . 0.0 111.619 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.764 ' CD2' ' HA3' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -127.69 -16.67 4.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.79 179.197 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.422 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -155.66 62.43 0.6 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.302 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.78 26.4 57.58 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.479 ' C ' ' HB3' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -155.14 127.43 7.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.197 -0.501 . . . . 0.0 110.545 -178.442 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 12.9 m -51.17 118.67 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.67 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 95.3 m 64.52 49.95 2.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -176.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.764 ' HA3' ' CD2' ' A' ' 10' ' ' TYR . . . 17.87 48.29 0.01 OUTLIER Glycine 0 C--N 1.341 0.845 0 CA-C-N 114.467 -1.242 . . . . 0.0 115.047 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 15' ' ' CYS . . . 96.94 147.84 23.25 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.823 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.415 ' HA ' ' HB3' ' A' ' 22' ' ' LEU . 26.3 Cg_exo -61.66 -15.72 43.74 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.531 2.154 . . . . 0.0 113.039 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -46.59 -45.63 17.58 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.088 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -102.96 -44.1 5.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.186 0.517 . . . . 0.0 110.033 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -157.87 144.84 10.95 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.502 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -132.62 135.91 46.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.988 0.394 . . . . 0.0 111.764 -179.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.926 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 11.8 t -97.55 128.78 44.56 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.406 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.623 ' CE1' ' HB2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -156.89 -157.8 0.72 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.783 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.519 ' C ' ' O ' ' A' ' 24' ' ' PHE . 39.9 t -24.87 94.21 0.01 OUTLIER 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.105 0.478 . . . . 0.0 110.393 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.619 ' H ' HG13 ' A' ' 5' ' ' ILE . . . 102.83 -76.12 0.3 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.386 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -154.27 -160.65 1.11 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.926 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 50.5 t -92.39 112.65 24.68 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.881 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.623 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -84.74 94.15 8.61 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -93.55 156.72 16.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.07 -178.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -83.01 157.16 66.62 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.772 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -57.68 122.58 11.99 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 122.89 2.393 . . . . 0.0 113.197 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.54 49.23 2.59 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.719 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.466 ' CZ ' ' HG3' ' A' ' 20' ' ' ARG . 7.1 m-85 -139.99 150.09 44.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.965 0.412 . . . . 0.0 111.702 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 38' ' ' ALA . 1.9 mm-40 -155.33 -90.3 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.384 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.94 -145.52 43.55 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.994 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.449 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -91.36 -1.72 57.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.129 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.67 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -146.27 -83.2 0.13 Allowed 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.639 -1.618 . . . . 0.0 109.088 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 69.5 m -156.48 45.05 0.42 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.518 178.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.571 HE22 ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -97.83 -36.05 10.32 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.521 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.963 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.753 0.311 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.482 ' CB ' ' HA ' ' A' ' 25' ' ' CYS . 4.9 t 68.05 -64.58 0.28 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.236 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.99 -161.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.685 0.278 . . . . 0.0 111.089 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 5' ' ' ILE . 12.4 p -84.49 91.27 7.81 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.557 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -155.75 79.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.134 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.2 151.3 25.73 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.886 -177.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.51 ' HB3' ' CG1' ' A' ' 14' ' ' VAL . 5.2 m -50.0 135.88 19.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.043 -0.981 . . . . 0.0 113.333 -177.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -96.01 148.6 22.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.989 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.1 154.93 23.57 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 122.069 0.938 . . . . 0.0 111.248 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.83 ' CZ ' ' HA2' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -112.68 -27.63 8.1 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.421 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -156.24 -38.07 0.08 Allowed 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.16 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.74 1.27 0.05 OUTLIER Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.891 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.413 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -101.05 -17.64 16.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.346 0.573 . . . . 0.0 110.22 179.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 7' ' ' CYS . 3.5 t 84.96 98.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.514 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.768 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 1.0 OUTLIER 69.43 47.37 0.69 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.53 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.83 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 45.51 61.25 3.8 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.521 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 54.96 168.48 0.05 OUTLIER Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.953 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.489 ' CB ' HD13 ' A' ' 22' ' ' LEU . 95.6 Cg_endo -80.98 -26.82 3.32 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.663 2.242 . . . . 0.0 112.763 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.6 -25.62 6.78 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.696 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.97 -51.64 3.0 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 30' ' ' CYS . . . -165.18 144.76 9.56 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.668 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.512 ' O ' ' CA ' ' A' ' 28' ' ' CYS . 0.7 OUTLIER -96.51 -177.76 4.05 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 122.651 0.38 . . . . 0.0 111.434 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 29.3 p -126.51 116.18 20.69 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.553 ' CZ ' ' HB3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -157.6 -162.94 1.25 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.191 -1.003 . . . . 0.0 112.533 177.262 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.482 ' HA ' ' CB ' ' A' ' 2' ' ' CYS . 9.2 t -24.04 122.19 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.236 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.532 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 80.02 -73.01 2.51 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.169 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.532 ' HG2' ' C ' ' A' ' 26' ' ' GLY . 5.5 mmmm -155.84 -157.93 0.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.613 0.721 . . . . 0.0 112.39 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.1 m -85.5 124.58 32.24 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.049 178.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.553 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . 10.2 ttt-85 -84.72 84.57 7.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.932 0.396 . . . . 0.0 110.279 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.416 ' HA ' ' CA ' ' A' ' 21' ' ' GLY . 0.8 OUTLIER -96.99 141.76 29.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.169 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -61.68 158.6 40.08 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.45 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.65 114.98 2.29 Favored 'Trans proline' 0 CA--C 1.512 -0.597 0 C-N-CA 122.539 2.159 . . . . 0.0 112.755 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.1 34.71 1.76 Allowed Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.754 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -135.09 147.55 49.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.874 0.368 . . . . 0.0 111.111 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' O ' ' C ' ' A' ' 38' ' ' ALA . 2.4 mt-10 -155.08 -83.69 0.07 Allowed 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.03 -155.42 4.46 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.234 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.1 m -75.73 -12.35 60.17 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.768 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -138.53 -81.84 0.31 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.286 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.0 m -156.93 44.21 0.38 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.456 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.519 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -100.1 -33.44 10.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.305 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.519 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.777 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.419 ' CA ' ' HA2' ' A' ' 26' ' ' GLY . 6.5 pt-20 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.803 0.335 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.948 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -46.28 -25.63 0.66 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.595 0.712 . . . . 0.0 111.479 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.544 ' O ' ' O ' ' A' ' 2' ' ' CYS . 7.7 t70 -47.1 -123.36 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.761 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.9 p -84.89 92.79 8.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.457 . . . . 0.0 109.935 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.487 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -156.16 71.77 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-O 122.191 0.996 . . . . 0.0 108.719 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.57 136.57 33.73 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.27 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -58.13 159.1 6.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.38 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' CYS . 2.4 mt-10 -95.22 169.6 9.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 3.0 mtp180 -123.9 127.84 48.59 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 122.2 1.0 . . . . 0.0 112.244 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.605 ' CE2' ' HA2' ' A' ' 16' ' ' GLY . 1.2 p90 -92.15 -32.86 14.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.069 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -155.89 -74.4 0.1 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.027 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.9 24.58 0.62 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.797 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.469 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 37.9 mm-40 -135.3 14.32 3.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.627 0.251 . . . . 0.0 110.966 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 8.2 m 43.53 105.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.451 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.623 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER 80.98 36.62 0.09 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 178.274 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.605 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 49.69 48.71 35.72 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.991 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.7 150.77 0.01 OUTLIER Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.301 -0.476 . . . . 0.0 113.15 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 45.1 Cg_endo -68.57 -29.26 30.61 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.571 2.181 . . . . 0.0 112.017 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.425 ' O ' ' CD2' ' A' ' 31' ' ' HIS . . . -49.04 -38.36 24.5 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.861 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.495 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -97.11 -45.02 6.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.058 0.456 . . . . 0.0 110.195 179.33 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -156.47 142.6 8.89 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.961 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.29 132.86 15.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.866 0.365 . . . . 0.0 111.351 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.735 ' CA ' ' HA ' ' A' ' 28' ' ' CYS . 20.8 p -98.44 157.15 16.39 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.111 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -155.82 -95.47 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.586 -0.845 . . . . 0.0 112.123 179.328 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.948 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 24.0 t -93.66 73.19 4.32 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 121.37 0.605 . . . . 0.0 110.338 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.44 ' H ' HG13 ' A' ' 5' ' ' ILE . . . 133.58 -65.49 0.58 Allowed Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.854 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 6.6 mttt -156.58 -174.49 4.96 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.735 ' HA ' ' CA ' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -85.01 109.11 17.96 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.453 178.182 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -84.39 91.11 7.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.398 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.536 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -92.93 134.4 35.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.582 -179.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.425 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 1.2 m-70 -67.16 159.73 75.17 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.817 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.23 118.07 4.9 Favored 'Trans proline' 0 CA--C 1.511 -0.633 0 C-N-CA 122.696 2.264 . . . . 0.0 112.832 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.3 47.66 0.98 Allowed Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.678 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.495 ' CE2' ' HA ' ' A' ' 20' ' ' ARG . 26.4 m-85 -146.13 149.29 33.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 111.264 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 38' ' ' ALA . 22.0 mt-10 -154.4 -82.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.819 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 47.25 -156.88 0.69 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.631 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.01 -13.28 60.49 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.623 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -137.84 -82.74 0.33 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.24 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 97.3 m -156.5 44.19 0.4 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.634 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.499 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -98.38 -32.9 11.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.828 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.764 0.316 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER 62.41 120.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.007 0.432 . . . . 0.0 110.279 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -148.1 -135.28 0.07 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.307 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 p -84.12 107.08 16.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -155.63 66.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.132 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -84.35 85.73 7.35 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.833 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.5 m -44.66 173.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.732 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -69.98 132.21 45.57 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.504 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -100.58 132.25 46.07 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.58 0.705 . . . . 0.0 111.955 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 1.04 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -84.0 -31.37 25.53 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.688 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.401 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 9.0 m120 -156.21 -85.72 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.24 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.63 -18.15 11.23 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.56 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 25.3 mm100 -106.98 156.75 18.4 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 3.1 m -92.28 29.53 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 23' ' ' CYS . 66.2 m -166.0 49.25 0.08 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.705 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 1.04 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 58.37 16.97 30.3 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 118.191 -1.957 . . . . 0.0 111.404 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.531 ' HA2' ' HG3' ' A' ' 13' ' ' GLN . . . 90.07 145.44 13.13 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 121.433 -0.413 . . . . 0.0 112.453 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.423 ' CD ' ' HG3' ' A' ' 13' ' ' GLN . 15.1 Cg_endo -57.37 -41.81 68.7 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.913 2.409 . . . . 0.0 112.628 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -45.38 -36.85 6.0 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.679 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.469 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 1.1 mpp_? -106.96 -22.82 12.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.721 -0.239 . . . . 0.0 111.098 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . 177.7 148.11 7.16 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.018 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -140.19 143.62 36.17 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.194 0.521 . . . . 0.0 112.283 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 9.5 t -101.36 143.22 31.66 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.346 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -155.84 -108.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 118.753 -1.179 . . . . 0.0 113.255 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 43.6 t -72.26 68.41 0.74 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -177.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.93 -38.72 3.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.279 -0.962 . . . . 0.0 115.167 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -155.82 -165.98 2.09 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -177.172 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.7 m -83.09 -175.19 5.71 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.22 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 20.8 ttt180 -155.17 64.67 0.63 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -89.64 138.9 31.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.402 -178.488 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -80.65 162.9 58.82 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.692 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.71 117.16 3.81 Favored 'Trans proline' 0 CA--C 1.512 -0.606 0 C-N-CA 122.669 2.246 . . . . 0.0 112.738 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.18 46.98 0.97 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.75 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.469 ' CE2' ' HA ' ' A' ' 20' ' ' ARG . 24.3 m-85 -146.04 147.49 31.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.691 0.282 . . . . 0.0 111.126 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 -87.25 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.48 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.45 ' HA3' ' HG2' ' A' ' 40' ' ' GLN . . . 50.85 -154.91 3.37 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.343 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.8 t -78.3 -20.46 51.47 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.408 ' O ' ' SG ' ' A' ' 39' ' ' CYS . . . -127.86 -83.65 0.59 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.582 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 93.9 m -156.36 43.45 0.4 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.931 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.541 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 15.5 pm0 -102.92 -33.18 9.41 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.492 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.484 -0.77 . . . . 0.0 111.649 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.748 0.309 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.1 103.84 14.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.997 0.427 . . . . 0.0 110.368 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.473 ' O ' HD13 ' A' ' 5' ' ' ILE . 64.5 m-20 -158.2 -124.76 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.429 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.85 87.87 7.36 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.514 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -156.23 69.51 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-O 122.126 0.965 . . . . 0.0 108.787 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.55 153.86 23.0 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.963 -177.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.8 m -40.63 145.41 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.194 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 15' ' ' CYS . 76.0 mt-10 -87.76 179.15 6.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.671 178.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.574 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -137.95 128.25 26.17 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.093 0.949 . . . . 0.0 112.251 178.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.776 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 1.0 OUTLIER -95.12 -147.09 0.27 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.572 178.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.452 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 3.0 t-20 -91.41 71.47 6.05 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.98 -24.83 2.25 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 119.673 -1.251 . . . . 0.0 115.216 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.761 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 9.5 mt-30 -155.56 -156.33 0.64 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.941 0.871 . . . . 0.0 110.386 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 32.9 m -107.23 115.01 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.195 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.598 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 1.2 m 68.87 47.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.71 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.776 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 54.47 29.77 48.19 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.19 -1.481 . . . . 0.0 111.227 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.14 150.69 0.27 Allowed Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.405 -0.398 . . . . 0.0 112.358 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.0 -31.55 95.94 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.72 2.28 . . . . 0.0 112.672 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.28 -21.96 13.58 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.625 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -107.74 -33.49 7.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.358 . . . . 0.0 110.987 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.32 161.54 29.06 Favored Glycine 0 CA--C 1.517 0.198 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.069 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.649 ' O ' ' N ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -125.93 -175.18 3.28 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 120.672 0.273 . . . . 0.0 110.41 179.387 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.745 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 14.6 p -137.42 148.24 46.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.386 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -156.61 -169.41 2.99 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.496 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.444 ' C ' ' O ' ' A' ' 24' ' ' PHE . 4.7 t -24.71 85.94 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.314 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 120.39 -68.42 0.4 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.382 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.52 -163.69 1.5 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.745 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 3.6 t -84.34 169.5 14.58 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.679 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.649 ' N ' ' O ' ' A' ' 22' ' ' LEU . 2.0 tpp85 -145.47 94.55 2.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.944 ' SG ' ' HB2' ' A' ' 34' ' ' PHE . 30.5 t -85.61 157.12 20.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.842 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 20' ' ' ARG . 9.5 m-70 -77.88 158.21 78.15 Favored Pre-proline 0 C--O 1.231 0.124 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.348 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -64.71 113.54 2.37 Favored 'Trans proline' 0 CA--C 1.515 -0.434 0 C-N-CA 122.712 2.274 . . . . 0.0 112.665 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.91 -24.88 5.94 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.922 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.944 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.8 m-85 -85.53 164.68 17.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.719 0.295 . . . . 0.0 110.846 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -155.0 -90.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.134 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 49.23 -153.52 2.61 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.129 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.45 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 0.3 OUTLIER -88.63 -0.11 56.94 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.598 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -154.92 -78.61 0.09 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.051 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.455 ' SG ' ' CB ' ' A' ' 34' ' ' PHE . 23.2 t -156.29 35.67 0.33 Allowed 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.858 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.6 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -91.81 -35.28 14.19 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.473 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.659 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.804 0.335 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.425 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -109.28 -74.94 0.64 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.746 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.7 -170.59 0.14 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.032 0.444 . . . . 0.0 111.493 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.0 p -84.42 76.8 10.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.596 HG23 ' HA2' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -98.15 -20.21 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.387 -178.065 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.46 94.63 2.71 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.296 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.41 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 4.7 m -134.06 134.91 42.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.155 0.502 . . . . 0.0 111.145 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 15' ' ' CYS . 9.1 mm-40 -95.41 154.58 17.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.412 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 24.8 mtt180 -129.78 130.14 44.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.716 0.77 . . . . 0.0 111.209 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.847 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 1.5 p90 -96.28 -33.6 11.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.445 -1.252 . . . . 0.0 112.908 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -155.62 44.71 0.46 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.253 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.75 -13.4 56.36 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.285 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.715 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 32.4 mm-40 -84.59 -77.74 0.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.516 ' CB ' ' O ' ' A' ' 13' ' ' GLN . 3.7 p 145.72 108.29 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.553 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.629 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER 67.81 42.55 1.93 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 178.16 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.847 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 62.78 33.65 87.49 Favored Glycine 0 C--N 1.316 -0.554 0 C-N-CA 119.162 -1.495 . . . . 0.0 111.784 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.459 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 73.52 163.39 8.36 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.434 -0.412 . . . . 0.0 112.742 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.86 -42.36 2.32 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.774 2.316 . . . . 0.0 112.809 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -47.42 -27.95 4.44 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.858 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.481 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -106.11 -49.55 3.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.71 0.29 . . . . 0.0 110.925 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.19 132.91 3.47 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.342 -0.933 . . . . 0.0 113.018 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.405 ' HB2' ' CG ' ' A' ' 29' ' ' ARG . 2.6 mm? -96.21 170.98 8.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.21 0.529 . . . . 0.0 112.226 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -112.75 131.66 55.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.068 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -135.08 -173.25 3.27 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.425 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -31.74 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.464 -1.698 . . . . 0.0 111.446 179.03 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.596 ' HA2' HG23 ' A' ' 5' ' ' ILE . . . 56.56 4.87 1.0 Allowed Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.829 -0.623 . . . . 0.0 114.042 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' A' ' 24' ' ' PHE . 15.0 mttt -156.16 152.65 28.15 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 118.064 0.932 . . . . 0.0 112.995 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -84.45 175.76 9.11 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.004 178.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.405 ' CG ' ' HB2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -148.79 86.0 1.5 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.825 0.345 . . . . 0.0 111.421 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.909 ' SG ' ' HB2' ' A' ' 34' ' ' PHE . 19.2 t -85.03 154.79 21.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.368 . . . . 0.0 110.916 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 20' ' ' ARG . 2.9 m-70 -78.21 153.97 79.65 Favored Pre-proline 0 N--CA 1.455 -0.194 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.36 111.62 1.51 Allowed 'Trans proline' 0 CA--C 1.514 -0.524 0 C-N-CA 122.434 2.09 . . . . 0.0 112.743 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.08 31.67 2.01 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.349 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.909 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 6.3 m-85 -131.12 158.5 40.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -148.17 -88.22 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.036 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 47.99 -154.85 1.37 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.118 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 m -79.31 -8.24 58.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.629 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -155.18 -74.67 0.11 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.377 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.449 ' SG ' ' CB ' ' A' ' 34' ' ' PHE . 45.3 t -155.74 33.54 0.36 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.21 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.55 -29.74 13.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.725 0.297 . . . . 0.0 111.742 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.207 -0.901 . . . . 0.0 111.146 -179.852 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 42.3 t . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.844 0.354 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.71 172.76 13.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.6 p -84.63 62.93 7.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -155.84 164.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 -178.173 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.477 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -154.9 151.49 28.62 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.68 -178.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.58 ' HB3' HG12 ' A' ' 14' ' ' VAL . 58.8 m -29.2 133.25 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.278 -0.873 . . . . 0.0 113.343 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 15' ' ' CYS . 4.0 mt-10 -95.65 113.02 24.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.37 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.579 ' HG3' HG13 ' A' ' 14' ' ' VAL . 3.3 mtp180 -84.8 134.1 34.32 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.556 0.693 . . . . 0.0 110.673 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.877 ' HE1' ' HB2' ' A' ' 13' ' ' GLN . 1.2 p90 -92.65 -27.38 17.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.339 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -155.45 -86.14 0.05 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.393 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.95 -2.83 9.23 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.851 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.877 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 7.1 mp0 -106.58 -116.11 0.26 Allowed 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.58 HG12 ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -168.65 111.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.651 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.8 OUTLIER 71.7 40.08 0.81 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.03 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.681 ' HA2' ' CD2' ' A' ' 10' ' ' TYR . . . 59.56 39.75 95.43 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.504 -1.331 . . . . 0.0 111.089 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 62.54 141.11 0.01 OUTLIER Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.203 -0.499 . . . . 0.0 112.444 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.25 -30.94 92.43 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.569 2.18 . . . . 0.0 112.36 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.55 -37.21 40.77 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.916 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.433 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -97.08 -43.86 7.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.718 0.294 . . . . 0.0 110.924 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -154.73 137.3 5.6 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.033 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.408 HD23 ' CZ ' ' A' ' 24' ' ' PHE . 3.7 mp -101.75 138.57 38.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.923 0.392 . . . . 0.0 111.867 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.81 147.24 26.94 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 26' ' ' GLY . 19.8 m-85 -153.91 -173.86 4.74 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 122.017 0.913 . . . . 0.0 112.484 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -32.27 90.53 0.0 OUTLIER 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 113.089 -1.869 . . . . 0.0 111.292 178.509 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 54.34 22.28 22.36 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.761 -0.654 . . . . 0.0 113.282 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -155.11 -167.37 2.54 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.0 t -152.91 104.24 2.83 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.691 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.76 94.92 8.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.158 0.504 . . . . 0.0 111.009 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.573 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -96.03 166.22 11.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.836 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -85.39 159.6 55.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.971 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.56 114.07 2.22 Favored 'Trans proline' 0 CA--C 1.512 -0.589 0 C-N-CA 122.725 2.283 . . . . 0.0 112.402 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.78 26.72 3.23 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.626 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.433 ' CE2' ' HA ' ' A' ' 20' ' ' ARG . 24.3 m-85 -134.64 150.84 50.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.302 . . . . 0.0 110.774 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 38' ' ' ALA . 0.9 OUTLIER -155.07 -83.11 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.062 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.733 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 48.96 -155.22 1.73 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.259 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.02 -10.54 59.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.651 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -143.71 -80.46 0.19 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.712 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 4.9 m -155.96 41.37 0.39 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.731 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.517 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 6.0 pm0 -98.58 -32.28 11.52 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.733 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.32 -0.848 . . . . 0.0 111.72 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.756 0.312 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.596 ' O ' HD12 ' A' ' 5' ' ' ILE . 6.9 t70 -175.28 -124.79 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.691 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.85 93.43 8.51 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -156.3 80.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.851 0.834 . . . . 0.0 109.178 -179.32 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -84.26 137.79 33.29 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.425 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.542 ' O ' HG12 ' A' ' 14' ' ' VAL . 2.7 m -52.9 157.94 1.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.313 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 15' ' ' CYS . 4.8 mm-40 -84.24 129.56 34.88 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.346 178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.535 ' HG2' HG13 ' A' ' 14' ' ' VAL . 47.0 mtm180 -84.37 131.03 34.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.932 0.872 . . . . 0.0 110.905 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.892 ' HE1' ' HB2' ' A' ' 13' ' ' GLN . 0.9 OUTLIER -84.99 -60.66 1.98 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.833 -178.378 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.441 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 28.0 p30 -156.05 49.76 0.51 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.037 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.39 -45.96 1.08 Allowed Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.908 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.892 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 2.5 mp0 -105.05 -165.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -113.35 112.85 42.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.16 0.505 . . . . 0.0 111.354 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.635 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 74.7 46.15 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.388 178.574 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.638 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 54.32 33.53 52.92 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.631 -1.271 . . . . 0.0 111.34 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.84 145.25 0.02 OUTLIER Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.245 -0.477 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.52 -25.03 47.26 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.555 2.17 . . . . 0.0 112.024 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.8 -26.14 32.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.996 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.491 ' NE ' ' CE1' ' A' ' 34' ' ' PHE . 4.4 mmm180 -114.74 -51.42 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 110.307 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.663 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -139.94 139.77 10.16 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.597 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.1 tp -133.91 130.27 37.51 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 120.73 0.3 . . . . 0.0 110.913 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.86 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 1.7 p -104.0 157.94 16.76 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.624 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -156.06 -97.43 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.285 -0.966 . . . . 0.0 113.113 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.5 t -76.46 67.36 2.63 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.223 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.561 ' HA2' HG13 ' A' ' 5' ' ' ILE . . . 92.2 -6.97 78.7 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.97 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -155.63 163.15 40.31 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -178.879 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.86 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 7.8 t -103.19 100.47 10.38 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.052 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -84.54 96.19 9.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.998 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.663 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -87.58 151.99 22.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.236 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -70.26 153.62 95.09 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.487 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.15 116.9 3.59 Favored 'Trans proline' 0 CA--C 1.513 -0.555 0 C-N-CA 122.705 2.27 . . . . 0.0 112.851 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . 106.82 44.8 1.26 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.902 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.491 ' CE1' ' NE ' ' A' ' 20' ' ' ARG . 17.2 m-85 -145.42 154.74 42.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.383 . . . . 0.0 111.106 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -155.14 -83.53 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.111 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.666 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 47.63 -154.7 1.23 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.31 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.18 -9.16 59.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.635 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -145.18 -80.35 0.17 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.52 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 1.9 m -155.99 40.67 0.38 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.884 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.515 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 6.4 pm0 -97.16 -32.91 11.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.666 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.742 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 3' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.378 0 CA-C-O 120.471 0.177 . . . . 0.0 110.864 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 2' ' ' CYS . 24.1 t70 80.02 -118.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.266 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 p -84.13 90.67 7.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.235 0.541 . . . . 0.0 110.042 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.569 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -155.55 178.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -157.03 134.8 10.86 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.149 -1.021 . . . . 0.0 112.155 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.5 m -60.73 140.52 57.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.5 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -83.06 127.05 33.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.696 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.95 ' HG2' HG12 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -104.71 131.96 51.52 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.573 0.702 . . . . 0.0 111.949 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.854 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 1.3 p90 -88.37 -149.26 0.17 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.435 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.456 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 3.4 p-10 -91.31 77.46 5.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.502 ' C ' ' HG2' ' A' ' 13' ' ' GLN . . . 138.29 -28.99 2.65 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 119.963 -1.113 . . . . 0.0 114.87 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.71 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 4.0 mm-40 -152.23 -162.64 1.55 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.718 0.759 . . . . 0.0 110.372 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.95 HG12 ' HG2' ' A' ' 9' ' ' ARG . 34.4 m -106.06 108.13 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.283 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.674 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER 84.36 43.69 0.02 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.969 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.854 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 59.97 30.0 69.07 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.217 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.484 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 76.03 134.74 0.51 Allowed Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.259 -0.471 . . . . 0.0 112.654 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.496 ' HB3' HD11 ' A' ' 22' ' ' LEU . 63.2 Cg_exo -51.93 -33.91 53.88 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.631 2.221 . . . . 0.0 112.678 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.69 -22.57 11.92 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.857 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' A' ' 40' ' ' GLN . 38.4 mtm-85 -110.13 -36.7 5.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.604 0.24 . . . . 0.0 111.304 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 30' ' ' CYS . . . -171.33 139.87 5.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.139 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.496 HD11 ' HB3' ' A' ' 18' ' ' PRO . 1.6 mm? -91.71 -179.52 5.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.233 0.54 . . . . 0.0 112.15 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.879 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 16.0 p -121.26 143.16 49.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 27' ' ' LYS . 5.3 m-85 -143.93 179.28 7.28 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -37.46 102.51 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 112.718 -2.037 . . . . 0.0 111.04 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.423 ' H ' HG13 ' A' ' 5' ' ' ILE . . . 93.61 -44.37 2.42 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.312 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 24' ' ' PHE . 26.6 mtmm -155.04 -179.28 7.91 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.879 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -84.44 160.69 20.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.833 179.425 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 95.54 2.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.898 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.444 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 2.2 p -100.37 162.02 13.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.949 0.404 . . . . 0.0 111.102 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -64.16 157.68 68.59 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.498 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.08 112.08 1.43 Allowed 'Trans proline' 0 CA--C 1.513 -0.57 0 C-N-CA 122.531 2.154 . . . . 0.0 112.476 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.46 32.79 2.65 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.93 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -125.52 150.53 47.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.003 0.43 . . . . 0.0 111.11 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 40' ' ' GLN . 45.7 mt-10 -155.4 -152.98 0.42 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.304 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.88 -161.22 12.89 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.291 -0.956 . . . . 0.0 111.892 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.3 m -62.25 -21.48 65.21 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.674 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -140.84 -81.39 0.25 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.026 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.5 m -157.1 39.33 0.31 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.121 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 35' ' ' GLU . 1.4 pt20 -85.94 -31.29 22.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.934 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.401 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.633 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.587 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 52.3 t . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.554 0.216 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.54 162.87 40.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.381 . . . . 0.0 111.346 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.436 ' O ' HG12 ' A' ' 5' ' ' ILE . 28.5 p -84.88 63.48 8.08 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.682 HG22 ' HA2' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -155.5 169.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -177.575 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.503 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -153.65 163.34 40.16 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.494 -0.883 . . . . 0.0 112.525 -179.038 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.567 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 8.7 m -18.85 136.61 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.649 -1.159 . . . . 0.0 114.029 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 15' ' ' CYS . 24.6 mt-10 -95.24 128.17 41.87 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.477 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 24.0 mtm105 -103.02 130.97 50.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.835 0.826 . . . . 0.0 111.456 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.651 ' CE2' ' HA2' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -92.42 -32.9 14.76 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.584 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.423 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.4 m-20 -156.14 -79.96 0.08 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.003 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.05 26.86 1.27 Allowed Glycine 0 C--N 1.331 0.306 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.566 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.485 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 37.4 mm-40 -136.0 11.73 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.466 0.174 . . . . 0.0 110.854 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 1.5 p 43.59 106.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.876 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 77.1 m 80.28 40.13 0.08 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.746 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.651 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 44.15 52.65 6.95 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.118 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.06 146.75 2.94 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.986 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 84.3 Cg_endo -78.3 -35.65 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.81 2.34 . . . . 0.0 112.727 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.94 -21.17 29.71 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.892 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.459 ' CD ' ' CE1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -99.71 -31.56 11.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.95 0.405 . . . . 0.0 110.832 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 18' ' ' PRO . . . -175.45 158.43 25.71 Favored Glycine 0 N--CA 1.453 -0.189 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.716 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -104.1 -150.08 0.42 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 117.33 0.565 . . . . 0.0 111.629 -179.636 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.6 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 11.4 p -155.69 125.58 6.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.873 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.623 ' CZ ' ' HB3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -156.45 -102.72 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.453 177.522 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.587 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 8.3 t -56.08 77.31 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.148 0.499 . . . . 0.0 110.227 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.682 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 46.42 21.49 0.77 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.968 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.16 168.16 28.16 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 14.7 m -105.11 125.12 50.63 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.452 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.737 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -84.45 88.43 7.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.629 0.728 . . . . 0.0 109.481 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -92.81 160.01 15.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.906 -178.041 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.26 163.62 24.33 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.495 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.84 115.1 2.31 Favored 'Trans proline' 0 CA--C 1.512 -0.62 0 C-N-CA 122.753 2.302 . . . . 0.0 112.762 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . 116.26 36.9 1.06 Allowed Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 114.704 -1.134 . . . . 0.0 112.913 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.459 ' CE1' ' CD ' ' A' ' 20' ' ' ARG . 30.0 m-85 -148.03 156.12 42.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.739 0.304 . . . . 0.0 110.935 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -154.33 -90.28 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.23 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.62 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 47.95 -162.86 0.34 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.419 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -16.83 62.45 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.594 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -136.84 -81.96 0.37 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.079 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -156.13 42.4 0.39 Allowed 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.014 178.506 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.48 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 5.7 pm0 -92.82 -31.24 15.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.886 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.62 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.468 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 25' ' ' CYS . 42.0 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.818 0.342 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.644 ' C ' HD13 ' A' ' 5' ' ' ILE . 1.7 t0 178.72 -148.81 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.687 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.6 p -84.75 94.56 8.71 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.644 HD13 ' C ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -155.45 67.22 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 121.89 0.852 . . . . 0.0 108.983 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.38 135.73 34.16 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.503 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.534 ' HA ' ' HB3' ' A' ' 23' ' ' CYS . 22.6 m -40.47 146.42 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.033 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 44.4 mm-40 -93.67 178.74 5.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.867 ' HG2' HG12 ' A' ' 14' ' ' VAL . 14.0 mtt85 -133.15 131.79 40.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.131 0.967 . . . . 0.0 113.233 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.931 ' HE1' ' HB2' ' A' ' 13' ' ' GLN . 5.6 p90 -92.16 -146.19 0.22 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.301 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -91.46 68.57 5.78 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 145.37 -32.5 1.63 Allowed Glycine 0 C--N 1.338 0.69 0 C-N-CA 119.818 -1.182 . . . . 0.0 114.868 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.931 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 3.1 mm100 -149.57 -156.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.528 0.664 . . . . 0.0 110.489 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.867 HG12 ' HG2' ' A' ' 9' ' ' ARG . 23.0 m -104.89 115.05 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.978 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.674 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER 64.63 53.58 1.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.3 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.655 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 51.33 31.95 28.72 Favored Glycine 0 C--N 1.318 -0.442 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.954 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.404 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 64.25 158.0 0.24 Allowed Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.498 -0.351 . . . . 0.0 112.855 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.3 -13.02 35.71 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.75 2.3 . . . . 0.0 112.902 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.74 27.58 4.26 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.792 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.487 ' C ' ' SG ' ' A' ' 39' ' ' CYS . 26.3 mtp85 -155.13 -42.45 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 30' ' ' CYS . . . 179.19 176.0 46.59 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.15 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.571 HD12 ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -143.08 -175.04 4.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.931 0.396 . . . . 0.0 110.82 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.912 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 8.2 p -101.43 143.2 31.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.47 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.571 ' CE1' HD12 ' A' ' 22' ' ' LEU . 7.3 m-85 -126.42 -179.05 4.57 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.923 0.868 . . . . 0.0 112.977 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 2' ' ' CYS . 1.7 t -55.04 72.76 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.801 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 141.66 -55.84 0.6 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.482 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.57 -177.6 6.67 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.912 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -84.33 128.84 34.82 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.913 178.491 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -113.24 103.96 11.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.366 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.609 ' SG ' ' CB ' ' A' ' 34' ' ' PHE . 7.7 t -85.08 156.14 21.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.819 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.459 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 26.6 m170 -65.48 157.13 79.78 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.882 0.372 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.85 116.46 3.37 Favored 'Trans proline' 0 CA--C 1.512 -0.584 0 C-N-CA 122.804 2.336 . . . . 0.0 112.696 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.12 29.08 5.01 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.756 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.609 ' CB ' ' SG ' ' A' ' 30' ' ' CYS . 5.4 m-85 -125.1 170.92 10.71 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.908 -0.172 . . . . 0.0 110.811 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.41 ' N ' ' OXT' ' A' ' 41' ' ' ALA . 6.2 mm-40 -155.44 -102.65 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.063 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.784 ' N ' ' HB3' ' A' ' 41' ' ' ALA . . . 63.51 -157.19 41.54 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.367 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.87 -18.1 21.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.674 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -138.56 -73.62 0.4 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.433 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.599 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 53.4 t -157.35 20.21 0.29 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.938 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.586 ' OE1' ' HB2' ' A' ' 10' ' ' TYR . 1.2 pt20 -77.62 -33.33 53.68 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.784 ' HB3' ' N ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 117.961 -1.019 . . . . 0.0 111.36 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 10.8 t . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 120.587 0.232 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.56 -155.61 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.67 0.271 . . . . 0.0 110.807 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 48.0 p -84.08 113.93 21.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.782 HG23 ' HA2' ' A' ' 26' ' ' GLY . 0.4 OUTLIER -147.78 74.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-O 121.799 0.809 . . . . 0.0 111.141 -177.364 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 7' ' ' CYS . 6.2 p30 -93.89 53.52 1.81 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.486 -1.233 . . . . 0.0 108.55 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' ASN . 21.4 m -7.77 135.16 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 113.448 -1.706 . . . . 0.0 114.813 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -89.96 128.77 36.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.985 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.636 ' CG ' HG12 ' A' ' 14' ' ' VAL . 4.7 mpp_? -92.33 134.0 35.32 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.331 0.586 . . . . 0.0 111.809 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 1.149 ' CE1' ' HB2' ' A' ' 13' ' ' GLN . 9.7 p90 -85.59 -134.83 0.06 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.806 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -83.26 72.18 10.19 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.03 -18.52 45.95 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 1.149 ' HB2' ' CE1' ' A' ' 10' ' ' TYR . 2.7 mp0 -115.21 -133.51 0.34 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.889 0.844 . . . . 0.0 111.317 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.636 HG12 ' CG ' ' A' ' 9' ' ' ARG . 2.9 m -147.4 114.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 121.079 0.466 . . . . 0.0 111.739 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.664 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 66.43 44.41 2.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.379 178.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.719 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 60.29 18.08 48.42 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.769 -1.205 . . . . 0.0 111.83 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.637 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 66.2 144.98 0.06 OUTLIER Glycine 0 C--N 1.338 0.655 0 C-N-CA 121.79 -0.243 . . . . 0.0 113.076 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.68 -31.81 52.04 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.69 2.26 . . . . 0.0 112.449 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -48.29 -28.71 6.46 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.927 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HD2' ' CE2' ' A' ' 34' ' ' PHE . 6.6 mmm-85 -118.25 -31.47 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 110.636 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.468 ' CA ' ' HA ' ' A' ' 30' ' ' CYS . . . -168.43 149.69 14.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.738 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.777 HD11 ' CE2' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -128.8 166.27 19.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.097 0.475 . . . . 0.0 111.208 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -84.75 134.88 34.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.105 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.777 ' CE2' HD11 ' A' ' 22' ' ' LEU . 1.1 m-85 -130.16 -177.56 4.36 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.702 0.763 . . . . 0.0 112.111 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.523 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 0.1 OUTLIER -41.95 86.25 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.224 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.782 ' HA2' HG23 ' A' ' 5' ' ' ILE . . . 70.47 6.31 57.9 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.731 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -156.3 142.03 17.85 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -90.43 115.46 27.61 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.685 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -99.66 102.43 13.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.135 0.493 . . . . 0.0 111.726 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.468 ' HA ' ' CA ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -96.32 144.07 26.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.375 179.163 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.469 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 12.3 m-70 -53.76 149.82 15.51 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.22 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 23.9 Cg_exo -62.67 117.48 4.37 Favored 'Trans proline' 0 CA--C 1.514 -0.51 0 C-N-CA 122.698 2.265 . . . . 0.0 112.834 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.421 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . 109.03 31.49 3.32 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.84 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 31' ' ' HIS . 17.9 m-85 -136.46 146.66 46.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.921 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.639 ' CG ' ' HB3' ' A' ' 41' ' ' ALA . 18.9 pt-20 -142.44 -140.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.076 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 35' ' ' GLU . . . 102.1 -162.38 17.16 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.517 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.36 -16.15 63.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.664 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -145.77 -79.88 0.17 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.694 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -155.9 26.56 0.37 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.027 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.579 ' OE1' ' HB2' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -69.46 -31.02 69.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.639 ' HB3' ' CG ' ' A' ' 35' ' ' GLU . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.156 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.591 ' CB ' ' HA ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.301 0.096 . . . . 0.0 110.773 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 13.0 t70 -177.19 -4.04 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.6 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -84.42 57.41 4.27 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.371 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.577 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -84.73 92.88 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.862 -177.138 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.76 37.99 0.37 Allowed 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.474 -1.693 . . . . 0.0 108.925 -177.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.439 ' HB2' ' CG1' ' A' ' 14' ' ' VAL . 13.6 m -35.51 147.77 0.02 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 113.811 -1.541 . . . . 0.0 112.896 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.24 121.47 33.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.928 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.765 ' HG3' HG13 ' A' ' 14' ' ' VAL . 17.4 mtm180 -95.73 131.36 42.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.639 0.733 . . . . 0.0 112.133 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.793 ' CD2' ' HA2' ' A' ' 16' ' ' GLY . 1.6 p90 -84.97 -33.08 22.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.495 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.71 -77.86 0.09 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.007 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -148.06 16.41 1.35 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.19 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.563 ' C ' HG23 ' A' ' 14' ' ' VAL . 11.7 mm100 -118.68 -19.04 8.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.972 0.415 . . . . 0.0 110.577 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.765 HG13 ' HG3' ' A' ' 9' ' ' ARG . 1.6 t 70.67 92.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.662 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.636 ' CB ' ' O ' ' A' ' 14' ' ' VAL . 8.2 t 104.96 34.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.765 0.666 . . . . 0.0 112.123 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.793 ' HA2' ' CD2' ' A' ' 10' ' ' TYR . . . 56.48 41.23 88.18 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.051 -1.071 . . . . 0.0 113.109 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.35 148.95 4.03 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.188 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 25.3 Cg_exo -62.67 -44.8 15.84 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.71 2.274 . . . . 0.0 112.087 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.46 -31.65 14.22 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.341 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.449 ' HG3' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -95.51 -30.44 13.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.771 0.32 . . . . 0.0 110.712 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.477 ' CA ' ' HA ' ' A' ' 30' ' ' CYS . . . 179.68 156.02 16.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.879 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.643 HD12 ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -122.43 -166.16 1.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 5.3 t -145.2 145.56 31.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.622 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.643 ' CE2' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -155.78 -101.21 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.573 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.591 ' HA ' ' CB ' ' A' ' 2' ' ' CYS . 0.8 OUTLIER -55.61 80.3 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.611 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 41.38 26.35 0.21 Allowed Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.616 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.61 142.3 18.83 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -87.92 111.1 21.08 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.923 178.582 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.609 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 7.3 ttp85 -97.63 100.45 11.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.916 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.477 ' HA ' ' CA ' ' A' ' 21' ' ' GLY . 1.8 p -95.87 165.04 12.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.074 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -73.37 159.15 85.53 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.498 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.17 112.66 1.61 Allowed 'Trans proline' 0 CA--C 1.513 -0.551 0 C-N-CA 122.609 2.206 . . . . 0.0 112.527 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.36 22.53 4.07 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.046 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.473 ' HA ' ' OXT' ' A' ' 41' ' ' ALA . 40.5 m-85 -125.49 148.82 48.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.659 0.266 . . . . 0.0 110.842 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 39' ' ' CYS . 1.2 mt-10 -155.54 -96.6 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.664 ' CA ' ' HB3' ' A' ' 41' ' ' ALA . . . 67.21 -144.36 44.44 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.174 -1.013 . . . . 0.0 111.883 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.462 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 40.3 t -90.46 -3.06 57.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.578 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -148.68 -79.96 0.14 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.29 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 35' ' ' GLU . 9.0 m -157.17 39.37 0.3 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.635 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.593 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 17.6 pm0 -106.11 -33.49 7.84 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.664 ' HB3' ' CA ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.346 -0.835 . . . . 0.0 112.121 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 25' ' ' CYS . 46.0 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.737 0.303 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.452 ' OD1' HD12 ' A' ' 5' ' ' ILE . 14.9 p-10 -167.17 -160.24 0.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.858 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.75 86.33 7.37 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.532 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -156.34 79.35 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-O 121.981 0.896 . . . . 0.0 108.92 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 7' ' ' CYS . 6.9 p30 -84.22 72.88 10.5 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.867 -177.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.576 ' HB3' ' HB ' ' A' ' 14' ' ' VAL . 69.9 m 47.73 149.35 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.433 -1.258 . . . . 0.0 113.457 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.684 ' O ' ' N ' ' A' ' 15' ' ' CYS . 15.1 mm-40 -94.93 131.43 40.86 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.558 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.743 ' CG ' HG12 ' A' ' 14' ' ' VAL . 4.0 mtp85 -100.08 131.36 46.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.794 0.807 . . . . 0.0 111.347 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.7 ' CD2' ' HA2' ' A' ' 16' ' ' GLY . 1.2 p90 -91.37 -30.4 16.56 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.842 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -155.79 -85.33 0.05 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.825 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.56 -16.39 10.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.255 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.541 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -110.76 -159.96 0.7 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.743 HG12 ' CG ' ' A' ' 9' ' ' ARG . 28.2 m -124.4 104.09 13.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.137 0.494 . . . . 0.0 111.267 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.686 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER 86.21 48.15 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.501 179.504 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.7 ' HA2' ' CD2' ' A' ' 10' ' ' TYR . . . 53.64 30.39 42.88 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.352 -1.404 . . . . 0.0 111.726 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.21 143.81 0.82 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.602 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.0 -35.33 98.87 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.521 2.147 . . . . 0.0 112.27 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -48.17 -28.95 6.42 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.845 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.452 ' O ' ' CG ' ' A' ' 31' ' ' HIS . 0.1 OUTLIER -101.48 -36.43 8.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.104 0.478 . . . . 0.0 109.778 179.165 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 30' ' ' CYS . . . 177.02 152.39 9.83 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.634 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.45 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -113.7 175.73 5.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.784 0.326 . . . . 0.0 110.721 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.69 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -98.71 156.07 17.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.295 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.601 ' O ' ' N ' ' A' ' 26' ' ' GLY . 6.2 m-85 -139.29 -175.23 4.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.875 0.845 . . . . 0.0 112.26 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 1.5 t -47.27 77.36 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 113.406 -1.725 . . . . 0.0 110.874 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 80.7 19.26 68.53 Favored Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.316 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -155.18 -164.86 1.87 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 117.388 0.594 . . . . 0.0 112.246 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.69 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -145.49 115.59 7.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.625 179.439 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.39 88.0 7.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.12 0.486 . . . . 0.0 110.913 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.988 ' SG ' ' HB2' ' A' ' 34' ' ' PHE . 18.2 t -85.03 155.47 21.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.931 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.452 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 18.8 m170 -78.46 154.5 79.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.959 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.04 112.73 1.61 Allowed 'Trans proline' 0 CA--C 1.513 -0.54 0 C-N-CA 122.481 2.121 . . . . 0.0 112.883 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.5 28.53 2.52 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.356 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.988 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 12.4 m-85 -130.86 164.04 26.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.81 0.305 . . . . 0.0 110.955 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -153.39 -91.61 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.98 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.707 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 48.6 -152.21 2.66 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.07 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.7 p -92.18 1.04 57.46 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.686 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -155.21 -79.31 0.09 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.092 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 43.2 t -156.55 36.95 0.32 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.682 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.476 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -92.46 -34.85 13.94 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.707 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.655 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.748 0.309 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -178.75 -138.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.903 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.9 90.01 6.91 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.527 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -155.23 72.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.243 -177.225 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -84.15 -179.51 7.24 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.891 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.58 ' HB2' HG12 ' A' ' 14' ' ' VAL . 1.5 m -78.88 140.88 38.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.567 -177.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 15' ' ' CYS . 2.4 mt-10 -94.81 124.8 39.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.613 ' HG3' HG13 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -84.52 132.11 34.57 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.832 0.825 . . . . 0.0 112.863 -177.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 1.083 ' CE1' ' HB2' ' A' ' 13' ' ' GLN . 4.2 p90 -84.91 -125.51 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.574 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -83.71 51.58 2.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.89 -28.48 6.12 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 119.965 -1.112 . . . . 0.0 115.641 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 1.083 ' HB2' ' CE1' ' A' ' 10' ' ' TYR . 2.8 mp0 -101.75 -125.95 0.19 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.942 0.871 . . . . 0.0 111.439 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.613 HG13 ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -150.37 110.52 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 120.998 0.428 . . . . 0.0 111.495 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.681 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 65.87 44.13 2.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.657 179.014 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.718 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 60.58 22.72 59.68 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.315 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.545 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 69.45 144.87 0.19 Allowed Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.407 -0.397 . . . . 0.0 112.739 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -50.61 -30.26 27.85 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.701 2.268 . . . . 0.0 112.441 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.7 -26.7 54.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.435 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.93 -28.49 9.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.612 0.244 . . . . 0.0 111.109 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.553 ' HA3' ' HB3' ' A' ' 30' ' ' CYS . . . -179.86 158.34 21.91 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.843 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 29' ' ' ARG . 5.7 mp -124.56 142.26 51.48 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 111.697 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.829 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -84.73 127.76 34.27 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.53 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.529 ' O ' ' N ' ' A' ' 26' ' ' GLY . 16.2 m-85 -141.71 175.83 9.39 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -177.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -34.46 83.57 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 111.814 -2.448 . . . . 0.0 111.031 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 120.77 -57.94 0.58 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.234 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -155.79 -178.29 7.19 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.829 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 4.8 t -89.16 107.58 19.13 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.348 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 22' ' ' LEU . 5.2 tpt85 -84.81 88.57 7.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.989 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.553 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 1.0 OUTLIER -95.01 156.77 16.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -63.13 153.39 81.5 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.647 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.14 113.05 1.58 Allowed 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 122.591 2.194 . . . . 0.0 112.564 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.4 23.03 4.6 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.932 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -124.49 148.98 47.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.871 0.367 . . . . 0.0 111.089 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.44 ' HB2' ' OXT' ' A' ' 41' ' ' ALA . 4.5 mm-40 -155.4 -88.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.218 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.599 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 61.45 -147.89 47.39 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.044 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.466 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 1.1 m -87.22 -5.04 59.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.681 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -144.09 -82.89 0.16 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.232 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 7.3 m -157.47 42.88 0.32 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.057 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.536 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 9.9 pm0 -108.56 -33.77 6.93 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.599 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.115 -0.945 . . . . 0.0 111.983 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 33.8 m . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.438 0.161 . . . . 0.0 110.714 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.483 ' O ' HD12 ' A' ' 5' ' ' ILE . 0.8 OUTLIER 82.23 -141.68 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.0 p -84.4 117.15 23.44 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.541 0.686 . . . . 0.0 109.896 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.71 HG13 ' H ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -155.31 74.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.4 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -84.85 140.67 31.0 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.281 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.613 ' O ' HG12 ' A' ' 14' ' ' VAL . 75.8 m -100.16 -177.98 3.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.272 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 15' ' ' CYS . 3.5 mp0 -67.82 144.89 55.13 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.322 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.495 ' HB3' ' C ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -105.12 160.69 14.86 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.501 0.667 . . . . 0.0 111.619 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.783 ' CD2' ' HA3' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -127.69 -16.67 4.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.79 179.197 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -155.66 62.43 0.6 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.302 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.78 26.4 57.58 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.495 ' C ' ' HB3' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -155.14 127.43 7.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.197 -0.501 . . . . 0.0 110.545 -178.442 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.862 HG21 ' HB3' ' A' ' 23' ' ' CYS . 12.9 m -51.17 118.67 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.657 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 95.3 m 64.52 49.95 2.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -176.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.783 ' HA3' ' CD2' ' A' ' 10' ' ' TYR . . . 17.87 48.29 0.01 OUTLIER Glycine 0 C--N 1.341 0.845 0 CA-C-N 114.467 -1.242 . . . . 0.0 115.047 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 15' ' ' CYS . . . 96.94 147.84 23.25 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.823 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.66 -15.72 43.74 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.531 2.154 . . . . 0.0 113.039 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -46.59 -45.63 17.58 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.088 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.471 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -102.96 -44.1 5.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.186 0.517 . . . . 0.0 110.033 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -157.87 144.84 10.95 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.502 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -132.62 135.91 46.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.988 0.394 . . . . 0.0 111.764 -179.17 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.967 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 11.8 t -97.55 128.78 44.56 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.406 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.636 ' CE1' ' HB2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -156.89 -157.8 0.72 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.783 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.519 ' C ' ' O ' ' A' ' 24' ' ' PHE . 39.9 t -24.87 94.21 0.01 OUTLIER 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.105 0.478 . . . . 0.0 110.393 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.71 ' H ' HG13 ' A' ' 5' ' ' ILE . . . 102.83 -76.12 0.3 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.386 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -154.27 -160.65 1.11 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.967 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 50.5 t -92.39 112.65 24.68 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.881 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.636 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -84.74 94.15 8.61 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.17 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -93.55 156.72 16.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.07 -178.413 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -83.01 157.16 66.62 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.772 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -57.68 122.58 11.99 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 122.89 2.393 . . . . 0.0 113.197 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.54 49.23 2.59 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.719 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.471 ' CZ ' ' HG3' ' A' ' 20' ' ' ARG . 7.1 m-85 -139.99 150.09 44.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.965 0.412 . . . . 0.0 111.702 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 38' ' ' ALA . 1.9 mm-40 -155.33 -90.3 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.384 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.681 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 58.94 -145.52 43.55 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.994 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.36 -1.72 57.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.657 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -146.27 -83.2 0.13 Allowed 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.639 -1.618 . . . . 0.0 109.088 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 69.5 m -156.48 45.05 0.42 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.518 178.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.567 ' HB3' ' CD2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -97.83 -36.05 10.32 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.681 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.963 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.489 ' CB ' ' HA ' ' A' ' 25' ' ' CYS . 4.9 t . . . . . 0 CA--C 1.53 0.19 0 CA-C-O 120.551 0.215 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.99 -161.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.685 0.278 . . . . 0.0 111.089 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.4 p -84.49 91.27 7.81 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.602 HG21 ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -155.75 79.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.134 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -83.2 151.3 25.73 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.886 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.538 ' HB3' ' CG1' ' A' ' 14' ' ' VAL . 5.2 m -50.0 135.88 19.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.043 -0.981 . . . . 0.0 113.333 -177.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -96.01 148.6 22.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.989 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.405 ' HA ' ' H ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -111.1 154.93 23.57 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 122.069 0.938 . . . . 0.0 111.248 179.014 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.851 ' CZ ' ' HA2' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -112.68 -27.63 8.1 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.421 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -156.24 -38.07 0.08 Allowed 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.16 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.74 1.27 0.05 OUTLIER Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.891 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.569 ' C ' HG23 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -101.05 -17.64 16.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.346 0.573 . . . . 0.0 110.22 179.322 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.569 HG23 ' C ' ' A' ' 13' ' ' GLN . 3.5 t 84.96 98.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.514 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.784 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 1.0 OUTLIER 69.43 47.37 0.69 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.53 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.851 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 45.51 61.25 3.8 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.521 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 54.96 168.48 0.05 OUTLIER Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.953 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.493 ' CB ' HD11 ' A' ' 22' ' ' LEU . 95.6 Cg_endo -80.98 -26.82 3.32 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.663 2.242 . . . . 0.0 112.763 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.6 -25.62 6.78 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.696 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -104.97 -51.64 3.0 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 30' ' ' CYS . . . -165.18 144.76 9.56 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.668 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.512 ' O ' ' CA ' ' A' ' 28' ' ' CYS . 0.7 OUTLIER -96.51 -177.76 4.05 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 122.651 0.38 . . . . 0.0 111.434 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 29.3 p -126.51 116.18 20.69 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -157.6 -162.94 1.25 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.191 -1.003 . . . . 0.0 112.533 177.262 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.489 ' HA ' ' CB ' ' A' ' 2' ' ' CYS . 9.2 t -24.04 122.19 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.236 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.602 ' O ' HG21 ' A' ' 5' ' ' ILE . . . 80.02 -73.01 2.51 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.169 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.535 ' HG2' ' C ' ' A' ' 26' ' ' GLY . 5.5 mmmm -155.84 -157.93 0.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.613 0.721 . . . . 0.0 112.39 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.1 m -85.5 124.58 32.24 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.049 178.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . 10.2 ttt-85 -84.72 84.57 7.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.932 0.396 . . . . 0.0 110.279 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.436 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 0.8 OUTLIER -96.99 141.76 29.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.169 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -61.68 158.6 40.08 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.45 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.65 114.98 2.29 Favored 'Trans proline' 0 CA--C 1.512 -0.597 0 C-N-CA 122.539 2.159 . . . . 0.0 112.755 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.1 34.71 1.76 Allowed Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.754 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -135.09 147.55 49.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.874 0.368 . . . . 0.0 111.111 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.488 ' O ' ' C ' ' A' ' 38' ' ' ALA . 2.4 mt-10 -155.08 -83.69 0.07 Allowed 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.677 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 52.03 -155.42 4.46 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.234 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.1 m -75.73 -12.35 60.17 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.784 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -138.53 -81.84 0.31 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.286 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.0 m -156.93 44.21 0.38 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.456 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.535 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 5.6 pm0 -100.1 -33.44 10.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.677 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.777 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.977 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 121.595 0.712 . . . . 0.0 111.479 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.544 ' O ' ' O ' ' A' ' 2' ' ' CYS . 7.7 t70 -47.1 -123.36 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.761 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.405 ' C ' HG23 ' A' ' 5' ' ' ILE . 13.9 p -84.89 92.79 8.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.457 . . . . 0.0 109.935 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.553 HG13 ' H ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -156.16 71.77 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-O 122.191 0.996 . . . . 0.0 108.719 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.57 136.57 33.73 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.27 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -58.13 159.1 6.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.38 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' CYS . 2.4 mt-10 -95.22 169.6 9.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.69 ' CG ' HG12 ' A' ' 14' ' ' VAL . 3.0 mtp180 -123.9 127.84 48.59 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 122.2 1.0 . . . . 0.0 112.244 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.631 ' CE2' ' HA2' ' A' ' 16' ' ' GLY . 1.2 p90 -92.15 -32.86 14.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.069 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -155.89 -74.4 0.1 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.027 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.9 24.58 0.62 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.797 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.47 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 9.0 mm100 -135.3 14.32 3.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.627 0.251 . . . . 0.0 110.966 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.69 HG12 ' CG ' ' A' ' 9' ' ' ARG . 8.2 m 43.53 105.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.451 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.637 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER 80.98 36.62 0.09 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 178.274 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.631 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 49.69 48.71 35.72 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.991 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.7 150.77 0.01 OUTLIER Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.301 -0.476 . . . . 0.0 113.15 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 45.1 Cg_endo -68.57 -29.26 30.61 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.571 2.181 . . . . 0.0 112.017 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.425 ' O ' ' CD2' ' A' ' 31' ' ' HIS . . . -49.04 -38.36 24.5 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.861 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.514 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -97.11 -45.02 6.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.058 0.456 . . . . 0.0 110.195 179.33 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -156.47 142.6 8.89 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.961 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.686 HD21 ' HE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -150.29 132.86 15.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.866 0.365 . . . . 0.0 111.351 -178.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.757 ' CA ' ' HA ' ' A' ' 28' ' ' CYS . 20.8 p -98.44 157.15 16.39 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.111 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.686 ' HE2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -155.82 -95.47 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.586 -0.845 . . . . 0.0 112.123 179.328 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.977 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 24.0 t -93.66 73.19 4.32 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 121.37 0.605 . . . . 0.0 110.338 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.553 ' H ' HG13 ' A' ' 5' ' ' ILE . . . 133.58 -65.49 0.58 Allowed Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.854 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.715 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 6.6 mttt -156.58 -174.49 4.96 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.757 ' HA ' ' CA ' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -85.01 109.11 17.96 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.453 178.182 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -84.39 91.11 7.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.398 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.579 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -92.93 134.4 35.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.582 -179.537 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.425 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 1.2 m-70 -67.16 159.73 75.17 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.817 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.23 118.07 4.9 Favored 'Trans proline' 0 CA--C 1.511 -0.633 0 C-N-CA 122.696 2.264 . . . . 0.0 112.832 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.3 47.66 0.98 Allowed Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.678 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.514 ' CE2' ' HA ' ' A' ' 20' ' ' ARG . 26.4 m-85 -146.13 149.29 33.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 111.264 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 38' ' ' ALA . 22.0 mt-10 -154.4 -82.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.819 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.736 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 47.25 -156.88 0.69 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.631 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.01 -13.28 60.49 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.637 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -137.84 -82.74 0.33 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.24 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 97.3 m -156.5 44.19 0.4 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.634 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.515 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 5.2 pm0 -98.38 -32.9 11.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.736 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.828 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 121.007 0.432 . . . . 0.0 110.279 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.708 ' O ' HD13 ' A' ' 5' ' ' ILE . 3.7 t70 -148.1 -135.28 0.07 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.307 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 p -84.12 107.08 16.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.708 HD13 ' O ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -155.63 66.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.132 -179.225 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -84.35 85.73 7.35 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.833 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.533 ' HB2' HG23 ' A' ' 14' ' ' VAL . 94.5 m -44.66 173.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.732 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -69.98 132.21 45.57 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.504 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.851 ' HG2' HG12 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -100.58 132.25 46.07 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.58 0.705 . . . . 0.0 111.955 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 1.06 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -84.0 -31.37 25.53 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.688 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.401 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 9.0 m120 -156.21 -85.72 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.24 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.63 -18.15 11.23 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.561 ' HG3' ' HA2' ' A' ' 17' ' ' GLY . 91.8 mm-40 -106.98 156.75 18.4 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.851 HG12 ' HG2' ' A' ' 9' ' ' ARG . 3.1 m -92.28 29.53 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.67 ' SG ' ' HB2' ' A' ' 23' ' ' CYS . 66.2 m -166.0 49.25 0.08 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.705 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 1.06 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 58.37 16.97 30.3 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 118.191 -1.957 . . . . 0.0 111.404 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.561 ' HA2' ' HG3' ' A' ' 13' ' ' GLN . . . 90.07 145.44 13.13 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 121.433 -0.413 . . . . 0.0 112.453 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.471 ' HD2' ' HG3' ' A' ' 13' ' ' GLN . 15.1 Cg_endo -57.37 -41.81 68.7 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.913 2.409 . . . . 0.0 112.628 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -45.38 -36.85 6.0 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.679 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.483 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 1.1 mpp_? -106.96 -22.82 12.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.721 -0.239 . . . . 0.0 111.098 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . 177.7 148.11 7.16 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.018 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.646 HD21 ' CD ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -140.19 143.62 36.17 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.194 0.521 . . . . 0.0 112.283 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.721 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 9.5 t -101.36 143.22 31.66 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.346 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -155.84 -108.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 118.753 -1.179 . . . . 0.0 113.255 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 43.6 t -72.26 68.41 0.74 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -177.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.426 ' HA2' HG21 ' A' ' 5' ' ' ILE . . . 114.93 -38.72 3.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.279 -0.962 . . . . 0.0 115.167 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.705 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -155.82 -165.98 2.09 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -177.172 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.721 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.7 m -83.09 -175.19 5.71 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.22 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.646 ' CD ' HD21 ' A' ' 22' ' ' LEU . 20.8 ttt180 -155.17 64.67 0.63 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -89.64 138.9 31.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.402 -178.488 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -80.65 162.9 58.82 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.692 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.71 117.16 3.81 Favored 'Trans proline' 0 CA--C 1.512 -0.606 0 C-N-CA 122.669 2.246 . . . . 0.0 112.738 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.18 46.98 0.97 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.75 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 20' ' ' ARG . 24.3 m-85 -146.04 147.49 31.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.691 0.282 . . . . 0.0 111.126 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 -87.25 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.48 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.684 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 50.85 -154.91 3.37 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.343 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.433 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 34.8 t -78.3 -20.46 51.47 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.63 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -127.86 -83.65 0.59 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.582 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 93.9 m -156.36 43.45 0.4 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.931 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.568 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 15.5 pm0 -102.92 -33.18 9.41 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.684 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.484 -0.77 . . . . 0.0 111.649 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.997 0.427 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.449 ' O ' HD12 ' A' ' 5' ' ' ILE . 64.5 m-20 -158.2 -124.76 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.429 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.85 87.87 7.36 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.514 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -156.23 69.51 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-O 122.126 0.965 . . . . 0.0 108.787 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.55 153.86 23.0 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.963 -177.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.8 m -40.63 145.41 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.194 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 15' ' ' CYS . 76.0 mt-10 -87.76 179.15 6.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.671 178.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.867 ' HG2' HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -137.95 128.25 26.17 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.093 0.949 . . . . 0.0 112.251 178.712 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.798 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 1.0 OUTLIER -95.12 -147.09 0.27 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.572 178.96 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.452 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 3.0 t-20 -91.41 71.47 6.05 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.98 -24.83 2.25 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 119.673 -1.251 . . . . 0.0 115.216 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.752 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 18.7 mt-30 -155.56 -156.33 0.64 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.941 0.871 . . . . 0.0 110.386 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.867 HG12 ' HG2' ' A' ' 9' ' ' ARG . 32.9 m -107.23 115.01 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.195 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.642 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 1.2 m 68.87 47.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.71 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.798 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 54.47 29.77 48.19 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.19 -1.481 . . . . 0.0 111.227 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.14 150.69 0.27 Allowed Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.405 -0.398 . . . . 0.0 112.358 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 19.3 Cg_endo -59.0 -31.55 95.94 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.72 2.28 . . . . 0.0 112.672 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.28 -21.96 13.58 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.625 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -107.74 -33.49 7.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.358 . . . . 0.0 110.987 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 18' ' ' PRO . . . -177.32 161.54 29.06 Favored Glycine 0 CA--C 1.517 0.198 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.069 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.649 ' O ' ' N ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -125.93 -175.18 3.28 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 120.672 0.273 . . . . 0.0 110.41 179.387 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 14.6 p -137.42 148.24 46.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.386 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.601 ' CE2' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -156.61 -169.41 2.99 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.496 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.444 ' C ' ' O ' ' A' ' 24' ' ' PHE . 4.7 t -24.71 85.94 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.314 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 120.39 -68.42 0.4 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.382 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.52 -163.69 1.5 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 3.6 t -84.34 169.5 14.58 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.679 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.649 ' N ' ' O ' ' A' ' 22' ' ' LEU . 2.0 tpp85 -145.47 94.55 2.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.98 ' SG ' ' HB2' ' A' ' 34' ' ' PHE . 30.5 t -85.61 157.12 20.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.842 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 20' ' ' ARG . 9.5 m-70 -77.88 158.21 78.15 Favored Pre-proline 0 C--O 1.231 0.124 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.348 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -64.71 113.54 2.37 Favored 'Trans proline' 0 CA--C 1.515 -0.434 0 C-N-CA 122.712 2.274 . . . . 0.0 112.665 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.91 -24.88 5.94 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.922 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.98 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.8 m-85 -85.53 164.68 17.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.719 0.295 . . . . 0.0 110.846 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -155.0 -90.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.134 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.74 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 49.23 -153.52 2.61 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.129 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.63 -0.11 56.94 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.642 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -154.92 -78.61 0.09 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.051 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.455 ' SG ' ' CB ' ' A' ' 34' ' ' PHE . 23.2 t -156.29 35.67 0.33 Allowed 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.858 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.492 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -91.81 -35.28 14.19 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.75 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.74 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.659 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.684 0.278 . . . . 0.0 110.746 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.7 -170.59 0.14 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.032 0.444 . . . . 0.0 111.493 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.625 HG22 ' SG ' ' A' ' 23' ' ' CYS . 21.0 p -84.42 76.8 10.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.017 HG23 ' HA2' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -98.15 -20.21 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.387 -178.065 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.46 94.63 2.71 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.296 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.427 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 4.7 m -134.06 134.91 42.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.155 0.502 . . . . 0.0 111.145 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 15' ' ' CYS . 9.1 mm-40 -95.41 154.58 17.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.412 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 24.8 mtt180 -129.78 130.14 44.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.716 0.77 . . . . 0.0 111.209 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.868 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 1.5 p90 -96.28 -33.6 11.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.445 -1.252 . . . . 0.0 112.908 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -155.62 44.71 0.46 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.253 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.75 -13.4 56.36 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.285 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.72 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 32.4 mm-40 -84.59 -77.74 0.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 13' ' ' GLN . 3.7 p 145.72 108.29 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.553 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.696 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER 67.81 42.55 1.93 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 178.16 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.868 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 62.78 33.65 87.49 Favored Glycine 0 C--N 1.316 -0.554 0 C-N-CA 119.162 -1.495 . . . . 0.0 111.784 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.459 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 73.52 163.39 8.36 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.434 -0.412 . . . . 0.0 112.742 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.597 ' HB3' HD11 ' A' ' 22' ' ' LEU . 57.3 Cg_endo -70.86 -42.36 2.32 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.774 2.316 . . . . 0.0 112.809 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -47.42 -27.95 4.44 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.858 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.481 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -106.11 -49.55 3.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.71 0.29 . . . . 0.0 110.925 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.19 132.91 3.47 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.342 -0.933 . . . . 0.0 113.018 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' ' 18' ' ' PRO . 2.6 mm? -96.21 170.98 8.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.21 0.529 . . . . 0.0 112.226 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -112.75 131.66 55.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.068 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -135.08 -173.25 3.27 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -31.74 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.464 -1.698 . . . . 0.0 111.446 179.03 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 1.017 ' HA2' HG23 ' A' ' 5' ' ' ILE . . . 56.56 4.87 1.0 Allowed Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.829 -0.623 . . . . 0.0 114.042 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' A' ' 24' ' ' PHE . 15.0 mttt -156.16 152.65 28.15 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 118.064 0.932 . . . . 0.0 112.995 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -84.45 175.76 9.11 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.004 178.678 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.421 ' CG ' ' HB2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -148.79 86.0 1.5 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.825 0.345 . . . . 0.0 111.421 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.938 ' SG ' ' HB2' ' A' ' 34' ' ' PHE . 19.2 t -85.03 154.79 21.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.368 . . . . 0.0 110.916 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 20' ' ' ARG . 2.9 m-70 -78.21 153.97 79.65 Favored Pre-proline 0 N--CA 1.455 -0.194 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.36 111.62 1.51 Allowed 'Trans proline' 0 CA--C 1.514 -0.524 0 C-N-CA 122.434 2.09 . . . . 0.0 112.743 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.08 31.67 2.01 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.349 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.938 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 6.3 m-85 -131.12 158.5 40.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -148.17 -88.22 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.036 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.659 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 47.99 -154.85 1.37 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.118 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 m -79.31 -8.24 58.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.696 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -155.18 -74.67 0.11 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.377 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.449 ' SG ' ' CB ' ' A' ' 34' ' ' PHE . 45.3 t -155.74 33.54 0.36 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.21 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 2.7 pt20 -97.55 -29.74 13.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.725 0.297 . . . . 0.0 111.742 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.659 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.207 -0.901 . . . . 0.0 111.146 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.902 0.382 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 42.3 t -94.12 -31.13 14.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.948 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.71 172.76 13.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.6 p -84.63 62.93 7.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -155.84 164.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 -178.173 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.477 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -154.9 151.49 28.62 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.68 -178.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.58 ' HB3' HG12 ' A' ' 14' ' ' VAL . 58.8 m -29.2 133.25 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.278 -0.873 . . . . 0.0 113.343 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 15' ' ' CYS . 4.0 mt-10 -95.65 113.02 24.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.37 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.579 ' HG3' HG13 ' A' ' 14' ' ' VAL . 3.3 mtp180 -84.8 134.1 34.32 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.556 0.693 . . . . 0.0 110.673 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.877 ' HE1' ' HB2' ' A' ' 13' ' ' GLN . 1.2 p90 -92.65 -27.38 17.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.339 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -155.45 -86.14 0.05 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.393 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.95 -2.83 9.23 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.851 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.877 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 7.1 mp0 -106.58 -116.11 0.26 Allowed 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.58 HG12 ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -168.65 111.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.651 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.8 OUTLIER 71.7 40.08 0.81 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.03 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.681 ' HA2' ' CD2' ' A' ' 10' ' ' TYR . . . 59.56 39.75 95.43 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.504 -1.331 . . . . 0.0 111.089 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 62.54 141.11 0.01 OUTLIER Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.203 -0.499 . . . . 0.0 112.444 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.25 -30.94 92.43 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.569 2.18 . . . . 0.0 112.36 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.55 -37.21 40.77 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.916 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.433 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -97.08 -43.86 7.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.718 0.294 . . . . 0.0 110.924 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -154.73 137.3 5.6 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.033 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.408 HD23 ' CZ ' ' A' ' 24' ' ' PHE . 3.7 mp -101.75 138.57 38.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.923 0.392 . . . . 0.0 111.867 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.81 147.24 26.94 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 26' ' ' GLY . 19.8 m-85 -153.91 -173.86 4.74 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 122.017 0.913 . . . . 0.0 112.484 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -32.27 90.53 0.0 OUTLIER 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 113.089 -1.869 . . . . 0.0 111.292 178.509 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 54.34 22.28 22.36 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.761 -0.654 . . . . 0.0 113.282 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -155.11 -167.37 2.54 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.0 t -152.91 104.24 2.83 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.691 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.76 94.92 8.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.158 0.504 . . . . 0.0 111.009 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.573 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -96.03 166.22 11.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.836 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -85.39 159.6 55.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.971 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.56 114.07 2.22 Favored 'Trans proline' 0 CA--C 1.512 -0.589 0 C-N-CA 122.725 2.283 . . . . 0.0 112.402 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.78 26.72 3.23 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.626 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.433 ' CE2' ' HA ' ' A' ' 20' ' ' ARG . 24.3 m-85 -134.64 150.84 50.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.302 . . . . 0.0 110.774 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 38' ' ' ALA . 0.9 OUTLIER -155.07 -83.11 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.062 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.733 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 48.96 -155.22 1.73 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.259 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.02 -10.54 59.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.651 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -143.71 -80.46 0.19 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.712 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 4.9 m -155.96 41.37 0.39 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.731 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.517 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 6.0 pm0 -98.58 -32.28 11.52 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.733 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.32 -0.848 . . . . 0.0 111.72 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.793 0.33 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.77 123.87 47.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.245 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.596 ' O ' HD12 ' A' ' 5' ' ' ILE . 6.9 t70 -175.28 -124.79 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.691 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.85 93.43 8.51 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -156.3 80.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.851 0.834 . . . . 0.0 109.178 -179.32 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -84.26 137.79 33.29 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.425 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.542 ' O ' HG12 ' A' ' 14' ' ' VAL . 2.7 m -52.9 157.94 1.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.313 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 15' ' ' CYS . 4.8 mm-40 -84.24 129.56 34.88 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.346 178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.535 ' HG2' HG13 ' A' ' 14' ' ' VAL . 47.0 mtm180 -84.37 131.03 34.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.932 0.872 . . . . 0.0 110.905 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.892 ' HE1' ' HB2' ' A' ' 13' ' ' GLN . 0.9 OUTLIER -84.99 -60.66 1.98 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.833 -178.378 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.441 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 28.0 p30 -156.05 49.76 0.51 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.037 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.39 -45.96 1.08 Allowed Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.908 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.892 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 2.5 mp0 -105.05 -165.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -113.35 112.85 42.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.16 0.505 . . . . 0.0 111.354 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.635 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 74.7 46.15 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.388 178.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.638 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 54.32 33.53 52.92 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.631 -1.271 . . . . 0.0 111.34 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.84 145.25 0.02 OUTLIER Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.245 -0.477 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.52 -25.03 47.26 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.555 2.17 . . . . 0.0 112.024 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.8 -26.14 32.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.996 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.491 ' NE ' ' CE1' ' A' ' 34' ' ' PHE . 4.4 mmm180 -114.74 -51.42 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 110.307 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.663 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -139.94 139.77 10.16 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.597 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.1 tp -133.91 130.27 37.51 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 120.73 0.3 . . . . 0.0 110.913 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.86 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 1.7 p -104.0 157.94 16.76 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.624 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -156.06 -97.43 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.285 -0.966 . . . . 0.0 113.113 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.5 t -76.46 67.36 2.63 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.223 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.561 ' HA2' HG13 ' A' ' 5' ' ' ILE . . . 92.2 -6.97 78.7 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.97 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -155.63 163.15 40.31 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -178.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.86 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 7.8 t -103.19 100.47 10.38 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.052 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -84.54 96.19 9.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.998 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.663 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -87.58 151.99 22.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.236 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -70.26 153.62 95.09 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.487 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.15 116.9 3.59 Favored 'Trans proline' 0 CA--C 1.513 -0.555 0 C-N-CA 122.705 2.27 . . . . 0.0 112.851 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . 106.82 44.8 1.26 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.902 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.491 ' CE1' ' NE ' ' A' ' 20' ' ' ARG . 17.2 m-85 -145.42 154.74 42.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.383 . . . . 0.0 111.106 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -155.14 -83.53 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.111 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.666 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 47.63 -154.7 1.23 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.31 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.18 -9.16 59.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.635 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -145.18 -80.35 0.17 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.52 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 1.9 m -155.99 40.67 0.38 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.884 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.515 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 6.4 pm0 -97.16 -32.91 11.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.666 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.742 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.765 0.317 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 43.93 -164.53 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 2' ' ' CYS . 24.1 t70 80.02 -118.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.266 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 p -84.13 90.67 7.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.235 0.541 . . . . 0.0 110.042 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.569 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -155.55 178.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -157.03 134.8 10.86 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.149 -1.021 . . . . 0.0 112.155 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.5 m -60.73 140.52 57.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.5 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -83.06 127.05 33.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.696 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.95 ' HG2' HG12 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -104.71 131.96 51.52 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.573 0.702 . . . . 0.0 111.949 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.854 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 1.3 p90 -88.37 -149.26 0.17 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.435 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.456 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 3.4 p-10 -91.31 77.46 5.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.502 ' C ' ' HG2' ' A' ' 13' ' ' GLN . . . 138.29 -28.99 2.65 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 119.963 -1.113 . . . . 0.0 114.87 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.71 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 4.0 mm-40 -152.23 -162.64 1.55 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.718 0.759 . . . . 0.0 110.372 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.95 HG12 ' HG2' ' A' ' 9' ' ' ARG . 34.4 m -106.06 108.13 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.283 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.674 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER 84.36 43.69 0.02 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.969 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.854 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 59.97 30.0 69.07 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.217 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.484 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 76.03 134.74 0.51 Allowed Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.259 -0.471 . . . . 0.0 112.654 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.496 ' HB3' HD11 ' A' ' 22' ' ' LEU . 63.2 Cg_exo -51.93 -33.91 53.88 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.631 2.221 . . . . 0.0 112.678 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.69 -22.57 11.92 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.857 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' A' ' 40' ' ' GLN . 38.4 mtm-85 -110.13 -36.7 5.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.604 0.24 . . . . 0.0 111.304 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 30' ' ' CYS . . . -171.33 139.87 5.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.139 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.496 HD11 ' HB3' ' A' ' 18' ' ' PRO . 1.6 mm? -91.71 -179.52 5.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.233 0.54 . . . . 0.0 112.15 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.879 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 16.0 p -121.26 143.16 49.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 27' ' ' LYS . 5.3 m-85 -143.93 179.28 7.28 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -37.46 102.51 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 112.718 -2.037 . . . . 0.0 111.04 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.423 ' H ' HG13 ' A' ' 5' ' ' ILE . . . 93.61 -44.37 2.42 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.312 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 24' ' ' PHE . 26.6 mtmm -155.04 -179.28 7.91 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.879 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -84.44 160.69 20.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.833 179.425 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 95.54 2.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.898 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.444 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 2.2 p -100.37 162.02 13.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.949 0.404 . . . . 0.0 111.102 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -64.16 157.68 68.59 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.498 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.08 112.08 1.43 Allowed 'Trans proline' 0 CA--C 1.513 -0.57 0 C-N-CA 122.531 2.154 . . . . 0.0 112.476 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.46 32.79 2.65 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.93 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -125.52 150.53 47.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.003 0.43 . . . . 0.0 111.11 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 40' ' ' GLN . 45.7 mt-10 -155.4 -152.98 0.42 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.304 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.88 -161.22 12.89 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.291 -0.956 . . . . 0.0 111.892 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.3 m -62.25 -21.48 65.21 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.674 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -140.84 -81.39 0.25 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.026 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.5 m -157.1 39.33 0.31 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.121 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 35' ' ' GLU . 1.4 pt20 -85.94 -31.29 22.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.934 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.401 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.633 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.859 0.361 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.587 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 52.3 t -177.1 -36.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.277 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.54 162.87 40.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.381 . . . . 0.0 111.346 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.436 ' O ' HG12 ' A' ' 5' ' ' ILE . 28.5 p -84.88 63.48 8.08 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.682 HG22 ' HA2' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -155.5 169.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -177.575 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.503 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -153.65 163.34 40.16 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.494 -0.883 . . . . 0.0 112.525 -179.038 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.567 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 8.7 m -18.85 136.61 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.649 -1.159 . . . . 0.0 114.029 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 15' ' ' CYS . 24.6 mt-10 -95.24 128.17 41.87 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.477 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 24.0 mtm105 -103.02 130.97 50.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.835 0.826 . . . . 0.0 111.456 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.651 ' CE2' ' HA2' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -92.42 -32.9 14.76 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.584 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.423 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.4 m-20 -156.14 -79.96 0.08 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.003 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.05 26.86 1.27 Allowed Glycine 0 C--N 1.331 0.306 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.566 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.485 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 37.4 mm-40 -136.0 11.73 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.466 0.174 . . . . 0.0 110.854 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 1.5 p 43.59 106.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.876 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 77.1 m 80.28 40.13 0.08 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.746 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.651 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 44.15 52.65 6.95 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.118 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.06 146.75 2.94 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.986 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 84.3 Cg_endo -78.3 -35.65 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.81 2.34 . . . . 0.0 112.727 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.94 -21.17 29.71 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.892 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.459 ' CD ' ' CE1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -99.71 -31.56 11.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.95 0.405 . . . . 0.0 110.832 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 18' ' ' PRO . . . -175.45 158.43 25.71 Favored Glycine 0 N--CA 1.453 -0.189 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.716 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -104.1 -150.08 0.42 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 117.33 0.565 . . . . 0.0 111.629 -179.636 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.6 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 11.4 p -155.69 125.58 6.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.873 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.623 ' CZ ' ' HB3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -156.45 -102.72 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.453 177.522 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.587 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 8.3 t -56.08 77.31 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.148 0.499 . . . . 0.0 110.227 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.682 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 46.42 21.49 0.77 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.968 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.16 168.16 28.16 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 14.7 m -105.11 125.12 50.63 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.452 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.737 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -84.45 88.43 7.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.629 0.728 . . . . 0.0 109.481 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -92.81 160.01 15.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.906 -178.041 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.26 163.62 24.33 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.495 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.84 115.1 2.31 Favored 'Trans proline' 0 CA--C 1.512 -0.62 0 C-N-CA 122.753 2.302 . . . . 0.0 112.762 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . 116.26 36.9 1.06 Allowed Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 114.704 -1.134 . . . . 0.0 112.913 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.459 ' CE1' ' CD ' ' A' ' 20' ' ' ARG . 30.0 m-85 -148.03 156.12 42.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.739 0.304 . . . . 0.0 110.935 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -154.33 -90.28 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.23 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.62 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 47.95 -162.86 0.34 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.419 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -16.83 62.45 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.594 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -136.84 -81.96 0.37 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.079 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -156.13 42.4 0.39 Allowed 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.014 178.506 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.48 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 5.7 pm0 -92.82 -31.24 15.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.886 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.62 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.468 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.824 0.345 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 25' ' ' CYS . 42.0 t -112.83 -55.42 2.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.718 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.644 ' C ' HD13 ' A' ' 5' ' ' ILE . 1.7 t0 178.72 -148.81 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.687 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.6 p -84.75 94.56 8.71 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.644 HD13 ' C ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -155.45 67.22 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 121.89 0.852 . . . . 0.0 108.983 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.38 135.73 34.16 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.503 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.534 ' HA ' ' HB3' ' A' ' 23' ' ' CYS . 22.6 m -40.47 146.42 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.033 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 44.4 mm-40 -93.67 178.74 5.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.867 ' HG2' HG12 ' A' ' 14' ' ' VAL . 14.0 mtt85 -133.15 131.79 40.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.131 0.967 . . . . 0.0 113.233 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.931 ' HE1' ' HB2' ' A' ' 13' ' ' GLN . 5.6 p90 -92.16 -146.19 0.22 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.301 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -91.46 68.57 5.78 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 145.37 -32.5 1.63 Allowed Glycine 0 C--N 1.338 0.69 0 C-N-CA 119.818 -1.182 . . . . 0.0 114.868 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.931 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 3.1 mm100 -149.57 -156.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.528 0.664 . . . . 0.0 110.489 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.867 HG12 ' HG2' ' A' ' 9' ' ' ARG . 23.0 m -104.89 115.05 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.978 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.674 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER 64.63 53.58 1.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.3 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.655 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 51.33 31.95 28.72 Favored Glycine 0 C--N 1.318 -0.442 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.954 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.404 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 64.25 158.0 0.24 Allowed Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.498 -0.351 . . . . 0.0 112.855 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.3 -13.02 35.71 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.75 2.3 . . . . 0.0 112.902 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.74 27.58 4.26 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.792 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.487 ' C ' ' SG ' ' A' ' 39' ' ' CYS . 26.3 mtp85 -155.13 -42.45 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 30' ' ' CYS . . . 179.19 176.0 46.59 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.15 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.571 HD12 ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -143.08 -175.04 4.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.931 0.396 . . . . 0.0 110.82 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.912 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 8.2 p -101.43 143.2 31.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.47 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.571 ' CE1' HD12 ' A' ' 22' ' ' LEU . 7.3 m-85 -126.42 -179.05 4.57 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.923 0.868 . . . . 0.0 112.977 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 2' ' ' CYS . 1.7 t -55.04 72.76 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.801 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 141.66 -55.84 0.6 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.482 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.57 -177.6 6.67 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.912 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -84.33 128.84 34.82 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.913 178.491 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -113.24 103.96 11.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.366 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.609 ' SG ' ' CB ' ' A' ' 34' ' ' PHE . 7.7 t -85.08 156.14 21.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.819 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.459 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 26.6 m170 -65.48 157.13 79.78 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.882 0.372 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.85 116.46 3.37 Favored 'Trans proline' 0 CA--C 1.512 -0.584 0 C-N-CA 122.804 2.336 . . . . 0.0 112.696 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.12 29.08 5.01 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.756 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.609 ' CB ' ' SG ' ' A' ' 30' ' ' CYS . 5.4 m-85 -125.1 170.92 10.71 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.908 -0.172 . . . . 0.0 110.811 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.41 ' N ' ' OXT' ' A' ' 41' ' ' ALA . 6.2 mm-40 -155.44 -102.65 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.063 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.784 ' N ' ' HB3' ' A' ' 41' ' ' ALA . . . 63.51 -157.19 41.54 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.367 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.87 -18.1 21.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.674 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -138.56 -73.62 0.4 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.433 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.599 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 53.4 t -157.35 20.21 0.29 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.938 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.586 ' OE1' ' HB2' ' A' ' 10' ' ' TYR . 1.2 pt20 -77.62 -33.33 53.68 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.784 ' HB3' ' N ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 117.961 -1.019 . . . . 0.0 111.36 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.707 0.289 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 10.8 t -177.48 -32.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.505 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.56 -155.61 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.67 0.271 . . . . 0.0 110.807 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 48.0 p -84.08 113.93 21.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.782 HG23 ' HA2' ' A' ' 26' ' ' GLY . 0.4 OUTLIER -147.78 74.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-O 121.799 0.809 . . . . 0.0 111.141 -177.364 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 7' ' ' CYS . 6.2 p30 -93.89 53.52 1.81 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.486 -1.233 . . . . 0.0 108.55 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' ASN . 21.4 m -7.77 135.16 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 113.448 -1.706 . . . . 0.0 114.813 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -89.96 128.77 36.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.985 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.636 ' CG ' HG12 ' A' ' 14' ' ' VAL . 4.7 mpp_? -92.33 134.0 35.32 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.331 0.586 . . . . 0.0 111.809 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 1.149 ' CE1' ' HB2' ' A' ' 13' ' ' GLN . 9.7 p90 -85.59 -134.83 0.06 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.806 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -83.26 72.18 10.19 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.03 -18.52 45.95 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 1.149 ' HB2' ' CE1' ' A' ' 10' ' ' TYR . 2.7 mp0 -115.21 -133.51 0.34 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.889 0.844 . . . . 0.0 111.317 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.636 HG12 ' CG ' ' A' ' 9' ' ' ARG . 2.9 m -147.4 114.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 121.079 0.466 . . . . 0.0 111.739 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.664 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 66.43 44.41 2.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.379 178.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.719 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 60.29 18.08 48.42 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.769 -1.205 . . . . 0.0 111.83 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.637 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 66.2 144.98 0.06 OUTLIER Glycine 0 C--N 1.338 0.655 0 C-N-CA 121.79 -0.243 . . . . 0.0 113.076 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.68 -31.81 52.04 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.69 2.26 . . . . 0.0 112.449 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -48.29 -28.71 6.46 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.927 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HD2' ' CE2' ' A' ' 34' ' ' PHE . 6.6 mmm-85 -118.25 -31.47 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 110.636 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.468 ' CA ' ' HA ' ' A' ' 30' ' ' CYS . . . -168.43 149.69 14.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.738 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.777 HD11 ' CE2' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -128.8 166.27 19.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.097 0.475 . . . . 0.0 111.208 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -84.75 134.88 34.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.105 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.777 ' CE2' HD11 ' A' ' 22' ' ' LEU . 1.1 m-85 -130.16 -177.56 4.36 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.702 0.763 . . . . 0.0 112.111 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.523 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 0.1 OUTLIER -41.95 86.25 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.224 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.782 ' HA2' HG23 ' A' ' 5' ' ' ILE . . . 70.47 6.31 57.9 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.731 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -156.3 142.03 17.85 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -90.43 115.46 27.61 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.685 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -99.66 102.43 13.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.135 0.493 . . . . 0.0 111.726 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.468 ' HA ' ' CA ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -96.32 144.07 26.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.375 179.163 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.469 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 12.3 m-70 -53.76 149.82 15.51 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.22 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 23.9 Cg_exo -62.67 117.48 4.37 Favored 'Trans proline' 0 CA--C 1.514 -0.51 0 C-N-CA 122.698 2.265 . . . . 0.0 112.834 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.421 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . 109.03 31.49 3.32 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.84 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 31' ' ' HIS . 17.9 m-85 -136.46 146.66 46.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.921 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.639 ' CG ' ' HB3' ' A' ' 41' ' ' ALA . 18.9 pt-20 -142.44 -140.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.076 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 35' ' ' GLU . . . 102.1 -162.38 17.16 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.517 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.36 -16.15 63.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.664 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -145.77 -79.88 0.17 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.694 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -155.9 26.56 0.37 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.027 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.579 ' OE1' ' HB2' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -69.46 -31.02 69.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.639 ' HB3' ' CG ' ' A' ' 35' ' ' GLU . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.156 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.591 ' CB ' ' HA ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -136.82 -166.29 1.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.773 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 13.0 t70 -177.19 -4.04 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.6 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -84.42 57.41 4.27 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.371 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.577 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -84.73 92.88 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.862 -177.138 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.76 37.99 0.37 Allowed 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.474 -1.693 . . . . 0.0 108.925 -177.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.439 ' HB2' ' CG1' ' A' ' 14' ' ' VAL . 13.6 m -35.51 147.77 0.02 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 113.811 -1.541 . . . . 0.0 112.896 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.24 121.47 33.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.928 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.765 ' HG3' HG13 ' A' ' 14' ' ' VAL . 17.4 mtm180 -95.73 131.36 42.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.639 0.733 . . . . 0.0 112.133 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.793 ' CD2' ' HA2' ' A' ' 16' ' ' GLY . 1.6 p90 -84.97 -33.08 22.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.495 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.71 -77.86 0.09 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.007 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -148.06 16.41 1.35 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.19 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.563 ' C ' HG23 ' A' ' 14' ' ' VAL . 11.7 mm100 -118.68 -19.04 8.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.972 0.415 . . . . 0.0 110.577 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.765 HG13 ' HG3' ' A' ' 9' ' ' ARG . 1.6 t 70.67 92.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.662 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.636 ' CB ' ' O ' ' A' ' 14' ' ' VAL . 8.2 t 104.96 34.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.765 0.666 . . . . 0.0 112.123 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.793 ' HA2' ' CD2' ' A' ' 10' ' ' TYR . . . 56.48 41.23 88.18 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.051 -1.071 . . . . 0.0 113.109 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.35 148.95 4.03 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.188 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 25.3 Cg_exo -62.67 -44.8 15.84 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.71 2.274 . . . . 0.0 112.087 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.46 -31.65 14.22 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.341 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.449 ' HG3' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -95.51 -30.44 13.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.771 0.32 . . . . 0.0 110.712 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.477 ' CA ' ' HA ' ' A' ' 30' ' ' CYS . . . 179.68 156.02 16.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.879 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.643 HD12 ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -122.43 -166.16 1.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 5.3 t -145.2 145.56 31.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.622 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.643 ' CE2' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -155.78 -101.21 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.573 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.591 ' HA ' ' CB ' ' A' ' 2' ' ' CYS . 0.8 OUTLIER -55.61 80.3 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.611 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 41.38 26.35 0.21 Allowed Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.616 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.61 142.3 18.83 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -87.92 111.1 21.08 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.923 178.582 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.609 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 7.3 ttp85 -97.63 100.45 11.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.916 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.477 ' HA ' ' CA ' ' A' ' 21' ' ' GLY . 1.8 p -95.87 165.04 12.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.074 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -73.37 159.15 85.53 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.498 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.17 112.66 1.61 Allowed 'Trans proline' 0 CA--C 1.513 -0.551 0 C-N-CA 122.609 2.206 . . . . 0.0 112.527 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.36 22.53 4.07 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.046 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.473 ' HA ' ' OXT' ' A' ' 41' ' ' ALA . 40.5 m-85 -125.49 148.82 48.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.659 0.266 . . . . 0.0 110.842 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 39' ' ' CYS . 1.2 mt-10 -155.54 -96.6 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.664 ' CA ' ' HB3' ' A' ' 41' ' ' ALA . . . 67.21 -144.36 44.44 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.174 -1.013 . . . . 0.0 111.883 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.462 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 40.3 t -90.46 -3.06 57.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.578 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -148.68 -79.96 0.14 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.29 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 35' ' ' GLU . 9.0 m -157.17 39.37 0.3 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.635 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.593 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 17.6 pm0 -106.11 -33.49 7.84 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.664 ' HB3' ' CA ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.346 -0.835 . . . . 0.0 112.121 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.888 0.375 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 25' ' ' CYS . 46.0 t -145.23 -62.17 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.452 ' OD1' HD12 ' A' ' 5' ' ' ILE . 14.9 p-10 -167.17 -160.24 0.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.858 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.75 86.33 7.37 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.532 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -156.34 79.35 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-O 121.981 0.896 . . . . 0.0 108.92 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 7' ' ' CYS . 6.9 p30 -84.22 72.88 10.5 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.867 -177.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.576 ' HB3' ' HB ' ' A' ' 14' ' ' VAL . 69.9 m 47.73 149.35 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.433 -1.258 . . . . 0.0 113.457 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.684 ' O ' ' N ' ' A' ' 15' ' ' CYS . 15.1 mm-40 -94.93 131.43 40.86 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.558 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.743 ' CG ' HG12 ' A' ' 14' ' ' VAL . 4.0 mtp85 -100.08 131.36 46.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.794 0.807 . . . . 0.0 111.347 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.7 ' CD2' ' HA2' ' A' ' 16' ' ' GLY . 1.2 p90 -91.37 -30.4 16.56 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.842 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -155.79 -85.33 0.05 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.825 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.56 -16.39 10.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.255 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.541 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -110.76 -159.96 0.7 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.743 HG12 ' CG ' ' A' ' 9' ' ' ARG . 28.2 m -124.4 104.09 13.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.137 0.494 . . . . 0.0 111.267 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.686 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER 86.21 48.15 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.501 179.504 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.7 ' HA2' ' CD2' ' A' ' 10' ' ' TYR . . . 53.64 30.39 42.88 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.352 -1.404 . . . . 0.0 111.726 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.21 143.81 0.82 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.602 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.0 -35.33 98.87 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.521 2.147 . . . . 0.0 112.27 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -48.17 -28.95 6.42 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.845 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.452 ' O ' ' CG ' ' A' ' 31' ' ' HIS . 0.1 OUTLIER -101.48 -36.43 8.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.104 0.478 . . . . 0.0 109.778 179.165 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 30' ' ' CYS . . . 177.02 152.39 9.83 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.634 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.45 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -113.7 175.73 5.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.784 0.326 . . . . 0.0 110.721 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.69 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -98.71 156.07 17.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.295 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.601 ' O ' ' N ' ' A' ' 26' ' ' GLY . 6.2 m-85 -139.29 -175.23 4.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.875 0.845 . . . . 0.0 112.26 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 1.5 t -47.27 77.36 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 113.406 -1.725 . . . . 0.0 110.874 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 80.7 19.26 68.53 Favored Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.316 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -155.18 -164.86 1.87 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 117.388 0.594 . . . . 0.0 112.246 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.69 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -145.49 115.59 7.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.625 179.439 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.39 88.0 7.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.12 0.486 . . . . 0.0 110.913 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.988 ' SG ' ' HB2' ' A' ' 34' ' ' PHE . 18.2 t -85.03 155.47 21.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.931 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.452 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 18.8 m170 -78.46 154.5 79.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.959 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.04 112.73 1.61 Allowed 'Trans proline' 0 CA--C 1.513 -0.54 0 C-N-CA 122.481 2.121 . . . . 0.0 112.883 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.5 28.53 2.52 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.356 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.988 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 12.4 m-85 -130.86 164.04 26.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.81 0.305 . . . . 0.0 110.955 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -153.39 -91.61 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.98 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.707 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 48.6 -152.21 2.66 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.07 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.7 p -92.18 1.04 57.46 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.686 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -155.21 -79.31 0.09 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.092 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 43.2 t -156.55 36.95 0.32 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.682 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.476 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -92.46 -34.85 13.94 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.707 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.655 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.668 0.27 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 157.26 16.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.325 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -178.75 -138.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.903 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.9 90.01 6.91 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.527 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -155.23 72.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.243 -177.225 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -84.15 -179.51 7.24 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.891 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.58 ' HB2' HG12 ' A' ' 14' ' ' VAL . 1.5 m -78.88 140.88 38.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.567 -177.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 15' ' ' CYS . 2.4 mt-10 -94.81 124.8 39.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.613 ' HG3' HG13 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -84.52 132.11 34.57 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.832 0.825 . . . . 0.0 112.863 -177.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 1.083 ' CE1' ' HB2' ' A' ' 13' ' ' GLN . 4.2 p90 -84.91 -125.51 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.574 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -83.71 51.58 2.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.89 -28.48 6.12 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 119.965 -1.112 . . . . 0.0 115.641 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 1.083 ' HB2' ' CE1' ' A' ' 10' ' ' TYR . 2.8 mp0 -101.75 -125.95 0.19 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.942 0.871 . . . . 0.0 111.439 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.613 HG13 ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -150.37 110.52 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 120.998 0.428 . . . . 0.0 111.495 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.681 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 65.87 44.13 2.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.657 179.014 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.718 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 60.58 22.72 59.68 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.315 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.545 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 69.45 144.87 0.19 Allowed Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.407 -0.397 . . . . 0.0 112.739 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -50.61 -30.26 27.85 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.701 2.268 . . . . 0.0 112.441 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.7 -26.7 54.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.435 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.93 -28.49 9.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.612 0.244 . . . . 0.0 111.109 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.553 ' HA3' ' HB3' ' A' ' 30' ' ' CYS . . . -179.86 158.34 21.91 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.843 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 29' ' ' ARG . 5.7 mp -124.56 142.26 51.48 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 111.697 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.829 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -84.73 127.76 34.27 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.53 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.529 ' O ' ' N ' ' A' ' 26' ' ' GLY . 16.2 m-85 -141.71 175.83 9.39 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -177.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -34.46 83.57 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 111.814 -2.448 . . . . 0.0 111.031 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 120.77 -57.94 0.58 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.234 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -155.79 -178.29 7.19 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.829 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 4.8 t -89.16 107.58 19.13 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.348 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 22' ' ' LEU . 5.2 tpt85 -84.81 88.57 7.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.989 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.553 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 1.0 OUTLIER -95.01 156.77 16.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -63.13 153.39 81.5 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.647 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.14 113.05 1.58 Allowed 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 122.591 2.194 . . . . 0.0 112.564 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.4 23.03 4.6 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.932 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -124.49 148.98 47.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.871 0.367 . . . . 0.0 111.089 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.44 ' HB2' ' OXT' ' A' ' 41' ' ' ALA . 4.5 mm-40 -155.4 -88.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.218 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.599 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 61.45 -147.89 47.39 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.044 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.466 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 1.1 m -87.22 -5.04 59.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.681 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -144.09 -82.89 0.16 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.232 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 7.3 m -157.47 42.88 0.32 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.057 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.536 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 9.9 pm0 -108.56 -33.77 6.93 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.599 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.115 -0.945 . . . . 0.0 111.983 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.782 0.325 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 33.8 m -72.52 -68.86 0.44 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.714 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.483 ' O ' HD12 ' A' ' 5' ' ' ILE . 0.8 OUTLIER 82.23 -141.68 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.0 p -84.4 117.15 23.44 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.541 0.686 . . . . 0.0 109.896 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.71 HG13 ' H ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -155.31 74.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.4 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -84.85 140.67 31.0 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.281 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.613 ' O ' HG12 ' A' ' 14' ' ' VAL . 75.8 m -100.16 -177.98 3.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.272 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 15' ' ' CYS . 3.5 mp0 -67.82 144.89 55.13 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.322 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.495 ' HB3' ' C ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -105.12 160.69 14.86 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.501 0.667 . . . . 0.0 111.619 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.783 ' CD2' ' HA3' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -127.69 -16.67 4.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.79 179.197 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -155.66 62.43 0.6 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.302 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.78 26.4 57.58 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.495 ' C ' ' HB3' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -155.14 127.43 7.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.197 -0.501 . . . . 0.0 110.545 -178.442 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.862 HG21 ' HB3' ' A' ' 23' ' ' CYS . 12.9 m -51.17 118.67 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.657 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 95.3 m 64.52 49.95 2.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -176.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.783 ' HA3' ' CD2' ' A' ' 10' ' ' TYR . . . 17.87 48.29 0.01 OUTLIER Glycine 0 C--N 1.341 0.845 0 CA-C-N 114.467 -1.242 . . . . 0.0 115.047 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 15' ' ' CYS . . . 96.94 147.84 23.25 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.823 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.66 -15.72 43.74 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.531 2.154 . . . . 0.0 113.039 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -46.59 -45.63 17.58 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.088 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.471 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -102.96 -44.1 5.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.186 0.517 . . . . 0.0 110.033 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -157.87 144.84 10.95 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.502 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -132.62 135.91 46.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.988 0.394 . . . . 0.0 111.764 -179.17 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.967 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 11.8 t -97.55 128.78 44.56 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.406 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.636 ' CE1' ' HB2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -156.89 -157.8 0.72 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.783 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.519 ' C ' ' O ' ' A' ' 24' ' ' PHE . 39.9 t -24.87 94.21 0.01 OUTLIER 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.105 0.478 . . . . 0.0 110.393 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.71 ' H ' HG13 ' A' ' 5' ' ' ILE . . . 102.83 -76.12 0.3 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.386 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -154.27 -160.65 1.11 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.967 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 50.5 t -92.39 112.65 24.68 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.881 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.636 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -84.74 94.15 8.61 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.17 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -93.55 156.72 16.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.07 -178.413 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -83.01 157.16 66.62 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.772 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -57.68 122.58 11.99 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 122.89 2.393 . . . . 0.0 113.197 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.54 49.23 2.59 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.719 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.471 ' CZ ' ' HG3' ' A' ' 20' ' ' ARG . 7.1 m-85 -139.99 150.09 44.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.965 0.412 . . . . 0.0 111.702 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 38' ' ' ALA . 1.9 mm-40 -155.33 -90.3 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.384 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.681 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 58.94 -145.52 43.55 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.994 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.36 -1.72 57.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.657 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -146.27 -83.2 0.13 Allowed 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.639 -1.618 . . . . 0.0 109.088 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 69.5 m -156.48 45.05 0.42 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.518 178.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.567 ' HB3' ' CD2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -97.83 -36.05 10.32 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.681 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.963 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.753 0.311 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.489 ' CB ' ' HA ' ' A' ' 25' ' ' CYS . 4.9 t 68.05 -64.58 0.28 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.236 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.99 -161.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.685 0.278 . . . . 0.0 111.089 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.4 p -84.49 91.27 7.81 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.602 HG21 ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -155.75 79.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.134 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -83.2 151.3 25.73 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.886 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.538 ' HB3' ' CG1' ' A' ' 14' ' ' VAL . 5.2 m -50.0 135.88 19.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.043 -0.981 . . . . 0.0 113.333 -177.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -96.01 148.6 22.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.989 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.405 ' HA ' ' H ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -111.1 154.93 23.57 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 122.069 0.938 . . . . 0.0 111.248 179.014 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.851 ' CZ ' ' HA2' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -112.68 -27.63 8.1 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.421 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -156.24 -38.07 0.08 Allowed 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.16 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.74 1.27 0.05 OUTLIER Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.891 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.569 ' C ' HG23 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -101.05 -17.64 16.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.346 0.573 . . . . 0.0 110.22 179.322 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.569 HG23 ' C ' ' A' ' 13' ' ' GLN . 3.5 t 84.96 98.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.514 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.784 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 1.0 OUTLIER 69.43 47.37 0.69 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.53 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.851 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 45.51 61.25 3.8 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.521 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 54.96 168.48 0.05 OUTLIER Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.953 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.493 ' CB ' HD11 ' A' ' 22' ' ' LEU . 95.6 Cg_endo -80.98 -26.82 3.32 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.663 2.242 . . . . 0.0 112.763 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.6 -25.62 6.78 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.696 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -104.97 -51.64 3.0 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 30' ' ' CYS . . . -165.18 144.76 9.56 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.668 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.512 ' O ' ' CA ' ' A' ' 28' ' ' CYS . 0.7 OUTLIER -96.51 -177.76 4.05 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 122.651 0.38 . . . . 0.0 111.434 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 29.3 p -126.51 116.18 20.69 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -157.6 -162.94 1.25 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.191 -1.003 . . . . 0.0 112.533 177.262 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.489 ' HA ' ' CB ' ' A' ' 2' ' ' CYS . 9.2 t -24.04 122.19 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.236 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.602 ' O ' HG21 ' A' ' 5' ' ' ILE . . . 80.02 -73.01 2.51 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.169 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.535 ' HG2' ' C ' ' A' ' 26' ' ' GLY . 5.5 mmmm -155.84 -157.93 0.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.613 0.721 . . . . 0.0 112.39 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.1 m -85.5 124.58 32.24 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.049 178.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . 10.2 ttt-85 -84.72 84.57 7.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.932 0.396 . . . . 0.0 110.279 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.436 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 0.8 OUTLIER -96.99 141.76 29.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.169 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -61.68 158.6 40.08 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.45 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.65 114.98 2.29 Favored 'Trans proline' 0 CA--C 1.512 -0.597 0 C-N-CA 122.539 2.159 . . . . 0.0 112.755 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.1 34.71 1.76 Allowed Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.754 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -135.09 147.55 49.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.874 0.368 . . . . 0.0 111.111 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' O ' ' C ' ' A' ' 38' ' ' ALA . 2.4 mt-10 -155.08 -83.69 0.07 Allowed 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.677 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 52.03 -155.42 4.46 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.234 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.1 m -75.73 -12.35 60.17 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.784 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -138.53 -81.84 0.31 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.286 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.0 m -156.93 44.21 0.38 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.456 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.535 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 5.6 pm0 -100.1 -33.44 10.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.677 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.777 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.455 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 6.5 pt-20 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.803 0.335 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.977 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -46.28 -25.63 0.66 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.595 0.712 . . . . 0.0 111.479 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.544 ' O ' ' O ' ' A' ' 2' ' ' CYS . 7.7 t70 -47.1 -123.36 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.761 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.405 ' C ' HG23 ' A' ' 5' ' ' ILE . 13.9 p -84.89 92.79 8.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.457 . . . . 0.0 109.935 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.553 HG13 ' H ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -156.16 71.77 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-O 122.191 0.996 . . . . 0.0 108.719 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.57 136.57 33.73 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.27 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -58.13 159.1 6.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.38 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' CYS . 2.4 mt-10 -95.22 169.6 9.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.69 ' CG ' HG12 ' A' ' 14' ' ' VAL . 3.0 mtp180 -123.9 127.84 48.59 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 122.2 1.0 . . . . 0.0 112.244 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.631 ' CE2' ' HA2' ' A' ' 16' ' ' GLY . 1.2 p90 -92.15 -32.86 14.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.069 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -155.89 -74.4 0.1 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.027 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.9 24.58 0.62 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.797 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.47 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 9.0 mm100 -135.3 14.32 3.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.627 0.251 . . . . 0.0 110.966 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.69 HG12 ' CG ' ' A' ' 9' ' ' ARG . 8.2 m 43.53 105.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.451 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.637 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER 80.98 36.62 0.09 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 178.274 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.631 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 49.69 48.71 35.72 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.991 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.7 150.77 0.01 OUTLIER Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.301 -0.476 . . . . 0.0 113.15 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 45.1 Cg_endo -68.57 -29.26 30.61 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.571 2.181 . . . . 0.0 112.017 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.425 ' O ' ' CD2' ' A' ' 31' ' ' HIS . . . -49.04 -38.36 24.5 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.861 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.514 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -97.11 -45.02 6.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.058 0.456 . . . . 0.0 110.195 179.33 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -156.47 142.6 8.89 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.961 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.686 HD21 ' HE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -150.29 132.86 15.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.866 0.365 . . . . 0.0 111.351 -178.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.757 ' CA ' ' HA ' ' A' ' 28' ' ' CYS . 20.8 p -98.44 157.15 16.39 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.111 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.686 ' HE2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -155.82 -95.47 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.586 -0.845 . . . . 0.0 112.123 179.328 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.977 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 24.0 t -93.66 73.19 4.32 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 121.37 0.605 . . . . 0.0 110.338 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.553 ' H ' HG13 ' A' ' 5' ' ' ILE . . . 133.58 -65.49 0.58 Allowed Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.854 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.715 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 6.6 mttt -156.58 -174.49 4.96 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.757 ' HA ' ' CA ' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -85.01 109.11 17.96 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.453 178.182 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -84.39 91.11 7.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.398 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.579 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -92.93 134.4 35.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.582 -179.537 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.425 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 1.2 m-70 -67.16 159.73 75.17 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.817 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.23 118.07 4.9 Favored 'Trans proline' 0 CA--C 1.511 -0.633 0 C-N-CA 122.696 2.264 . . . . 0.0 112.832 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.3 47.66 0.98 Allowed Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.678 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.514 ' CE2' ' HA ' ' A' ' 20' ' ' ARG . 26.4 m-85 -146.13 149.29 33.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 111.264 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 38' ' ' ALA . 22.0 mt-10 -154.4 -82.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.819 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.736 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 47.25 -156.88 0.69 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.631 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.01 -13.28 60.49 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.637 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -137.84 -82.74 0.33 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.24 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 97.3 m -156.5 44.19 0.4 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.634 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.515 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 5.2 pm0 -98.38 -32.9 11.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.736 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.828 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.764 0.316 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER 62.41 120.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.007 0.432 . . . . 0.0 110.279 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.708 ' O ' HD13 ' A' ' 5' ' ' ILE . 3.7 t70 -148.1 -135.28 0.07 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.307 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 p -84.12 107.08 16.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.708 HD13 ' O ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -155.63 66.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.132 -179.225 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -84.35 85.73 7.35 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.833 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.533 ' HB2' HG23 ' A' ' 14' ' ' VAL . 94.5 m -44.66 173.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.732 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -69.98 132.21 45.57 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.504 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.851 ' HG2' HG12 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -100.58 132.25 46.07 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.58 0.705 . . . . 0.0 111.955 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 1.06 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -84.0 -31.37 25.53 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.688 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.401 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 9.0 m120 -156.21 -85.72 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.24 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.63 -18.15 11.23 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.561 ' HG3' ' HA2' ' A' ' 17' ' ' GLY . 91.8 mm-40 -106.98 156.75 18.4 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.851 HG12 ' HG2' ' A' ' 9' ' ' ARG . 3.1 m -92.28 29.53 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.67 ' SG ' ' HB2' ' A' ' 23' ' ' CYS . 66.2 m -166.0 49.25 0.08 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.705 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 1.06 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 58.37 16.97 30.3 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 118.191 -1.957 . . . . 0.0 111.404 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.561 ' HA2' ' HG3' ' A' ' 13' ' ' GLN . . . 90.07 145.44 13.13 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 121.433 -0.413 . . . . 0.0 112.453 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.471 ' HD2' ' HG3' ' A' ' 13' ' ' GLN . 15.1 Cg_endo -57.37 -41.81 68.7 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.913 2.409 . . . . 0.0 112.628 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -45.38 -36.85 6.0 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.679 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.483 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 1.1 mpp_? -106.96 -22.82 12.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.721 -0.239 . . . . 0.0 111.098 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . 177.7 148.11 7.16 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.018 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.646 HD21 ' CD ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -140.19 143.62 36.17 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.194 0.521 . . . . 0.0 112.283 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.721 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 9.5 t -101.36 143.22 31.66 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.346 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -155.84 -108.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 118.753 -1.179 . . . . 0.0 113.255 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 43.6 t -72.26 68.41 0.74 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -177.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.426 ' HA2' HG21 ' A' ' 5' ' ' ILE . . . 114.93 -38.72 3.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.279 -0.962 . . . . 0.0 115.167 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.705 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -155.82 -165.98 2.09 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -177.172 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.721 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.7 m -83.09 -175.19 5.71 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.22 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.646 ' CD ' HD21 ' A' ' 22' ' ' LEU . 20.8 ttt180 -155.17 64.67 0.63 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -89.64 138.9 31.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.402 -178.488 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -80.65 162.9 58.82 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.692 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.71 117.16 3.81 Favored 'Trans proline' 0 CA--C 1.512 -0.606 0 C-N-CA 122.669 2.246 . . . . 0.0 112.738 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.18 46.98 0.97 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.75 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 20' ' ' ARG . 24.3 m-85 -146.04 147.49 31.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.691 0.282 . . . . 0.0 111.126 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 -87.25 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.48 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.684 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 50.85 -154.91 3.37 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.343 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.433 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 34.8 t -78.3 -20.46 51.47 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.63 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -127.86 -83.65 0.59 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.582 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 93.9 m -156.36 43.45 0.4 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.931 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.568 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 15.5 pm0 -102.92 -33.18 9.41 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.684 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.484 -0.77 . . . . 0.0 111.649 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.748 0.309 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.1 103.84 14.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.997 0.427 . . . . 0.0 110.368 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.449 ' O ' HD12 ' A' ' 5' ' ' ILE . 64.5 m-20 -158.2 -124.76 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.429 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.85 87.87 7.36 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.514 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -156.23 69.51 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-O 122.126 0.965 . . . . 0.0 108.787 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.55 153.86 23.0 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.963 -177.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.8 m -40.63 145.41 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.194 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 15' ' ' CYS . 76.0 mt-10 -87.76 179.15 6.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.671 178.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.867 ' HG2' HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -137.95 128.25 26.17 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.093 0.949 . . . . 0.0 112.251 178.712 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.798 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 1.0 OUTLIER -95.12 -147.09 0.27 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.572 178.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.452 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 3.0 t-20 -91.41 71.47 6.05 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.98 -24.83 2.25 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 119.673 -1.251 . . . . 0.0 115.216 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.752 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 18.7 mt-30 -155.56 -156.33 0.64 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.941 0.871 . . . . 0.0 110.386 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.867 HG12 ' HG2' ' A' ' 9' ' ' ARG . 32.9 m -107.23 115.01 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.195 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.642 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 1.2 m 68.87 47.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.71 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.798 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 54.47 29.77 48.19 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.19 -1.481 . . . . 0.0 111.227 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.14 150.69 0.27 Allowed Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.405 -0.398 . . . . 0.0 112.358 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 19.3 Cg_endo -59.0 -31.55 95.94 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.72 2.28 . . . . 0.0 112.672 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.28 -21.96 13.58 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.625 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -107.74 -33.49 7.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.358 . . . . 0.0 110.987 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 18' ' ' PRO . . . -177.32 161.54 29.06 Favored Glycine 0 CA--C 1.517 0.198 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.069 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.649 ' O ' ' N ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -125.93 -175.18 3.28 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 120.672 0.273 . . . . 0.0 110.41 179.387 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 14.6 p -137.42 148.24 46.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.386 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.601 ' CE2' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -156.61 -169.41 2.99 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.496 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.444 ' C ' ' O ' ' A' ' 24' ' ' PHE . 4.7 t -24.71 85.94 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.314 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 120.39 -68.42 0.4 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.382 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.52 -163.69 1.5 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 3.6 t -84.34 169.5 14.58 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.679 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.649 ' N ' ' O ' ' A' ' 22' ' ' LEU . 2.0 tpp85 -145.47 94.55 2.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.98 ' SG ' ' HB2' ' A' ' 34' ' ' PHE . 30.5 t -85.61 157.12 20.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.842 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 20' ' ' ARG . 9.5 m-70 -77.88 158.21 78.15 Favored Pre-proline 0 C--O 1.231 0.124 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.348 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -64.71 113.54 2.37 Favored 'Trans proline' 0 CA--C 1.515 -0.434 0 C-N-CA 122.712 2.274 . . . . 0.0 112.665 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.91 -24.88 5.94 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.922 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.98 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.8 m-85 -85.53 164.68 17.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.719 0.295 . . . . 0.0 110.846 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -155.0 -90.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.134 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.74 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 49.23 -153.52 2.61 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.129 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.63 -0.11 56.94 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.642 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -154.92 -78.61 0.09 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.051 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.455 ' SG ' ' CB ' ' A' ' 34' ' ' PHE . 23.2 t -156.29 35.67 0.33 Allowed 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.858 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.492 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -91.81 -35.28 14.19 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.75 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.74 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.659 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.804 0.335 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -109.28 -74.94 0.64 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.746 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.7 -170.59 0.14 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.032 0.444 . . . . 0.0 111.493 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.625 HG22 ' SG ' ' A' ' 23' ' ' CYS . 21.0 p -84.42 76.8 10.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.017 HG23 ' HA2' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -98.15 -20.21 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.387 -178.065 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.46 94.63 2.71 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.296 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.427 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 4.7 m -134.06 134.91 42.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.155 0.502 . . . . 0.0 111.145 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 15' ' ' CYS . 9.1 mm-40 -95.41 154.58 17.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.412 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 24.8 mtt180 -129.78 130.14 44.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.716 0.77 . . . . 0.0 111.209 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.868 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 1.5 p90 -96.28 -33.6 11.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.445 -1.252 . . . . 0.0 112.908 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -155.62 44.71 0.46 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.253 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.75 -13.4 56.36 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.285 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.72 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 32.4 mm-40 -84.59 -77.74 0.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 13' ' ' GLN . 3.7 p 145.72 108.29 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.553 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.696 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER 67.81 42.55 1.93 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 178.16 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.868 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 62.78 33.65 87.49 Favored Glycine 0 C--N 1.316 -0.554 0 C-N-CA 119.162 -1.495 . . . . 0.0 111.784 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.459 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 73.52 163.39 8.36 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.434 -0.412 . . . . 0.0 112.742 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.597 ' HB3' HD11 ' A' ' 22' ' ' LEU . 57.3 Cg_endo -70.86 -42.36 2.32 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.774 2.316 . . . . 0.0 112.809 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -47.42 -27.95 4.44 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.858 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.481 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -106.11 -49.55 3.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.71 0.29 . . . . 0.0 110.925 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.19 132.91 3.47 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.342 -0.933 . . . . 0.0 113.018 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' ' 18' ' ' PRO . 2.6 mm? -96.21 170.98 8.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.21 0.529 . . . . 0.0 112.226 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -112.75 131.66 55.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.068 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -135.08 -173.25 3.27 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -31.74 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.464 -1.698 . . . . 0.0 111.446 179.03 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 1.017 ' HA2' HG23 ' A' ' 5' ' ' ILE . . . 56.56 4.87 1.0 Allowed Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.829 -0.623 . . . . 0.0 114.042 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' A' ' 24' ' ' PHE . 15.0 mttt -156.16 152.65 28.15 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 118.064 0.932 . . . . 0.0 112.995 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -84.45 175.76 9.11 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.004 178.678 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.421 ' CG ' ' HB2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -148.79 86.0 1.5 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.825 0.345 . . . . 0.0 111.421 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.938 ' SG ' ' HB2' ' A' ' 34' ' ' PHE . 19.2 t -85.03 154.79 21.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.368 . . . . 0.0 110.916 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 20' ' ' ARG . 2.9 m-70 -78.21 153.97 79.65 Favored Pre-proline 0 N--CA 1.455 -0.194 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.36 111.62 1.51 Allowed 'Trans proline' 0 CA--C 1.514 -0.524 0 C-N-CA 122.434 2.09 . . . . 0.0 112.743 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.08 31.67 2.01 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.349 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.938 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 6.3 m-85 -131.12 158.5 40.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -148.17 -88.22 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.036 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.659 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 47.99 -154.85 1.37 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.118 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 m -79.31 -8.24 58.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.696 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -155.18 -74.67 0.11 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.377 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.449 ' SG ' ' CB ' ' A' ' 34' ' ' PHE . 45.3 t -155.74 33.54 0.36 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.21 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 2.7 pt20 -97.55 -29.74 13.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.725 0.297 . . . . 0.0 111.742 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.659 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.207 -0.901 . . . . 0.0 111.146 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 42.3 t . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.844 0.354 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.71 172.76 13.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.6 p -84.63 62.93 7.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -155.84 164.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 -178.173 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.477 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -154.9 151.49 28.62 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.68 -178.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.58 ' HB3' HG12 ' A' ' 14' ' ' VAL . 58.8 m -29.2 133.25 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.278 -0.873 . . . . 0.0 113.343 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 15' ' ' CYS . 4.0 mt-10 -95.65 113.02 24.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.37 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.579 ' HG3' HG13 ' A' ' 14' ' ' VAL . 3.3 mtp180 -84.8 134.1 34.32 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.556 0.693 . . . . 0.0 110.673 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.877 ' HE1' ' HB2' ' A' ' 13' ' ' GLN . 1.2 p90 -92.65 -27.38 17.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.339 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -155.45 -86.14 0.05 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.393 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.95 -2.83 9.23 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.851 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.877 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 2.4 mp0 -106.58 -116.11 0.26 Allowed 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.58 HG12 ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -168.65 111.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.651 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.8 OUTLIER 71.7 40.08 0.81 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.03 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.681 ' HA2' ' CD2' ' A' ' 10' ' ' TYR . . . 59.56 39.75 95.43 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.504 -1.331 . . . . 0.0 111.089 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 62.54 141.11 0.01 OUTLIER Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.203 -0.499 . . . . 0.0 112.444 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.25 -30.94 92.43 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.569 2.18 . . . . 0.0 112.36 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.55 -37.21 40.77 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.916 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.433 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -97.08 -43.86 7.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.718 0.294 . . . . 0.0 110.924 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -154.73 137.3 5.6 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.033 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.408 HD23 ' CZ ' ' A' ' 24' ' ' PHE . 3.7 mp -101.75 138.57 38.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.923 0.392 . . . . 0.0 111.867 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.81 147.24 26.94 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 26' ' ' GLY . 19.8 m-85 -153.91 -173.86 4.74 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 122.017 0.913 . . . . 0.0 112.484 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -32.27 90.53 0.0 OUTLIER 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 113.089 -1.869 . . . . 0.0 111.292 178.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 54.34 22.28 22.36 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.761 -0.654 . . . . 0.0 113.282 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -155.11 -167.37 2.54 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.0 t -152.91 104.24 2.83 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.691 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.76 94.92 8.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.158 0.504 . . . . 0.0 111.009 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.573 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -96.03 166.22 11.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.836 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -85.39 159.6 55.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.971 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.56 114.07 2.22 Favored 'Trans proline' 0 CA--C 1.512 -0.589 0 C-N-CA 122.725 2.283 . . . . 0.0 112.402 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.78 26.72 3.23 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.626 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.433 ' CE2' ' HA ' ' A' ' 20' ' ' ARG . 24.3 m-85 -134.64 150.84 50.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.302 . . . . 0.0 110.774 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 38' ' ' ALA . 0.9 OUTLIER -155.07 -83.11 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.062 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.733 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 48.96 -155.22 1.73 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.259 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.02 -10.54 59.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.651 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -143.71 -80.46 0.19 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.712 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 4.9 m -155.96 41.37 0.39 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.731 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.517 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -98.58 -32.28 11.52 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.733 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.32 -0.848 . . . . 0.0 111.72 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.756 0.312 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.596 ' O ' HD12 ' A' ' 5' ' ' ILE . 6.9 t70 -175.28 -124.79 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.691 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.85 93.43 8.51 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -156.3 80.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.851 0.834 . . . . 0.0 109.178 -179.32 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -84.26 137.79 33.29 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.425 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.542 ' O ' HG12 ' A' ' 14' ' ' VAL . 2.7 m -52.9 157.94 1.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.313 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 15' ' ' CYS . 4.8 mm-40 -84.24 129.56 34.88 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.346 178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.535 ' HG2' HG13 ' A' ' 14' ' ' VAL . 47.0 mtm180 -84.37 131.03 34.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.932 0.872 . . . . 0.0 110.905 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.892 ' HE1' ' HB2' ' A' ' 13' ' ' GLN . 0.9 OUTLIER -84.99 -60.66 1.98 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.833 -178.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.441 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 28.0 p30 -156.05 49.76 0.51 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.037 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.39 -45.96 1.08 Allowed Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.908 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.892 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 2.5 mp0 -105.05 -165.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -113.35 112.85 42.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.16 0.505 . . . . 0.0 111.354 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.635 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 74.7 46.15 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.388 178.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.638 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 54.32 33.53 52.92 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.631 -1.271 . . . . 0.0 111.34 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.84 145.25 0.02 OUTLIER Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.245 -0.477 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.52 -25.03 47.26 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.555 2.17 . . . . 0.0 112.024 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.8 -26.14 32.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.996 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.491 ' NE ' ' CE1' ' A' ' 34' ' ' PHE . 4.4 mmm180 -114.74 -51.42 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 110.307 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.663 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -139.94 139.77 10.16 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.597 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.1 tp -133.91 130.27 37.51 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 120.73 0.3 . . . . 0.0 110.913 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.86 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 1.7 p -104.0 157.94 16.76 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.624 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -156.06 -97.43 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.285 -0.966 . . . . 0.0 113.113 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.5 t -76.46 67.36 2.63 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.223 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.561 ' HA2' HG13 ' A' ' 5' ' ' ILE . . . 92.2 -6.97 78.7 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.97 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -155.63 163.15 40.31 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -178.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.86 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 7.8 t -103.19 100.47 10.38 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.052 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -84.54 96.19 9.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.998 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.663 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -87.58 151.99 22.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.236 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -70.26 153.62 95.09 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.487 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.15 116.9 3.59 Favored 'Trans proline' 0 CA--C 1.513 -0.555 0 C-N-CA 122.705 2.27 . . . . 0.0 112.851 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . 106.82 44.8 1.26 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.902 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.491 ' CE1' ' NE ' ' A' ' 20' ' ' ARG . 17.2 m-85 -145.42 154.74 42.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.383 . . . . 0.0 111.106 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -155.14 -83.53 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.111 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.666 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 47.63 -154.7 1.23 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.31 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.18 -9.16 59.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.635 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -145.18 -80.35 0.17 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.52 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 1.9 m -155.99 40.67 0.38 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.884 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.515 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -97.16 -32.91 11.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.666 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.742 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 3' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.378 0 CA-C-O 120.471 0.177 . . . . 0.0 110.864 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 2' ' ' CYS . 24.1 t70 80.02 -118.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.266 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 p -84.13 90.67 7.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.235 0.541 . . . . 0.0 110.042 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -155.55 178.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.03 134.8 10.86 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.149 -1.021 . . . . 0.0 112.155 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.5 m -60.73 140.52 57.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.5 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -83.06 127.05 33.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.696 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.95 ' HG2' HG12 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -104.71 131.96 51.52 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.573 0.702 . . . . 0.0 111.949 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.854 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 1.3 p90 -88.37 -149.26 0.17 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.435 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.456 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 3.4 p-10 -91.31 77.46 5.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.502 ' C ' ' HG2' ' A' ' 13' ' ' GLN . . . 138.29 -28.99 2.65 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 119.963 -1.113 . . . . 0.0 114.87 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.71 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -152.23 -162.64 1.55 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.718 0.759 . . . . 0.0 110.372 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.95 HG12 ' HG2' ' A' ' 9' ' ' ARG . 34.4 m -106.06 108.13 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.283 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.674 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER 84.36 43.69 0.02 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.969 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.854 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 59.97 30.0 69.07 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.217 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.484 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 76.03 134.74 0.51 Allowed Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.259 -0.471 . . . . 0.0 112.654 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.496 ' HB3' HD11 ' A' ' 22' ' ' LEU . 63.2 Cg_exo -51.93 -33.91 53.88 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.631 2.221 . . . . 0.0 112.678 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.69 -22.57 11.92 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.857 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' A' ' 40' ' ' GLN . 38.4 mtm-85 -110.13 -36.7 5.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.604 0.24 . . . . 0.0 111.304 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 30' ' ' CYS . . . -171.33 139.87 5.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.139 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.496 HD11 ' HB3' ' A' ' 18' ' ' PRO . 1.6 mm? -91.71 -179.52 5.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.233 0.54 . . . . 0.0 112.15 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.879 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 16.0 p -121.26 143.16 49.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 27' ' ' LYS . 5.3 m-85 -143.93 179.28 7.28 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -37.46 102.51 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 112.718 -2.037 . . . . 0.0 111.04 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.423 ' H ' HG13 ' A' ' 5' ' ' ILE . . . 93.61 -44.37 2.42 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.312 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 24' ' ' PHE . 26.6 mtmm -155.04 -179.28 7.91 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.879 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -84.44 160.69 20.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.833 179.425 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 95.54 2.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.898 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.444 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 2.2 p -100.37 162.02 13.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.949 0.404 . . . . 0.0 111.102 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -64.16 157.68 68.59 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.498 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.08 112.08 1.43 Allowed 'Trans proline' 0 CA--C 1.513 -0.57 0 C-N-CA 122.531 2.154 . . . . 0.0 112.476 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.46 32.79 2.65 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.93 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -125.52 150.53 47.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.003 0.43 . . . . 0.0 111.11 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 40' ' ' GLN . 45.7 mt-10 -155.4 -152.98 0.42 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.304 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.88 -161.22 12.89 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.291 -0.956 . . . . 0.0 111.892 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.3 m -62.25 -21.48 65.21 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.674 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -140.84 -81.39 0.25 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.026 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.5 m -157.1 39.33 0.31 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.121 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -85.94 -31.29 22.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.934 -179.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.401 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.633 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.587 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 52.3 t . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.554 0.216 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.54 162.87 40.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.381 . . . . 0.0 111.346 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.436 ' O ' HG12 ' A' ' 5' ' ' ILE . 28.5 p -84.88 63.48 8.08 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.682 HG22 ' HA2' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -155.5 169.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -177.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.503 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -153.65 163.34 40.16 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.494 -0.883 . . . . 0.0 112.525 -179.038 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.567 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 8.7 m -18.85 136.61 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.649 -1.159 . . . . 0.0 114.029 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 15' ' ' CYS . 24.6 mt-10 -95.24 128.17 41.87 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.477 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 24.0 mtm105 -103.02 130.97 50.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.835 0.826 . . . . 0.0 111.456 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.651 ' CE2' ' HA2' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -92.42 -32.9 14.76 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.584 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.423 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.4 m-20 -156.14 -79.96 0.08 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.003 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.05 26.86 1.27 Allowed Glycine 0 C--N 1.331 0.306 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.566 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.485 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 37.4 mm-40 -136.0 11.73 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.466 0.174 . . . . 0.0 110.854 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 1.5 p 43.59 106.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.876 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 77.1 m 80.28 40.13 0.08 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.746 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.651 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 44.15 52.65 6.95 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.118 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.06 146.75 2.94 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.986 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 84.3 Cg_endo -78.3 -35.65 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.81 2.34 . . . . 0.0 112.727 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.94 -21.17 29.71 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.892 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.459 ' CD ' ' CE1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -99.71 -31.56 11.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.95 0.405 . . . . 0.0 110.832 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 18' ' ' PRO . . . -175.45 158.43 25.71 Favored Glycine 0 N--CA 1.453 -0.189 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.716 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -104.1 -150.08 0.42 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 117.33 0.565 . . . . 0.0 111.629 -179.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.6 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 11.4 p -155.69 125.58 6.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.873 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.623 ' CZ ' ' HB3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -156.45 -102.72 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.453 177.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.587 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 8.3 t -56.08 77.31 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.148 0.499 . . . . 0.0 110.227 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.682 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 46.42 21.49 0.77 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.968 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.16 168.16 28.16 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 14.7 m -105.11 125.12 50.63 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.452 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.737 ' HG3' ' O ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -84.45 88.43 7.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.629 0.728 . . . . 0.0 109.481 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -92.81 160.01 15.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.906 -178.041 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.26 163.62 24.33 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.495 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.84 115.1 2.31 Favored 'Trans proline' 0 CA--C 1.512 -0.62 0 C-N-CA 122.753 2.302 . . . . 0.0 112.762 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . 116.26 36.9 1.06 Allowed Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 114.704 -1.134 . . . . 0.0 112.913 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.459 ' CE1' ' CD ' ' A' ' 20' ' ' ARG . 30.0 m-85 -148.03 156.12 42.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.739 0.304 . . . . 0.0 110.935 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -154.33 -90.28 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.23 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.62 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 47.95 -162.86 0.34 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.419 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -16.83 62.45 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.594 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -136.84 -81.96 0.37 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.079 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -156.13 42.4 0.39 Allowed 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.014 178.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.505 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -92.82 -31.24 15.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.886 -179.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.62 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.468 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 25' ' ' CYS . 42.0 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.818 0.342 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.644 ' C ' HD13 ' A' ' 5' ' ' ILE . 1.7 t0 178.72 -148.81 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.687 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.6 p -84.75 94.56 8.71 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.644 HD13 ' C ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -155.45 67.22 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 121.89 0.852 . . . . 0.0 108.983 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.38 135.73 34.16 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.503 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.534 ' HA ' ' HB3' ' A' ' 23' ' ' CYS . 22.6 m -40.47 146.42 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.033 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 44.4 mm-40 -93.67 178.74 5.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.867 ' HG2' HG12 ' A' ' 14' ' ' VAL . 14.0 mtt85 -133.15 131.79 40.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.131 0.967 . . . . 0.0 113.233 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.931 ' HE1' ' HB2' ' A' ' 13' ' ' GLN . 5.6 p90 -92.16 -146.19 0.22 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.301 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -91.46 68.57 5.78 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 145.37 -32.5 1.63 Allowed Glycine 0 C--N 1.338 0.69 0 C-N-CA 119.818 -1.182 . . . . 0.0 114.868 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.931 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 3.1 mm100 -149.57 -156.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.528 0.664 . . . . 0.0 110.489 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.867 HG12 ' HG2' ' A' ' 9' ' ' ARG . 23.0 m -104.89 115.05 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.978 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.674 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER 64.63 53.58 1.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.3 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.655 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 51.33 31.95 28.72 Favored Glycine 0 C--N 1.318 -0.442 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.954 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.404 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 64.25 158.0 0.24 Allowed Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.498 -0.351 . . . . 0.0 112.855 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.3 -13.02 35.71 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.75 2.3 . . . . 0.0 112.902 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.74 27.58 4.26 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.792 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.487 ' C ' ' SG ' ' A' ' 39' ' ' CYS . 26.3 mtp85 -155.13 -42.45 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 30' ' ' CYS . . . 179.19 176.0 46.59 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.15 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.571 HD12 ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -143.08 -175.04 4.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.931 0.396 . . . . 0.0 110.82 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.912 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 8.2 p -101.43 143.2 31.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.47 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.571 ' CE1' HD12 ' A' ' 22' ' ' LEU . 7.3 m-85 -126.42 -179.05 4.57 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.923 0.868 . . . . 0.0 112.977 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 2' ' ' CYS . 1.7 t -55.04 72.76 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.801 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 141.66 -55.84 0.6 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.482 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.57 -177.6 6.67 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.912 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -84.33 128.84 34.82 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.913 178.491 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -113.24 103.96 11.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.366 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.609 ' SG ' ' CB ' ' A' ' 34' ' ' PHE . 7.7 t -85.08 156.14 21.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.819 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.459 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 9.5 m-70 -65.48 157.13 79.78 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.882 0.372 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.85 116.46 3.37 Favored 'Trans proline' 0 CA--C 1.512 -0.584 0 C-N-CA 122.804 2.336 . . . . 0.0 112.696 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.12 29.08 5.01 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.756 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.609 ' CB ' ' SG ' ' A' ' 30' ' ' CYS . 5.4 m-85 -125.1 170.92 10.71 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.908 -0.172 . . . . 0.0 110.811 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.41 ' N ' ' OXT' ' A' ' 41' ' ' ALA . 6.2 mm-40 -155.44 -102.65 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.063 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.784 ' N ' ' HB3' ' A' ' 41' ' ' ALA . . . 63.51 -157.19 41.54 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.367 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.549 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 0.5 OUTLIER -94.87 -18.1 21.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.04 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.674 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -138.56 -73.62 0.4 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.433 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.599 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 53.4 t -157.35 20.21 0.29 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.938 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.736 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -77.62 -33.33 53.68 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.784 ' HB3' ' N ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 117.961 -1.019 . . . . 0.0 111.36 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 10.8 t . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 120.587 0.232 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.56 -155.61 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.67 0.271 . . . . 0.0 110.807 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 48.0 p -84.08 113.93 21.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.782 HG23 ' HA2' ' A' ' 26' ' ' GLY . 0.4 OUTLIER -147.78 74.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-O 121.799 0.809 . . . . 0.0 111.141 -177.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 7' ' ' CYS . 6.2 p30 -93.89 53.52 1.81 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.486 -1.233 . . . . 0.0 108.55 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' ASN . 21.4 m -7.77 135.16 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 113.448 -1.706 . . . . 0.0 114.813 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -89.96 128.77 36.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.985 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.636 ' CG ' HG12 ' A' ' 14' ' ' VAL . 4.7 mpp_? -92.33 134.0 35.32 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.331 0.586 . . . . 0.0 111.809 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 1.149 ' CE1' ' HB2' ' A' ' 13' ' ' GLN . 9.7 p90 -85.59 -134.83 0.06 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.806 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -83.26 72.18 10.19 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.03 -18.52 45.95 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 1.149 ' HB2' ' CE1' ' A' ' 10' ' ' TYR . 2.7 mp0 -115.21 -133.51 0.34 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.889 0.844 . . . . 0.0 111.317 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.636 HG12 ' CG ' ' A' ' 9' ' ' ARG . 2.9 m -147.4 114.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 121.079 0.466 . . . . 0.0 111.739 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.664 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 66.43 44.41 2.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.379 178.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.719 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 60.29 18.08 48.42 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.769 -1.205 . . . . 0.0 111.83 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.637 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 66.2 144.98 0.06 OUTLIER Glycine 0 C--N 1.338 0.655 0 C-N-CA 121.79 -0.243 . . . . 0.0 113.076 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.68 -31.81 52.04 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.69 2.26 . . . . 0.0 112.449 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -48.29 -28.71 6.46 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.927 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HD2' ' CE2' ' A' ' 34' ' ' PHE . 6.6 mmm-85 -118.25 -31.47 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 110.636 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.468 ' CA ' ' HA ' ' A' ' 30' ' ' CYS . . . -168.43 149.69 14.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.738 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.777 HD11 ' CE2' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -128.8 166.27 19.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.097 0.475 . . . . 0.0 111.208 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -84.75 134.88 34.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.105 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.777 ' CE2' HD11 ' A' ' 22' ' ' LEU . 1.1 m-85 -130.16 -177.56 4.36 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.702 0.763 . . . . 0.0 112.111 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.523 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 0.1 OUTLIER -41.95 86.25 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.224 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.782 ' HA2' HG23 ' A' ' 5' ' ' ILE . . . 70.47 6.31 57.9 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.731 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -156.3 142.03 17.85 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -90.43 115.46 27.61 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -99.66 102.43 13.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.135 0.493 . . . . 0.0 111.726 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.468 ' HA ' ' CA ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -96.32 144.07 26.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.375 179.163 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.469 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 12.3 m-70 -53.76 149.82 15.51 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.22 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 23.9 Cg_exo -62.67 117.48 4.37 Favored 'Trans proline' 0 CA--C 1.514 -0.51 0 C-N-CA 122.698 2.265 . . . . 0.0 112.834 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.421 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . 109.03 31.49 3.32 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.84 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 31' ' ' HIS . 17.9 m-85 -136.46 146.66 46.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.921 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.639 ' CG ' ' HB3' ' A' ' 41' ' ' ALA . 18.9 pt-20 -142.44 -140.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.076 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 35' ' ' GLU . . . 102.1 -162.38 17.16 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.517 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.464 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 0.7 OUTLIER -69.36 -16.15 63.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.664 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -145.77 -79.88 0.17 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.694 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -155.9 26.56 0.37 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.027 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.735 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -69.46 -31.02 69.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.639 ' HB3' ' CG ' ' A' ' 35' ' ' GLU . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.156 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.591 ' CB ' ' HA ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.301 0.096 . . . . 0.0 110.773 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 13.0 t70 -177.19 -4.04 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.6 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -84.42 57.41 4.27 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.577 HD13 ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -84.73 92.88 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.862 -177.138 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.76 37.99 0.37 Allowed 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.474 -1.693 . . . . 0.0 108.925 -177.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.439 ' HB2' ' CG1' ' A' ' 14' ' ' VAL . 13.6 m -35.51 147.77 0.02 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 113.811 -1.541 . . . . 0.0 112.896 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.24 121.47 33.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.928 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.765 ' HG3' HG13 ' A' ' 14' ' ' VAL . 17.4 mtm180 -95.73 131.36 42.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.639 0.733 . . . . 0.0 112.133 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.793 ' CD2' ' HA2' ' A' ' 16' ' ' GLY . 1.6 p90 -84.97 -33.08 22.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.495 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.71 -77.86 0.09 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.007 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -148.06 16.41 1.35 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.19 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.563 ' C ' HG23 ' A' ' 14' ' ' VAL . 47.2 mm-40 -118.68 -19.04 8.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.972 0.415 . . . . 0.0 110.577 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.765 HG13 ' HG3' ' A' ' 9' ' ' ARG . 1.6 t 70.67 92.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.662 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.636 ' CB ' ' O ' ' A' ' 14' ' ' VAL . 8.2 t 104.96 34.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.765 0.666 . . . . 0.0 112.123 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.793 ' HA2' ' CD2' ' A' ' 10' ' ' TYR . . . 56.48 41.23 88.18 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.051 -1.071 . . . . 0.0 113.109 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.35 148.95 4.03 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.188 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 25.3 Cg_exo -62.67 -44.8 15.84 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.71 2.274 . . . . 0.0 112.087 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.46 -31.65 14.22 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.341 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.449 ' HG3' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -95.51 -30.44 13.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.771 0.32 . . . . 0.0 110.712 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.477 ' CA ' ' HA ' ' A' ' 30' ' ' CYS . . . 179.68 156.02 16.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.879 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.643 HD12 ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -122.43 -166.16 1.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 5.3 t -145.2 145.56 31.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.622 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.643 ' CE2' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -155.78 -101.21 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.573 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.591 ' HA ' ' CB ' ' A' ' 2' ' ' CYS . 0.8 OUTLIER -55.61 80.3 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 41.38 26.35 0.21 Allowed Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.616 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.61 142.3 18.83 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -87.92 111.1 21.08 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.923 178.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.609 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 7.3 ttp85 -97.63 100.45 11.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.916 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.477 ' HA ' ' CA ' ' A' ' 21' ' ' GLY . 1.8 p -95.87 165.04 12.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.074 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -73.37 159.15 85.53 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.498 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.17 112.66 1.61 Allowed 'Trans proline' 0 CA--C 1.513 -0.551 0 C-N-CA 122.609 2.206 . . . . 0.0 112.527 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.36 22.53 4.07 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.046 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.473 ' HA ' ' OXT' ' A' ' 41' ' ' ALA . 40.5 m-85 -125.49 148.82 48.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.659 0.266 . . . . 0.0 110.842 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 39' ' ' CYS . 1.2 mt-10 -155.54 -96.6 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.664 ' CA ' ' HB3' ' A' ' 41' ' ' ALA . . . 67.21 -144.36 44.44 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.174 -1.013 . . . . 0.0 111.883 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.462 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 40.3 t -90.46 -3.06 57.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.578 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -148.68 -79.96 0.14 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.29 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 35' ' ' GLU . 9.0 m -157.17 39.37 0.3 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.635 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.593 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 17.6 pm0 -106.11 -33.49 7.84 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.664 ' HB3' ' CA ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.346 -0.835 . . . . 0.0 112.121 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 25' ' ' CYS . 46.0 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.737 0.303 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.452 ' OD1' HD12 ' A' ' 5' ' ' ILE . 14.9 p-10 -167.17 -160.24 0.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.858 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.75 86.33 7.37 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.532 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -156.34 79.35 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-O 121.981 0.896 . . . . 0.0 108.92 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 7' ' ' CYS . 6.9 p30 -84.22 72.88 10.5 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.867 -177.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.576 ' HB3' ' HB ' ' A' ' 14' ' ' VAL . 69.9 m 47.73 149.35 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.433 -1.258 . . . . 0.0 113.457 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.684 ' O ' ' N ' ' A' ' 15' ' ' CYS . 15.1 mm-40 -94.93 131.43 40.86 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.558 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.743 ' CG ' HG12 ' A' ' 14' ' ' VAL . 4.0 mtp85 -100.08 131.36 46.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.794 0.807 . . . . 0.0 111.347 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.7 ' CD2' ' HA2' ' A' ' 16' ' ' GLY . 1.2 p90 -91.37 -30.4 16.56 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.842 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -155.79 -85.33 0.05 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.825 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.56 -16.39 10.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.255 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.541 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -110.76 -159.96 0.7 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.743 HG12 ' CG ' ' A' ' 9' ' ' ARG . 28.2 m -124.4 104.09 13.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.137 0.494 . . . . 0.0 111.267 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.686 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER 86.21 48.15 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.501 179.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.7 ' HA2' ' CD2' ' A' ' 10' ' ' TYR . . . 53.64 30.39 42.88 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.352 -1.404 . . . . 0.0 111.726 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.21 143.81 0.82 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.602 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.0 -35.33 98.87 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.521 2.147 . . . . 0.0 112.27 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -48.17 -28.95 6.42 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.845 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.46 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.1 OUTLIER -101.48 -36.43 8.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.104 0.478 . . . . 0.0 109.778 179.165 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 30' ' ' CYS . . . 177.02 152.39 9.83 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.634 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.45 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -113.7 175.73 5.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.784 0.326 . . . . 0.0 110.721 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.69 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -98.71 156.07 17.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.295 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.601 ' O ' ' N ' ' A' ' 26' ' ' GLY . 6.2 m-85 -139.29 -175.23 4.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.875 0.845 . . . . 0.0 112.26 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 25' ' ' CYS . 1.5 t -47.27 77.36 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 113.406 -1.725 . . . . 0.0 110.874 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 80.7 19.26 68.53 Favored Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.316 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -155.18 -164.86 1.87 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 117.388 0.594 . . . . 0.0 112.246 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.69 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -145.49 115.59 7.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.625 179.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.39 88.0 7.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.12 0.486 . . . . 0.0 110.913 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.988 ' SG ' ' HB2' ' A' ' 34' ' ' PHE . 18.2 t -85.03 155.47 21.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.931 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.46 ' CD2' ' O ' ' A' ' 20' ' ' ARG . 11.6 m-70 -78.46 154.5 79.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.959 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.04 112.73 1.61 Allowed 'Trans proline' 0 CA--C 1.513 -0.54 0 C-N-CA 122.481 2.121 . . . . 0.0 112.883 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.5 28.53 2.52 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.356 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.988 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 12.4 m-85 -130.86 164.04 26.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.81 0.305 . . . . 0.0 110.955 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -153.39 -91.61 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.98 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.707 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 48.6 -152.21 2.66 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.07 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.449 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 27.7 p -92.18 1.04 57.46 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.686 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -155.21 -79.31 0.09 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.092 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 43.2 t -156.55 36.95 0.32 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.682 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.593 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -92.46 -34.85 13.94 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.707 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.655 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.748 0.309 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -178.75 -138.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.903 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.9 90.01 6.91 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.527 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -155.23 72.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.243 -177.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -84.15 -179.51 7.24 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.891 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.58 ' HB2' HG12 ' A' ' 14' ' ' VAL . 1.5 m -78.88 140.88 38.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.567 -177.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 15' ' ' CYS . 2.4 mt-10 -94.81 124.8 39.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.613 ' HG3' HG13 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -84.52 132.11 34.57 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.832 0.825 . . . . 0.0 112.863 -177.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 1.083 ' CE1' ' HB2' ' A' ' 13' ' ' GLN . 4.2 p90 -84.91 -125.51 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.574 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -83.71 51.58 2.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.89 -28.48 6.12 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 119.965 -1.112 . . . . 0.0 115.641 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 1.083 ' HB2' ' CE1' ' A' ' 10' ' ' TYR . 2.8 mp0 -101.75 -125.95 0.19 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.942 0.871 . . . . 0.0 111.439 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.613 HG13 ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -150.37 110.52 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 120.998 0.428 . . . . 0.0 111.495 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.681 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 65.87 44.13 2.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.657 179.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.718 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 60.58 22.72 59.68 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.315 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.545 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 69.45 144.87 0.19 Allowed Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.407 -0.397 . . . . 0.0 112.739 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -50.61 -30.26 27.85 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.701 2.268 . . . . 0.0 112.441 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.7 -26.7 54.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.435 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.93 -28.49 9.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.612 0.244 . . . . 0.0 111.109 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.553 ' HA3' ' HB3' ' A' ' 30' ' ' CYS . . . -179.86 158.34 21.91 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.843 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 29' ' ' ARG . 5.7 mp -124.56 142.26 51.48 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 111.697 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.829 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -84.73 127.76 34.27 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.53 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.529 ' O ' ' N ' ' A' ' 26' ' ' GLY . 16.2 m-85 -141.71 175.83 9.39 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -177.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -34.46 83.57 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 111.814 -2.448 . . . . 0.0 111.031 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 120.77 -57.94 0.58 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.234 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -155.79 -178.29 7.19 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.829 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 4.8 t -89.16 107.58 19.13 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.348 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 22' ' ' LEU . 5.2 tpt85 -84.81 88.57 7.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.989 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.553 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 1.0 OUTLIER -95.01 156.77 16.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -63.13 153.39 81.5 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.647 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.14 113.05 1.58 Allowed 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 122.591 2.194 . . . . 0.0 112.564 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.4 23.03 4.6 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.932 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -124.49 148.98 47.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.871 0.367 . . . . 0.0 111.089 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.44 ' HB2' ' OXT' ' A' ' 41' ' ' ALA . 4.5 mm-40 -155.4 -88.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.218 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.599 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 61.45 -147.89 47.39 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.044 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.466 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 1.1 m -87.22 -5.04 59.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.681 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -144.09 -82.89 0.16 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.232 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 7.3 m -157.47 42.88 0.32 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.057 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.536 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 9.9 pm0 -108.56 -33.77 6.93 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.599 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.115 -0.945 . . . . 0.0 111.983 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 33.8 m . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.438 0.161 . . . . 0.0 110.714 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.483 ' O ' HD12 ' A' ' 5' ' ' ILE . 0.8 OUTLIER 82.23 -141.68 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.0 p -84.4 117.15 23.44 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.541 0.686 . . . . 0.0 109.896 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.71 HG13 ' H ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -155.31 74.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.4 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -84.85 140.67 31.0 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.281 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.613 ' O ' HG12 ' A' ' 14' ' ' VAL . 75.8 m -100.16 -177.98 3.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.272 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 15' ' ' CYS . 3.5 mp0 -67.82 144.89 55.13 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.322 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.495 ' HB3' ' C ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -105.12 160.69 14.86 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.501 0.667 . . . . 0.0 111.619 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.783 ' CD2' ' HA3' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -127.69 -16.67 4.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.79 179.197 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -155.66 62.43 0.6 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.302 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.78 26.4 57.58 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.495 ' C ' ' HB3' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -155.14 127.43 7.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.197 -0.501 . . . . 0.0 110.545 -178.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.862 HG21 ' HB3' ' A' ' 23' ' ' CYS . 12.9 m -51.17 118.67 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.657 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 95.3 m 64.52 49.95 2.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -176.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.783 ' HA3' ' CD2' ' A' ' 10' ' ' TYR . . . 17.87 48.29 0.01 OUTLIER Glycine 0 C--N 1.341 0.845 0 CA-C-N 114.467 -1.242 . . . . 0.0 115.047 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 15' ' ' CYS . . . 96.94 147.84 23.25 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.823 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.66 -15.72 43.74 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.531 2.154 . . . . 0.0 113.039 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -46.59 -45.63 17.58 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.088 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.471 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -102.96 -44.1 5.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.186 0.517 . . . . 0.0 110.033 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -157.87 144.84 10.95 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.502 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -132.62 135.91 46.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.988 0.394 . . . . 0.0 111.764 -179.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.967 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 11.8 t -97.55 128.78 44.56 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.406 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.636 ' CE1' ' HB2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -156.89 -157.8 0.72 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.783 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.519 ' C ' ' O ' ' A' ' 24' ' ' PHE . 39.9 t -24.87 94.21 0.01 OUTLIER 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.105 0.478 . . . . 0.0 110.393 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.71 ' H ' HG13 ' A' ' 5' ' ' ILE . . . 102.83 -76.12 0.3 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.386 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -154.27 -160.65 1.11 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.967 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 50.5 t -92.39 112.65 24.68 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.881 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.636 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -84.74 94.15 8.61 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -93.55 156.72 16.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.07 -178.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -83.01 157.16 66.62 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.772 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -57.68 122.58 11.99 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 122.89 2.393 . . . . 0.0 113.197 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.54 49.23 2.59 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.719 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.471 ' CZ ' ' HG3' ' A' ' 20' ' ' ARG . 7.1 m-85 -139.99 150.09 44.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.965 0.412 . . . . 0.0 111.702 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 38' ' ' ALA . 1.9 mm-40 -155.33 -90.3 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.384 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.681 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 58.94 -145.52 43.55 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.994 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.433 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -91.36 -1.72 57.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.129 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.657 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -146.27 -83.2 0.13 Allowed 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.639 -1.618 . . . . 0.0 109.088 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 69.5 m -156.48 45.05 0.42 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.518 178.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.615 HE22 ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -97.83 -36.05 10.32 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.681 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.963 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.489 ' CB ' ' HA ' ' A' ' 25' ' ' CYS . 4.9 t . . . . . 0 CA--C 1.53 0.19 0 CA-C-O 120.551 0.215 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.99 -161.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.685 0.278 . . . . 0.0 111.089 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.4 p -84.49 91.27 7.81 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.602 HG21 ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -155.75 79.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.134 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.2 151.3 25.73 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.886 -177.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.538 ' HB3' ' CG1' ' A' ' 14' ' ' VAL . 5.2 m -50.0 135.88 19.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.043 -0.981 . . . . 0.0 113.333 -177.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -96.01 148.6 22.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.989 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.405 ' HA ' ' H ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -111.1 154.93 23.57 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 122.069 0.938 . . . . 0.0 111.248 179.014 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.851 ' CZ ' ' HA2' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -112.68 -27.63 8.1 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.421 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -156.24 -38.07 0.08 Allowed 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.16 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.74 1.27 0.05 OUTLIER Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.891 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.569 ' C ' HG23 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -101.05 -17.64 16.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.346 0.573 . . . . 0.0 110.22 179.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.569 HG23 ' C ' ' A' ' 13' ' ' GLN . 3.5 t 84.96 98.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.514 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.784 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 1.0 OUTLIER 69.43 47.37 0.69 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.53 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.851 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 45.51 61.25 3.8 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.521 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 54.96 168.48 0.05 OUTLIER Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.953 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.493 ' CB ' HD11 ' A' ' 22' ' ' LEU . 95.6 Cg_endo -80.98 -26.82 3.32 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.663 2.242 . . . . 0.0 112.763 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.6 -25.62 6.78 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.696 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -104.97 -51.64 3.0 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 30' ' ' CYS . . . -165.18 144.76 9.56 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.668 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.512 ' O ' ' CA ' ' A' ' 28' ' ' CYS . 0.7 OUTLIER -96.51 -177.76 4.05 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 122.651 0.38 . . . . 0.0 111.434 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 29.3 p -126.51 116.18 20.69 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -157.6 -162.94 1.25 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.191 -1.003 . . . . 0.0 112.533 177.262 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.489 ' HA ' ' CB ' ' A' ' 2' ' ' CYS . 9.2 t -24.04 122.19 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.236 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.602 ' O ' HG21 ' A' ' 5' ' ' ILE . . . 80.02 -73.01 2.51 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.169 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.535 ' HG2' ' C ' ' A' ' 26' ' ' GLY . 5.5 mmmm -155.84 -157.93 0.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.613 0.721 . . . . 0.0 112.39 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.1 m -85.5 124.58 32.24 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.049 178.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . 10.2 ttt-85 -84.72 84.57 7.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.932 0.396 . . . . 0.0 110.279 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.436 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 0.8 OUTLIER -96.99 141.76 29.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.169 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -61.68 158.6 40.08 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.45 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.65 114.98 2.29 Favored 'Trans proline' 0 CA--C 1.512 -0.597 0 C-N-CA 122.539 2.159 . . . . 0.0 112.755 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.1 34.71 1.76 Allowed Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.754 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -135.09 147.55 49.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.874 0.368 . . . . 0.0 111.111 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.488 ' O ' ' C ' ' A' ' 38' ' ' ALA . 2.4 mt-10 -155.08 -83.69 0.07 Allowed 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.677 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 52.03 -155.42 4.46 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.234 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.1 m -75.73 -12.35 60.17 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.784 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -138.53 -81.84 0.31 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.286 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.0 m -156.93 44.21 0.38 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.456 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.535 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -100.1 -33.44 10.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.677 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.777 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.977 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 121.595 0.712 . . . . 0.0 111.479 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.544 ' O ' ' O ' ' A' ' 2' ' ' CYS . 7.7 t70 -47.1 -123.36 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.761 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.405 ' C ' HG23 ' A' ' 5' ' ' ILE . 13.9 p -84.89 92.79 8.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.457 . . . . 0.0 109.935 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.553 HG13 ' H ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -156.16 71.77 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-O 122.191 0.996 . . . . 0.0 108.719 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.57 136.57 33.73 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.27 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -58.13 159.1 6.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.38 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' CYS . 2.4 mt-10 -95.22 169.6 9.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.69 ' CG ' HG12 ' A' ' 14' ' ' VAL . 3.0 mtp180 -123.9 127.84 48.59 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 122.2 1.0 . . . . 0.0 112.244 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.631 ' CE2' ' HA2' ' A' ' 16' ' ' GLY . 1.2 p90 -92.15 -32.86 14.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.069 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -155.89 -74.4 0.1 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.027 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.9 24.58 0.62 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.797 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.47 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 37.9 mm-40 -135.3 14.32 3.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.627 0.251 . . . . 0.0 110.966 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.69 HG12 ' CG ' ' A' ' 9' ' ' ARG . 8.2 m 43.53 105.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.451 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.637 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER 80.98 36.62 0.09 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 178.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.631 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 49.69 48.71 35.72 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.991 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.7 150.77 0.01 OUTLIER Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.301 -0.476 . . . . 0.0 113.15 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 45.1 Cg_endo -68.57 -29.26 30.61 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.571 2.181 . . . . 0.0 112.017 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.425 ' O ' ' CD2' ' A' ' 31' ' ' HIS . . . -49.04 -38.36 24.5 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.861 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.514 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -97.11 -45.02 6.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.058 0.456 . . . . 0.0 110.195 179.33 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -156.47 142.6 8.89 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.961 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.686 HD21 ' HE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -150.29 132.86 15.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.866 0.365 . . . . 0.0 111.351 -178.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.757 ' CA ' ' HA ' ' A' ' 28' ' ' CYS . 20.8 p -98.44 157.15 16.39 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.111 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.686 ' HE2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -155.82 -95.47 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.586 -0.845 . . . . 0.0 112.123 179.328 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.977 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 24.0 t -93.66 73.19 4.32 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 121.37 0.605 . . . . 0.0 110.338 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.553 ' H ' HG13 ' A' ' 5' ' ' ILE . . . 133.58 -65.49 0.58 Allowed Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.854 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.715 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 6.6 mttt -156.58 -174.49 4.96 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.757 ' HA ' ' CA ' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -85.01 109.11 17.96 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.453 178.182 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -84.39 91.11 7.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.398 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.579 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -92.93 134.4 35.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.582 -179.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.425 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 1.2 m-70 -67.16 159.73 75.17 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.817 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.23 118.07 4.9 Favored 'Trans proline' 0 CA--C 1.511 -0.633 0 C-N-CA 122.696 2.264 . . . . 0.0 112.832 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.3 47.66 0.98 Allowed Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.678 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.514 ' CE2' ' HA ' ' A' ' 20' ' ' ARG . 26.4 m-85 -146.13 149.29 33.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 111.264 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 38' ' ' ALA . 22.0 mt-10 -154.4 -82.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.819 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.736 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 47.25 -156.88 0.69 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.631 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.01 -13.28 60.49 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.637 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -137.84 -82.74 0.33 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.24 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 97.3 m -156.5 44.19 0.4 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.634 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.515 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -98.38 -32.9 11.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.736 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.828 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 121.007 0.432 . . . . 0.0 110.279 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.708 ' O ' HD13 ' A' ' 5' ' ' ILE . 3.7 t70 -148.1 -135.28 0.07 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.307 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 p -84.12 107.08 16.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.708 HD13 ' O ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -155.63 66.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.132 -179.225 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -84.35 85.73 7.35 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.833 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.533 ' HB2' HG23 ' A' ' 14' ' ' VAL . 94.5 m -44.66 173.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.732 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -69.98 132.21 45.57 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.504 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.851 ' HG2' HG12 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -100.58 132.25 46.07 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.58 0.705 . . . . 0.0 111.955 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 1.06 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -84.0 -31.37 25.53 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.688 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.401 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 9.0 m120 -156.21 -85.72 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.24 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.63 -18.15 11.23 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.561 ' HG3' ' HA2' ' A' ' 17' ' ' GLY . 25.3 mm100 -106.98 156.75 18.4 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.851 HG12 ' HG2' ' A' ' 9' ' ' ARG . 3.1 m -92.28 29.53 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.67 ' SG ' ' HB2' ' A' ' 23' ' ' CYS . 66.2 m -166.0 49.25 0.08 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.705 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 1.06 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 58.37 16.97 30.3 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 118.191 -1.957 . . . . 0.0 111.404 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.561 ' HA2' ' HG3' ' A' ' 13' ' ' GLN . . . 90.07 145.44 13.13 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 121.433 -0.413 . . . . 0.0 112.453 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.471 ' HD2' ' HG3' ' A' ' 13' ' ' GLN . 15.1 Cg_endo -57.37 -41.81 68.7 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.913 2.409 . . . . 0.0 112.628 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -45.38 -36.85 6.0 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.679 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.483 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 1.1 mpp_? -106.96 -22.82 12.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.721 -0.239 . . . . 0.0 111.098 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . 177.7 148.11 7.16 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.018 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.646 HD21 ' CD ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -140.19 143.62 36.17 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.194 0.521 . . . . 0.0 112.283 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.721 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 9.5 t -101.36 143.22 31.66 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.346 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -155.84 -108.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 118.753 -1.179 . . . . 0.0 113.255 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 43.6 t -72.26 68.41 0.74 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -177.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.426 ' HA2' HG21 ' A' ' 5' ' ' ILE . . . 114.93 -38.72 3.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.279 -0.962 . . . . 0.0 115.167 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.705 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -155.82 -165.98 2.09 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -177.172 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.721 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.7 m -83.09 -175.19 5.71 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.22 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.646 ' CD ' HD21 ' A' ' 22' ' ' LEU . 20.8 ttt180 -155.17 64.67 0.63 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -89.64 138.9 31.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.402 -178.488 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -80.65 162.9 58.82 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.692 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.71 117.16 3.81 Favored 'Trans proline' 0 CA--C 1.512 -0.606 0 C-N-CA 122.669 2.246 . . . . 0.0 112.738 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.18 46.98 0.97 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.75 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 20' ' ' ARG . 24.3 m-85 -146.04 147.49 31.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.691 0.282 . . . . 0.0 111.126 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 -87.25 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.48 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.684 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 50.85 -154.91 3.37 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.343 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.433 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 34.8 t -78.3 -20.46 51.47 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.63 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -127.86 -83.65 0.59 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.582 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 93.9 m -156.36 43.45 0.4 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.931 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.568 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 15.5 pm0 -102.92 -33.18 9.41 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.684 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.484 -0.77 . . . . 0.0 111.649 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.997 0.427 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.449 ' O ' HD12 ' A' ' 5' ' ' ILE . 64.5 m-20 -158.2 -124.76 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.429 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.85 87.87 7.36 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.514 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -156.23 69.51 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-O 122.126 0.965 . . . . 0.0 108.787 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.55 153.86 23.0 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.963 -177.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.8 m -40.63 145.41 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.194 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 15' ' ' CYS . 76.0 mt-10 -87.76 179.15 6.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.671 178.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.867 ' HG2' HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -137.95 128.25 26.17 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.093 0.949 . . . . 0.0 112.251 178.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.798 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 1.0 OUTLIER -95.12 -147.09 0.27 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.572 178.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.452 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 3.0 t-20 -91.41 71.47 6.05 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.98 -24.83 2.25 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 119.673 -1.251 . . . . 0.0 115.216 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.752 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 9.5 mt-30 -155.56 -156.33 0.64 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.941 0.871 . . . . 0.0 110.386 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.867 HG12 ' HG2' ' A' ' 9' ' ' ARG . 32.9 m -107.23 115.01 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.195 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.642 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 1.2 m 68.87 47.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.71 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.798 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 54.47 29.77 48.19 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.19 -1.481 . . . . 0.0 111.227 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.14 150.69 0.27 Allowed Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.405 -0.398 . . . . 0.0 112.358 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 19.3 Cg_endo -59.0 -31.55 95.94 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.72 2.28 . . . . 0.0 112.672 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.28 -21.96 13.58 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.625 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -107.74 -33.49 7.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.358 . . . . 0.0 110.987 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 18' ' ' PRO . . . -177.32 161.54 29.06 Favored Glycine 0 CA--C 1.517 0.198 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.069 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.649 ' O ' ' N ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -125.93 -175.18 3.28 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 120.672 0.273 . . . . 0.0 110.41 179.387 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 14.6 p -137.42 148.24 46.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.386 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.601 ' CE2' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -156.61 -169.41 2.99 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.496 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.444 ' C ' ' O ' ' A' ' 24' ' ' PHE . 4.7 t -24.71 85.94 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.314 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 120.39 -68.42 0.4 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.382 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.52 -163.69 1.5 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 3.6 t -84.34 169.5 14.58 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.679 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.649 ' N ' ' O ' ' A' ' 22' ' ' LEU . 2.0 tpp85 -145.47 94.55 2.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.98 ' SG ' ' HB2' ' A' ' 34' ' ' PHE . 30.5 t -85.61 157.12 20.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.842 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 20' ' ' ARG . 9.5 m-70 -77.88 158.21 78.15 Favored Pre-proline 0 C--O 1.231 0.124 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.348 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -64.71 113.54 2.37 Favored 'Trans proline' 0 CA--C 1.515 -0.434 0 C-N-CA 122.712 2.274 . . . . 0.0 112.665 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.91 -24.88 5.94 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.922 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.98 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.8 m-85 -85.53 164.68 17.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.719 0.295 . . . . 0.0 110.846 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -155.0 -90.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.134 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.74 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 49.23 -153.52 2.61 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.129 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.455 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 0.3 OUTLIER -88.63 -0.11 56.94 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.642 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -154.92 -78.61 0.09 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.051 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.455 ' SG ' ' CB ' ' A' ' 34' ' ' PHE . 23.2 t -156.29 35.67 0.33 Allowed 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.858 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.62 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -91.81 -35.28 14.19 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.74 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.659 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.684 0.278 . . . . 0.0 110.746 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.7 -170.59 0.14 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.032 0.444 . . . . 0.0 111.493 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.625 HG22 ' SG ' ' A' ' 23' ' ' CYS . 21.0 p -84.42 76.8 10.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.017 HG23 ' HA2' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -98.15 -20.21 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.387 -178.065 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.46 94.63 2.71 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.296 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.427 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 4.7 m -134.06 134.91 42.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.155 0.502 . . . . 0.0 111.145 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 15' ' ' CYS . 9.1 mm-40 -95.41 154.58 17.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.412 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 24.8 mtt180 -129.78 130.14 44.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.716 0.77 . . . . 0.0 111.209 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.868 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 1.5 p90 -96.28 -33.6 11.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.445 -1.252 . . . . 0.0 112.908 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -155.62 44.71 0.46 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.253 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.75 -13.4 56.36 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.285 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.72 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 32.4 mm-40 -84.59 -77.74 0.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 13' ' ' GLN . 3.7 p 145.72 108.29 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.553 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.696 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER 67.81 42.55 1.93 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 178.16 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.868 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 62.78 33.65 87.49 Favored Glycine 0 C--N 1.316 -0.554 0 C-N-CA 119.162 -1.495 . . . . 0.0 111.784 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.459 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 73.52 163.39 8.36 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.434 -0.412 . . . . 0.0 112.742 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.597 ' HB3' HD11 ' A' ' 22' ' ' LEU . 57.3 Cg_endo -70.86 -42.36 2.32 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.774 2.316 . . . . 0.0 112.809 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -47.42 -27.95 4.44 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.858 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.481 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -106.11 -49.55 3.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.71 0.29 . . . . 0.0 110.925 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.19 132.91 3.47 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.342 -0.933 . . . . 0.0 113.018 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' ' 18' ' ' PRO . 2.6 mm? -96.21 170.98 8.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.21 0.529 . . . . 0.0 112.226 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -112.75 131.66 55.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.068 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -135.08 -173.25 3.27 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -31.74 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.464 -1.698 . . . . 0.0 111.446 179.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 1.017 ' HA2' HG23 ' A' ' 5' ' ' ILE . . . 56.56 4.87 1.0 Allowed Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.829 -0.623 . . . . 0.0 114.042 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' A' ' 24' ' ' PHE . 15.0 mttt -156.16 152.65 28.15 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 118.064 0.932 . . . . 0.0 112.995 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -84.45 175.76 9.11 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.004 178.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.421 ' CG ' ' HB2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -148.79 86.0 1.5 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.825 0.345 . . . . 0.0 111.421 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.938 ' SG ' ' HB2' ' A' ' 34' ' ' PHE . 19.2 t -85.03 154.79 21.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.368 . . . . 0.0 110.916 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 20' ' ' ARG . 2.9 m-70 -78.21 153.97 79.65 Favored Pre-proline 0 N--CA 1.455 -0.194 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.36 111.62 1.51 Allowed 'Trans proline' 0 CA--C 1.514 -0.524 0 C-N-CA 122.434 2.09 . . . . 0.0 112.743 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.08 31.67 2.01 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.349 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.938 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 6.3 m-85 -131.12 158.5 40.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -148.17 -88.22 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.036 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.659 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 47.99 -154.85 1.37 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.118 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 m -79.31 -8.24 58.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.696 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -155.18 -74.67 0.11 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.377 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.449 ' SG ' ' CB ' ' A' ' 34' ' ' PHE . 45.3 t -155.74 33.54 0.36 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.21 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -97.55 -29.74 13.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.725 0.297 . . . . 0.0 111.742 -179.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.659 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.207 -0.901 . . . . 0.0 111.146 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.902 0.382 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 42.3 t -94.12 -31.13 14.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.948 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.71 172.76 13.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.6 p -84.63 62.93 7.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -155.84 164.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 -178.173 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.477 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -154.9 151.49 28.62 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.68 -178.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.58 ' HB3' HG12 ' A' ' 14' ' ' VAL . 58.8 m -29.2 133.25 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.278 -0.873 . . . . 0.0 113.343 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 15' ' ' CYS . 4.0 mt-10 -95.65 113.02 24.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.37 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.579 ' HG3' HG13 ' A' ' 14' ' ' VAL . 3.3 mtp180 -84.8 134.1 34.32 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.556 0.693 . . . . 0.0 110.673 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.877 ' HE1' ' HB2' ' A' ' 13' ' ' GLN . 1.2 p90 -92.65 -27.38 17.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.339 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -155.45 -86.14 0.05 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.393 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.95 -2.83 9.23 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.851 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.877 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 2.4 mp0 -106.58 -116.11 0.26 Allowed 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.58 HG12 ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -168.65 111.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.651 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.8 OUTLIER 71.7 40.08 0.81 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.03 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.681 ' HA2' ' CD2' ' A' ' 10' ' ' TYR . . . 59.56 39.75 95.43 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.504 -1.331 . . . . 0.0 111.089 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 62.54 141.11 0.01 OUTLIER Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.203 -0.499 . . . . 0.0 112.444 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.25 -30.94 92.43 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.569 2.18 . . . . 0.0 112.36 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.55 -37.21 40.77 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.916 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.433 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -97.08 -43.86 7.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.718 0.294 . . . . 0.0 110.924 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -154.73 137.3 5.6 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.033 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.408 HD23 ' CZ ' ' A' ' 24' ' ' PHE . 3.7 mp -101.75 138.57 38.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.923 0.392 . . . . 0.0 111.867 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.81 147.24 26.94 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 26' ' ' GLY . 19.8 m-85 -153.91 -173.86 4.74 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 122.017 0.913 . . . . 0.0 112.484 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -32.27 90.53 0.0 OUTLIER 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 113.089 -1.869 . . . . 0.0 111.292 178.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 54.34 22.28 22.36 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.761 -0.654 . . . . 0.0 113.282 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -155.11 -167.37 2.54 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.0 t -152.91 104.24 2.83 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.691 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.76 94.92 8.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.158 0.504 . . . . 0.0 111.009 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.573 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -96.03 166.22 11.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.836 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -85.39 159.6 55.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.971 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.56 114.07 2.22 Favored 'Trans proline' 0 CA--C 1.512 -0.589 0 C-N-CA 122.725 2.283 . . . . 0.0 112.402 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.78 26.72 3.23 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.626 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.433 ' CE2' ' HA ' ' A' ' 20' ' ' ARG . 24.3 m-85 -134.64 150.84 50.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.302 . . . . 0.0 110.774 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 38' ' ' ALA . 0.9 OUTLIER -155.07 -83.11 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.062 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.733 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 48.96 -155.22 1.73 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.259 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.02 -10.54 59.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.651 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -143.71 -80.46 0.19 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.712 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 4.9 m -155.96 41.37 0.39 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.731 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.517 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -98.58 -32.28 11.52 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.733 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.32 -0.848 . . . . 0.0 111.72 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.793 0.33 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.77 123.87 47.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.245 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.596 ' O ' HD12 ' A' ' 5' ' ' ILE . 6.9 t70 -175.28 -124.79 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.691 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.85 93.43 8.51 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -156.3 80.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.851 0.834 . . . . 0.0 109.178 -179.32 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -84.26 137.79 33.29 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.425 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.542 ' O ' HG12 ' A' ' 14' ' ' VAL . 2.7 m -52.9 157.94 1.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.313 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 15' ' ' CYS . 4.8 mm-40 -84.24 129.56 34.88 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.346 178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.535 ' HG2' HG13 ' A' ' 14' ' ' VAL . 47.0 mtm180 -84.37 131.03 34.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.932 0.872 . . . . 0.0 110.905 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.892 ' HE1' ' HB2' ' A' ' 13' ' ' GLN . 0.9 OUTLIER -84.99 -60.66 1.98 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.833 -178.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.441 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 28.0 p30 -156.05 49.76 0.51 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.037 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.39 -45.96 1.08 Allowed Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.908 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.892 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 2.5 mp0 -105.05 -165.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -113.35 112.85 42.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.16 0.505 . . . . 0.0 111.354 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.635 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 74.7 46.15 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.388 178.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.638 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 54.32 33.53 52.92 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.631 -1.271 . . . . 0.0 111.34 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.84 145.25 0.02 OUTLIER Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.245 -0.477 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.52 -25.03 47.26 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.555 2.17 . . . . 0.0 112.024 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.8 -26.14 32.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.996 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.491 ' NE ' ' CE1' ' A' ' 34' ' ' PHE . 4.4 mmm180 -114.74 -51.42 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 110.307 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.663 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -139.94 139.77 10.16 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.597 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.1 tp -133.91 130.27 37.51 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 120.73 0.3 . . . . 0.0 110.913 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.86 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 1.7 p -104.0 157.94 16.76 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.624 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -156.06 -97.43 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.285 -0.966 . . . . 0.0 113.113 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.5 t -76.46 67.36 2.63 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.223 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.561 ' HA2' HG13 ' A' ' 5' ' ' ILE . . . 92.2 -6.97 78.7 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.97 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -155.63 163.15 40.31 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -178.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.86 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 7.8 t -103.19 100.47 10.38 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.052 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -84.54 96.19 9.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.998 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.663 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -87.58 151.99 22.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.236 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -70.26 153.62 95.09 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.487 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.15 116.9 3.59 Favored 'Trans proline' 0 CA--C 1.513 -0.555 0 C-N-CA 122.705 2.27 . . . . 0.0 112.851 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . 106.82 44.8 1.26 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.902 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.491 ' CE1' ' NE ' ' A' ' 20' ' ' ARG . 17.2 m-85 -145.42 154.74 42.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.383 . . . . 0.0 111.106 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -155.14 -83.53 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.111 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.666 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 47.63 -154.7 1.23 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.31 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.18 -9.16 59.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.635 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -145.18 -80.35 0.17 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.52 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 1.9 m -155.99 40.67 0.38 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.884 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.515 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -97.16 -32.91 11.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.666 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.742 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.765 0.317 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 43.93 -164.53 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 2' ' ' CYS . 24.1 t70 80.02 -118.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.266 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 p -84.13 90.67 7.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.235 0.541 . . . . 0.0 110.042 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -155.55 178.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.03 134.8 10.86 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.149 -1.021 . . . . 0.0 112.155 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.5 m -60.73 140.52 57.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.5 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -83.06 127.05 33.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.696 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.95 ' HG2' HG12 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -104.71 131.96 51.52 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.573 0.702 . . . . 0.0 111.949 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.854 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 1.3 p90 -88.37 -149.26 0.17 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.435 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.456 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 3.4 p-10 -91.31 77.46 5.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.502 ' C ' ' HG2' ' A' ' 13' ' ' GLN . . . 138.29 -28.99 2.65 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 119.963 -1.113 . . . . 0.0 114.87 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.71 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -152.23 -162.64 1.55 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.718 0.759 . . . . 0.0 110.372 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.95 HG12 ' HG2' ' A' ' 9' ' ' ARG . 34.4 m -106.06 108.13 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.283 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.674 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER 84.36 43.69 0.02 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.969 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.854 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 59.97 30.0 69.07 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.217 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.484 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 76.03 134.74 0.51 Allowed Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.259 -0.471 . . . . 0.0 112.654 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.496 ' HB3' HD11 ' A' ' 22' ' ' LEU . 63.2 Cg_exo -51.93 -33.91 53.88 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.631 2.221 . . . . 0.0 112.678 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.69 -22.57 11.92 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.857 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' A' ' 40' ' ' GLN . 38.4 mtm-85 -110.13 -36.7 5.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.604 0.24 . . . . 0.0 111.304 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 30' ' ' CYS . . . -171.33 139.87 5.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.139 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.496 HD11 ' HB3' ' A' ' 18' ' ' PRO . 1.6 mm? -91.71 -179.52 5.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.233 0.54 . . . . 0.0 112.15 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.879 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 16.0 p -121.26 143.16 49.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 27' ' ' LYS . 5.3 m-85 -143.93 179.28 7.28 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -37.46 102.51 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 112.718 -2.037 . . . . 0.0 111.04 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.423 ' H ' HG13 ' A' ' 5' ' ' ILE . . . 93.61 -44.37 2.42 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.312 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 24' ' ' PHE . 26.6 mtmm -155.04 -179.28 7.91 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.879 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -84.44 160.69 20.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.833 179.425 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 95.54 2.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.898 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.444 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 2.2 p -100.37 162.02 13.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.949 0.404 . . . . 0.0 111.102 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -64.16 157.68 68.59 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.498 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.08 112.08 1.43 Allowed 'Trans proline' 0 CA--C 1.513 -0.57 0 C-N-CA 122.531 2.154 . . . . 0.0 112.476 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.46 32.79 2.65 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.93 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -125.52 150.53 47.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.003 0.43 . . . . 0.0 111.11 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 40' ' ' GLN . 45.7 mt-10 -155.4 -152.98 0.42 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.304 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.88 -161.22 12.89 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.291 -0.956 . . . . 0.0 111.892 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.3 m -62.25 -21.48 65.21 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.674 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -140.84 -81.39 0.25 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.026 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.5 m -157.1 39.33 0.31 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.121 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -85.94 -31.29 22.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.934 -179.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.401 ' N ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.633 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.859 0.361 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.587 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 52.3 t -177.1 -36.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.277 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.54 162.87 40.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.381 . . . . 0.0 111.346 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.436 ' O ' HG12 ' A' ' 5' ' ' ILE . 28.5 p -84.88 63.48 8.08 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.682 HG22 ' HA2' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -155.5 169.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -177.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.503 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -153.65 163.34 40.16 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.494 -0.883 . . . . 0.0 112.525 -179.038 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.567 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 8.7 m -18.85 136.61 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.649 -1.159 . . . . 0.0 114.029 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 15' ' ' CYS . 24.6 mt-10 -95.24 128.17 41.87 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.477 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 24.0 mtm105 -103.02 130.97 50.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.835 0.826 . . . . 0.0 111.456 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.651 ' CE2' ' HA2' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -92.42 -32.9 14.76 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.584 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.423 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.4 m-20 -156.14 -79.96 0.08 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.003 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.05 26.86 1.27 Allowed Glycine 0 C--N 1.331 0.306 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.566 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.485 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 37.4 mm-40 -136.0 11.73 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.466 0.174 . . . . 0.0 110.854 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 1.5 p 43.59 106.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.876 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 77.1 m 80.28 40.13 0.08 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.746 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.651 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 44.15 52.65 6.95 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.118 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.06 146.75 2.94 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.986 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 84.3 Cg_endo -78.3 -35.65 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.81 2.34 . . . . 0.0 112.727 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.94 -21.17 29.71 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.892 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.459 ' CD ' ' CE1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -99.71 -31.56 11.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.95 0.405 . . . . 0.0 110.832 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 18' ' ' PRO . . . -175.45 158.43 25.71 Favored Glycine 0 N--CA 1.453 -0.189 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.716 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -104.1 -150.08 0.42 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 117.33 0.565 . . . . 0.0 111.629 -179.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.6 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 11.4 p -155.69 125.58 6.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.873 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.623 ' CZ ' ' HB3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -156.45 -102.72 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.453 177.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.587 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 8.3 t -56.08 77.31 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.148 0.499 . . . . 0.0 110.227 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.682 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 46.42 21.49 0.77 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.968 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.16 168.16 28.16 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 14.7 m -105.11 125.12 50.63 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.452 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.737 ' HG3' ' O ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -84.45 88.43 7.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.629 0.728 . . . . 0.0 109.481 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -92.81 160.01 15.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.906 -178.041 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.26 163.62 24.33 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.495 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.84 115.1 2.31 Favored 'Trans proline' 0 CA--C 1.512 -0.62 0 C-N-CA 122.753 2.302 . . . . 0.0 112.762 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . 116.26 36.9 1.06 Allowed Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 114.704 -1.134 . . . . 0.0 112.913 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.459 ' CE1' ' CD ' ' A' ' 20' ' ' ARG . 30.0 m-85 -148.03 156.12 42.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.739 0.304 . . . . 0.0 110.935 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -154.33 -90.28 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.23 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.62 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 47.95 -162.86 0.34 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.419 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -16.83 62.45 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.594 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -136.84 -81.96 0.37 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.079 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -156.13 42.4 0.39 Allowed 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.014 178.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.505 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -92.82 -31.24 15.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.886 -179.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.62 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.468 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.824 0.345 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 25' ' ' CYS . 42.0 t -112.83 -55.42 2.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.718 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.644 ' C ' HD13 ' A' ' 5' ' ' ILE . 1.7 t0 178.72 -148.81 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.687 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.6 p -84.75 94.56 8.71 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.644 HD13 ' C ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -155.45 67.22 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 121.89 0.852 . . . . 0.0 108.983 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.38 135.73 34.16 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.503 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.534 ' HA ' ' HB3' ' A' ' 23' ' ' CYS . 22.6 m -40.47 146.42 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.033 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 44.4 mm-40 -93.67 178.74 5.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.867 ' HG2' HG12 ' A' ' 14' ' ' VAL . 14.0 mtt85 -133.15 131.79 40.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.131 0.967 . . . . 0.0 113.233 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.931 ' HE1' ' HB2' ' A' ' 13' ' ' GLN . 5.6 p90 -92.16 -146.19 0.22 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.301 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -91.46 68.57 5.78 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 145.37 -32.5 1.63 Allowed Glycine 0 C--N 1.338 0.69 0 C-N-CA 119.818 -1.182 . . . . 0.0 114.868 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.931 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 3.1 mm100 -149.57 -156.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.528 0.664 . . . . 0.0 110.489 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.867 HG12 ' HG2' ' A' ' 9' ' ' ARG . 23.0 m -104.89 115.05 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.978 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.674 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER 64.63 53.58 1.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.3 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.655 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 51.33 31.95 28.72 Favored Glycine 0 C--N 1.318 -0.442 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.954 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.404 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 64.25 158.0 0.24 Allowed Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.498 -0.351 . . . . 0.0 112.855 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.3 -13.02 35.71 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.75 2.3 . . . . 0.0 112.902 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.74 27.58 4.26 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.792 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.487 ' C ' ' SG ' ' A' ' 39' ' ' CYS . 26.3 mtp85 -155.13 -42.45 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 30' ' ' CYS . . . 179.19 176.0 46.59 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.15 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.571 HD12 ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -143.08 -175.04 4.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.931 0.396 . . . . 0.0 110.82 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.912 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 8.2 p -101.43 143.2 31.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.47 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.571 ' CE1' HD12 ' A' ' 22' ' ' LEU . 7.3 m-85 -126.42 -179.05 4.57 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.923 0.868 . . . . 0.0 112.977 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 2' ' ' CYS . 1.7 t -55.04 72.76 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.801 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 141.66 -55.84 0.6 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.482 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.57 -177.6 6.67 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.912 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -84.33 128.84 34.82 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.913 178.491 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -113.24 103.96 11.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.366 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.609 ' SG ' ' CB ' ' A' ' 34' ' ' PHE . 7.7 t -85.08 156.14 21.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.819 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.459 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 9.5 m-70 -65.48 157.13 79.78 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.882 0.372 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.85 116.46 3.37 Favored 'Trans proline' 0 CA--C 1.512 -0.584 0 C-N-CA 122.804 2.336 . . . . 0.0 112.696 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.12 29.08 5.01 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.756 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.609 ' CB ' ' SG ' ' A' ' 30' ' ' CYS . 5.4 m-85 -125.1 170.92 10.71 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.908 -0.172 . . . . 0.0 110.811 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.41 ' N ' ' OXT' ' A' ' 41' ' ' ALA . 6.2 mm-40 -155.44 -102.65 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.063 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.784 ' N ' ' HB3' ' A' ' 41' ' ' ALA . . . 63.51 -157.19 41.54 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.367 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.549 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 0.5 OUTLIER -94.87 -18.1 21.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.04 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.674 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -138.56 -73.62 0.4 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.433 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.599 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 53.4 t -157.35 20.21 0.29 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.938 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.736 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -77.62 -33.33 53.68 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.784 ' HB3' ' N ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 117.961 -1.019 . . . . 0.0 111.36 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.707 0.289 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 10.8 t -177.48 -32.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.505 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.56 -155.61 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.67 0.271 . . . . 0.0 110.807 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 48.0 p -84.08 113.93 21.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.782 HG23 ' HA2' ' A' ' 26' ' ' GLY . 0.4 OUTLIER -147.78 74.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-O 121.799 0.809 . . . . 0.0 111.141 -177.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 7' ' ' CYS . 6.2 p30 -93.89 53.52 1.81 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.486 -1.233 . . . . 0.0 108.55 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' ASN . 21.4 m -7.77 135.16 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 113.448 -1.706 . . . . 0.0 114.813 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -89.96 128.77 36.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.985 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.636 ' CG ' HG12 ' A' ' 14' ' ' VAL . 4.7 mpp_? -92.33 134.0 35.32 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.331 0.586 . . . . 0.0 111.809 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 1.149 ' CE1' ' HB2' ' A' ' 13' ' ' GLN . 9.7 p90 -85.59 -134.83 0.06 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.806 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -83.26 72.18 10.19 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.03 -18.52 45.95 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 1.149 ' HB2' ' CE1' ' A' ' 10' ' ' TYR . 2.7 mp0 -115.21 -133.51 0.34 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.889 0.844 . . . . 0.0 111.317 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.636 HG12 ' CG ' ' A' ' 9' ' ' ARG . 2.9 m -147.4 114.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 121.079 0.466 . . . . 0.0 111.739 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.664 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 66.43 44.41 2.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.379 178.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.719 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 60.29 18.08 48.42 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.769 -1.205 . . . . 0.0 111.83 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.637 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 66.2 144.98 0.06 OUTLIER Glycine 0 C--N 1.338 0.655 0 C-N-CA 121.79 -0.243 . . . . 0.0 113.076 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.68 -31.81 52.04 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.69 2.26 . . . . 0.0 112.449 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -48.29 -28.71 6.46 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.927 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HD2' ' CE2' ' A' ' 34' ' ' PHE . 6.6 mmm-85 -118.25 -31.47 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 110.636 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.468 ' CA ' ' HA ' ' A' ' 30' ' ' CYS . . . -168.43 149.69 14.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.738 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.777 HD11 ' CE2' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -128.8 166.27 19.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.097 0.475 . . . . 0.0 111.208 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -84.75 134.88 34.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.105 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.777 ' CE2' HD11 ' A' ' 22' ' ' LEU . 1.1 m-85 -130.16 -177.56 4.36 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.702 0.763 . . . . 0.0 112.111 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.523 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 0.1 OUTLIER -41.95 86.25 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.224 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.782 ' HA2' HG23 ' A' ' 5' ' ' ILE . . . 70.47 6.31 57.9 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.731 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -156.3 142.03 17.85 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -90.43 115.46 27.61 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -99.66 102.43 13.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.135 0.493 . . . . 0.0 111.726 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.468 ' HA ' ' CA ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -96.32 144.07 26.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.375 179.163 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.469 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 12.3 m-70 -53.76 149.82 15.51 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.22 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 23.9 Cg_exo -62.67 117.48 4.37 Favored 'Trans proline' 0 CA--C 1.514 -0.51 0 C-N-CA 122.698 2.265 . . . . 0.0 112.834 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.421 ' O ' ' CD1' ' A' ' 34' ' ' PHE . . . 109.03 31.49 3.32 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.84 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 31' ' ' HIS . 17.9 m-85 -136.46 146.66 46.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.921 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.639 ' CG ' ' HB3' ' A' ' 41' ' ' ALA . 18.9 pt-20 -142.44 -140.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.076 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 35' ' ' GLU . . . 102.1 -162.38 17.16 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.517 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.464 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 0.7 OUTLIER -69.36 -16.15 63.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.664 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -145.77 -79.88 0.17 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.694 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -155.9 26.56 0.37 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.027 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.735 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -69.46 -31.02 69.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.639 ' HB3' ' CG ' ' A' ' 35' ' ' GLU . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.156 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.591 ' CB ' ' HA ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -136.82 -166.29 1.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.773 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 13.0 t70 -177.19 -4.04 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.6 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -84.42 57.41 4.27 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.577 HD13 ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -84.73 92.88 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.862 -177.138 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.76 37.99 0.37 Allowed 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.474 -1.693 . . . . 0.0 108.925 -177.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.439 ' HB2' ' CG1' ' A' ' 14' ' ' VAL . 13.6 m -35.51 147.77 0.02 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 113.811 -1.541 . . . . 0.0 112.896 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.24 121.47 33.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.928 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.765 ' HG3' HG13 ' A' ' 14' ' ' VAL . 17.4 mtm180 -95.73 131.36 42.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.639 0.733 . . . . 0.0 112.133 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.793 ' CD2' ' HA2' ' A' ' 16' ' ' GLY . 1.6 p90 -84.97 -33.08 22.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.495 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.71 -77.86 0.09 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.007 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -148.06 16.41 1.35 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.19 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.563 ' C ' HG23 ' A' ' 14' ' ' VAL . 47.2 mm-40 -118.68 -19.04 8.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.972 0.415 . . . . 0.0 110.577 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.765 HG13 ' HG3' ' A' ' 9' ' ' ARG . 1.6 t 70.67 92.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.662 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.636 ' CB ' ' O ' ' A' ' 14' ' ' VAL . 8.2 t 104.96 34.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.765 0.666 . . . . 0.0 112.123 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.793 ' HA2' ' CD2' ' A' ' 10' ' ' TYR . . . 56.48 41.23 88.18 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.051 -1.071 . . . . 0.0 113.109 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.35 148.95 4.03 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.188 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 25.3 Cg_exo -62.67 -44.8 15.84 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.71 2.274 . . . . 0.0 112.087 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.46 -31.65 14.22 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.341 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.449 ' HG3' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -95.51 -30.44 13.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.771 0.32 . . . . 0.0 110.712 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.477 ' CA ' ' HA ' ' A' ' 30' ' ' CYS . . . 179.68 156.02 16.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.879 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.643 HD12 ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -122.43 -166.16 1.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 5.3 t -145.2 145.56 31.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.622 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.643 ' CE2' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -155.78 -101.21 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.573 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.591 ' HA ' ' CB ' ' A' ' 2' ' ' CYS . 0.8 OUTLIER -55.61 80.3 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 41.38 26.35 0.21 Allowed Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.616 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.61 142.3 18.83 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -87.92 111.1 21.08 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.923 178.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.609 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 7.3 ttp85 -97.63 100.45 11.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.916 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.477 ' HA ' ' CA ' ' A' ' 21' ' ' GLY . 1.8 p -95.87 165.04 12.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.074 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -73.37 159.15 85.53 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.498 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.17 112.66 1.61 Allowed 'Trans proline' 0 CA--C 1.513 -0.551 0 C-N-CA 122.609 2.206 . . . . 0.0 112.527 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.36 22.53 4.07 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.046 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.473 ' HA ' ' OXT' ' A' ' 41' ' ' ALA . 40.5 m-85 -125.49 148.82 48.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.659 0.266 . . . . 0.0 110.842 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 39' ' ' CYS . 1.2 mt-10 -155.54 -96.6 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.664 ' CA ' ' HB3' ' A' ' 41' ' ' ALA . . . 67.21 -144.36 44.44 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.174 -1.013 . . . . 0.0 111.883 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.462 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 40.3 t -90.46 -3.06 57.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.578 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -148.68 -79.96 0.14 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.29 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 35' ' ' GLU . 9.0 m -157.17 39.37 0.3 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.635 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.593 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 17.6 pm0 -106.11 -33.49 7.84 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.664 ' HB3' ' CA ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.346 -0.835 . . . . 0.0 112.121 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.888 0.375 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 25' ' ' CYS . 46.0 t -145.23 -62.17 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.452 ' OD1' HD12 ' A' ' 5' ' ' ILE . 14.9 p-10 -167.17 -160.24 0.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.858 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.75 86.33 7.37 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.532 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -156.34 79.35 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-O 121.981 0.896 . . . . 0.0 108.92 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 7' ' ' CYS . 6.9 p30 -84.22 72.88 10.5 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.867 -177.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.576 ' HB3' ' HB ' ' A' ' 14' ' ' VAL . 69.9 m 47.73 149.35 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.433 -1.258 . . . . 0.0 113.457 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.684 ' O ' ' N ' ' A' ' 15' ' ' CYS . 15.1 mm-40 -94.93 131.43 40.86 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.558 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.743 ' CG ' HG12 ' A' ' 14' ' ' VAL . 4.0 mtp85 -100.08 131.36 46.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.794 0.807 . . . . 0.0 111.347 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.7 ' CD2' ' HA2' ' A' ' 16' ' ' GLY . 1.2 p90 -91.37 -30.4 16.56 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.842 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -155.79 -85.33 0.05 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.825 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.56 -16.39 10.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.255 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.541 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -110.76 -159.96 0.7 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.743 HG12 ' CG ' ' A' ' 9' ' ' ARG . 28.2 m -124.4 104.09 13.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.137 0.494 . . . . 0.0 111.267 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.686 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER 86.21 48.15 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.501 179.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.7 ' HA2' ' CD2' ' A' ' 10' ' ' TYR . . . 53.64 30.39 42.88 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.352 -1.404 . . . . 0.0 111.726 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.21 143.81 0.82 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.602 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.0 -35.33 98.87 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.521 2.147 . . . . 0.0 112.27 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -48.17 -28.95 6.42 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.845 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.46 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.1 OUTLIER -101.48 -36.43 8.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.104 0.478 . . . . 0.0 109.778 179.165 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 30' ' ' CYS . . . 177.02 152.39 9.83 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.634 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.45 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -113.7 175.73 5.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.784 0.326 . . . . 0.0 110.721 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.69 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -98.71 156.07 17.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.295 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.601 ' O ' ' N ' ' A' ' 26' ' ' GLY . 6.2 m-85 -139.29 -175.23 4.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.875 0.845 . . . . 0.0 112.26 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 25' ' ' CYS . 1.5 t -47.27 77.36 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 113.406 -1.725 . . . . 0.0 110.874 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 80.7 19.26 68.53 Favored Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.316 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -155.18 -164.86 1.87 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 117.388 0.594 . . . . 0.0 112.246 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.69 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -145.49 115.59 7.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.625 179.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.39 88.0 7.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.12 0.486 . . . . 0.0 110.913 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.988 ' SG ' ' HB2' ' A' ' 34' ' ' PHE . 18.2 t -85.03 155.47 21.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.931 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.46 ' CD2' ' O ' ' A' ' 20' ' ' ARG . 11.6 m-70 -78.46 154.5 79.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.959 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.04 112.73 1.61 Allowed 'Trans proline' 0 CA--C 1.513 -0.54 0 C-N-CA 122.481 2.121 . . . . 0.0 112.883 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.5 28.53 2.52 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.356 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.988 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 12.4 m-85 -130.86 164.04 26.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.81 0.305 . . . . 0.0 110.955 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -153.39 -91.61 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.98 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.707 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 48.6 -152.21 2.66 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.07 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.449 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 27.7 p -92.18 1.04 57.46 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.686 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -155.21 -79.31 0.09 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.092 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 43.2 t -156.55 36.95 0.32 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.682 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.593 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -92.46 -34.85 13.94 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.707 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.655 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.668 0.27 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 157.26 16.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.325 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -178.75 -138.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.903 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.9 90.01 6.91 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.527 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -155.23 72.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.243 -177.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -84.15 -179.51 7.24 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.891 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.58 ' HB2' HG12 ' A' ' 14' ' ' VAL . 1.5 m -78.88 140.88 38.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.567 -177.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 15' ' ' CYS . 2.4 mt-10 -94.81 124.8 39.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.613 ' HG3' HG13 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -84.52 132.11 34.57 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.832 0.825 . . . . 0.0 112.863 -177.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 1.083 ' CE1' ' HB2' ' A' ' 13' ' ' GLN . 4.2 p90 -84.91 -125.51 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.574 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -83.71 51.58 2.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.89 -28.48 6.12 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 119.965 -1.112 . . . . 0.0 115.641 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 1.083 ' HB2' ' CE1' ' A' ' 10' ' ' TYR . 2.8 mp0 -101.75 -125.95 0.19 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.942 0.871 . . . . 0.0 111.439 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.613 HG13 ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -150.37 110.52 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 120.998 0.428 . . . . 0.0 111.495 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.681 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 65.87 44.13 2.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.657 179.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.718 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 60.58 22.72 59.68 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.315 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.545 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 69.45 144.87 0.19 Allowed Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.407 -0.397 . . . . 0.0 112.739 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -50.61 -30.26 27.85 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.701 2.268 . . . . 0.0 112.441 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.7 -26.7 54.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.435 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.93 -28.49 9.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.612 0.244 . . . . 0.0 111.109 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.553 ' HA3' ' HB3' ' A' ' 30' ' ' CYS . . . -179.86 158.34 21.91 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.843 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 29' ' ' ARG . 5.7 mp -124.56 142.26 51.48 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 111.697 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.829 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -84.73 127.76 34.27 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.53 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.529 ' O ' ' N ' ' A' ' 26' ' ' GLY . 16.2 m-85 -141.71 175.83 9.39 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -177.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -34.46 83.57 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 111.814 -2.448 . . . . 0.0 111.031 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 120.77 -57.94 0.58 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.234 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -155.79 -178.29 7.19 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.829 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 4.8 t -89.16 107.58 19.13 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.348 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 22' ' ' LEU . 5.2 tpt85 -84.81 88.57 7.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.989 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.553 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 1.0 OUTLIER -95.01 156.77 16.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -63.13 153.39 81.5 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.647 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.14 113.05 1.58 Allowed 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 122.591 2.194 . . . . 0.0 112.564 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.4 23.03 4.6 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.932 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -124.49 148.98 47.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.871 0.367 . . . . 0.0 111.089 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.44 ' HB2' ' OXT' ' A' ' 41' ' ' ALA . 4.5 mm-40 -155.4 -88.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.218 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.599 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 61.45 -147.89 47.39 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.044 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.466 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 1.1 m -87.22 -5.04 59.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.681 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -144.09 -82.89 0.16 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.232 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 7.3 m -157.47 42.88 0.32 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.057 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.536 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 9.9 pm0 -108.56 -33.77 6.93 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.599 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.115 -0.945 . . . . 0.0 111.983 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.782 0.325 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 33.8 m -72.52 -68.86 0.44 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.714 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.483 ' O ' HD12 ' A' ' 5' ' ' ILE . 0.8 OUTLIER 82.23 -141.68 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.0 p -84.4 117.15 23.44 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.541 0.686 . . . . 0.0 109.896 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.71 HG13 ' H ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -155.31 74.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.4 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -84.85 140.67 31.0 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.281 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.613 ' O ' HG12 ' A' ' 14' ' ' VAL . 75.8 m -100.16 -177.98 3.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.272 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 15' ' ' CYS . 3.5 mp0 -67.82 144.89 55.13 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.322 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.495 ' HB3' ' C ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -105.12 160.69 14.86 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.501 0.667 . . . . 0.0 111.619 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.783 ' CD2' ' HA3' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -127.69 -16.67 4.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.79 179.197 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -155.66 62.43 0.6 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.302 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.78 26.4 57.58 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.495 ' C ' ' HB3' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -155.14 127.43 7.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.197 -0.501 . . . . 0.0 110.545 -178.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.862 HG21 ' HB3' ' A' ' 23' ' ' CYS . 12.9 m -51.17 118.67 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.657 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 95.3 m 64.52 49.95 2.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -176.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.783 ' HA3' ' CD2' ' A' ' 10' ' ' TYR . . . 17.87 48.29 0.01 OUTLIER Glycine 0 C--N 1.341 0.845 0 CA-C-N 114.467 -1.242 . . . . 0.0 115.047 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 15' ' ' CYS . . . 96.94 147.84 23.25 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.823 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.66 -15.72 43.74 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.531 2.154 . . . . 0.0 113.039 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -46.59 -45.63 17.58 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.088 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.471 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -102.96 -44.1 5.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.186 0.517 . . . . 0.0 110.033 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -157.87 144.84 10.95 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.502 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -132.62 135.91 46.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.988 0.394 . . . . 0.0 111.764 -179.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.967 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 11.8 t -97.55 128.78 44.56 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.406 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.636 ' CE1' ' HB2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -156.89 -157.8 0.72 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.783 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.519 ' C ' ' O ' ' A' ' 24' ' ' PHE . 39.9 t -24.87 94.21 0.01 OUTLIER 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.105 0.478 . . . . 0.0 110.393 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.71 ' H ' HG13 ' A' ' 5' ' ' ILE . . . 102.83 -76.12 0.3 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.386 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -154.27 -160.65 1.11 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.967 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 50.5 t -92.39 112.65 24.68 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.881 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.636 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -84.74 94.15 8.61 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -93.55 156.72 16.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.07 -178.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -83.01 157.16 66.62 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.772 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -57.68 122.58 11.99 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 122.89 2.393 . . . . 0.0 113.197 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.54 49.23 2.59 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.719 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.471 ' CZ ' ' HG3' ' A' ' 20' ' ' ARG . 7.1 m-85 -139.99 150.09 44.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.965 0.412 . . . . 0.0 111.702 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 38' ' ' ALA . 1.9 mm-40 -155.33 -90.3 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.384 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.681 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 58.94 -145.52 43.55 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.994 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.433 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -91.36 -1.72 57.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.129 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.657 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -146.27 -83.2 0.13 Allowed 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.639 -1.618 . . . . 0.0 109.088 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 69.5 m -156.48 45.05 0.42 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.518 178.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.615 HE22 ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -97.83 -36.05 10.32 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.681 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.963 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.753 0.311 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.489 ' CB ' ' HA ' ' A' ' 25' ' ' CYS . 4.9 t 68.05 -64.58 0.28 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.236 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.99 -161.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.685 0.278 . . . . 0.0 111.089 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.4 p -84.49 91.27 7.81 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.602 HG21 ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -155.75 79.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.134 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.2 151.3 25.73 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.886 -177.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.538 ' HB3' ' CG1' ' A' ' 14' ' ' VAL . 5.2 m -50.0 135.88 19.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.043 -0.981 . . . . 0.0 113.333 -177.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -96.01 148.6 22.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.989 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.405 ' HA ' ' H ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -111.1 154.93 23.57 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 122.069 0.938 . . . . 0.0 111.248 179.014 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.851 ' CZ ' ' HA2' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -112.68 -27.63 8.1 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.421 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -156.24 -38.07 0.08 Allowed 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.16 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.74 1.27 0.05 OUTLIER Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.891 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.569 ' C ' HG23 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -101.05 -17.64 16.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.346 0.573 . . . . 0.0 110.22 179.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.569 HG23 ' C ' ' A' ' 13' ' ' GLN . 3.5 t 84.96 98.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.514 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.784 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 1.0 OUTLIER 69.43 47.37 0.69 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.53 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.851 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 45.51 61.25 3.8 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.521 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 54.96 168.48 0.05 OUTLIER Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.953 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.493 ' CB ' HD11 ' A' ' 22' ' ' LEU . 95.6 Cg_endo -80.98 -26.82 3.32 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.663 2.242 . . . . 0.0 112.763 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.6 -25.62 6.78 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.696 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -104.97 -51.64 3.0 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 30' ' ' CYS . . . -165.18 144.76 9.56 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.668 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.512 ' O ' ' CA ' ' A' ' 28' ' ' CYS . 0.7 OUTLIER -96.51 -177.76 4.05 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 122.651 0.38 . . . . 0.0 111.434 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 29.3 p -126.51 116.18 20.69 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -157.6 -162.94 1.25 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.191 -1.003 . . . . 0.0 112.533 177.262 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.489 ' HA ' ' CB ' ' A' ' 2' ' ' CYS . 9.2 t -24.04 122.19 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.236 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.602 ' O ' HG21 ' A' ' 5' ' ' ILE . . . 80.02 -73.01 2.51 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.169 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.535 ' HG2' ' C ' ' A' ' 26' ' ' GLY . 5.5 mmmm -155.84 -157.93 0.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.613 0.721 . . . . 0.0 112.39 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.1 m -85.5 124.58 32.24 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.049 178.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . 10.2 ttt-85 -84.72 84.57 7.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.932 0.396 . . . . 0.0 110.279 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.436 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 0.8 OUTLIER -96.99 141.76 29.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.169 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -61.68 158.6 40.08 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.45 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.65 114.98 2.29 Favored 'Trans proline' 0 CA--C 1.512 -0.597 0 C-N-CA 122.539 2.159 . . . . 0.0 112.755 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.1 34.71 1.76 Allowed Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.754 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -135.09 147.55 49.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.874 0.368 . . . . 0.0 111.111 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' O ' ' C ' ' A' ' 38' ' ' ALA . 2.4 mt-10 -155.08 -83.69 0.07 Allowed 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.677 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 52.03 -155.42 4.46 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.234 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.1 m -75.73 -12.35 60.17 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.784 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -138.53 -81.84 0.31 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.286 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.0 m -156.93 44.21 0.38 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.456 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.535 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -100.1 -33.44 10.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.677 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.777 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.455 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 6.5 pt-20 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.803 0.335 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.977 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -46.28 -25.63 0.66 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.595 0.712 . . . . 0.0 111.479 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.544 ' O ' ' O ' ' A' ' 2' ' ' CYS . 7.7 t70 -47.1 -123.36 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.761 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.405 ' C ' HG23 ' A' ' 5' ' ' ILE . 13.9 p -84.89 92.79 8.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.457 . . . . 0.0 109.935 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.553 HG13 ' H ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -156.16 71.77 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-O 122.191 0.996 . . . . 0.0 108.719 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.57 136.57 33.73 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.27 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -58.13 159.1 6.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.38 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' CYS . 2.4 mt-10 -95.22 169.6 9.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.69 ' CG ' HG12 ' A' ' 14' ' ' VAL . 3.0 mtp180 -123.9 127.84 48.59 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 122.2 1.0 . . . . 0.0 112.244 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.631 ' CE2' ' HA2' ' A' ' 16' ' ' GLY . 1.2 p90 -92.15 -32.86 14.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.069 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -155.89 -74.4 0.1 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.027 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.9 24.58 0.62 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.797 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.47 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 37.9 mm-40 -135.3 14.32 3.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.627 0.251 . . . . 0.0 110.966 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.69 HG12 ' CG ' ' A' ' 9' ' ' ARG . 8.2 m 43.53 105.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.451 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.637 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER 80.98 36.62 0.09 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 178.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.631 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 49.69 48.71 35.72 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.991 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.7 150.77 0.01 OUTLIER Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.301 -0.476 . . . . 0.0 113.15 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 45.1 Cg_endo -68.57 -29.26 30.61 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.571 2.181 . . . . 0.0 112.017 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.425 ' O ' ' CD2' ' A' ' 31' ' ' HIS . . . -49.04 -38.36 24.5 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.861 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.514 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -97.11 -45.02 6.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.058 0.456 . . . . 0.0 110.195 179.33 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 30' ' ' CYS . . . -156.47 142.6 8.89 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.961 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.686 HD21 ' HE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -150.29 132.86 15.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.866 0.365 . . . . 0.0 111.351 -178.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.757 ' CA ' ' HA ' ' A' ' 28' ' ' CYS . 20.8 p -98.44 157.15 16.39 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.111 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.686 ' HE2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -155.82 -95.47 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.586 -0.845 . . . . 0.0 112.123 179.328 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.977 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 24.0 t -93.66 73.19 4.32 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 121.37 0.605 . . . . 0.0 110.338 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.553 ' H ' HG13 ' A' ' 5' ' ' ILE . . . 133.58 -65.49 0.58 Allowed Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.854 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.715 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 6.6 mttt -156.58 -174.49 4.96 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.757 ' HA ' ' CA ' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -85.01 109.11 17.96 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.453 178.182 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -84.39 91.11 7.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.398 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.579 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -92.93 134.4 35.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.582 -179.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.425 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 1.2 m-70 -67.16 159.73 75.17 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.817 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.23 118.07 4.9 Favored 'Trans proline' 0 CA--C 1.511 -0.633 0 C-N-CA 122.696 2.264 . . . . 0.0 112.832 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.3 47.66 0.98 Allowed Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.678 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.514 ' CE2' ' HA ' ' A' ' 20' ' ' ARG . 26.4 m-85 -146.13 149.29 33.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 111.264 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 38' ' ' ALA . 22.0 mt-10 -154.4 -82.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.819 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.736 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 47.25 -156.88 0.69 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.631 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.01 -13.28 60.49 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.637 ' CB ' ' HA ' ' A' ' 15' ' ' CYS . . . -137.84 -82.74 0.33 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.24 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 97.3 m -156.5 44.19 0.4 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.634 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.515 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -98.38 -32.9 11.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.736 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.828 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.764 0.316 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER 62.41 120.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.007 0.432 . . . . 0.0 110.279 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.708 ' O ' HD13 ' A' ' 5' ' ' ILE . 3.7 t70 -148.1 -135.28 0.07 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.307 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 p -84.12 107.08 16.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.708 HD13 ' O ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -155.63 66.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.132 -179.225 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -84.35 85.73 7.35 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.833 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.533 ' HB2' HG23 ' A' ' 14' ' ' VAL . 94.5 m -44.66 173.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.732 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -69.98 132.21 45.57 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.504 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.851 ' HG2' HG12 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -100.58 132.25 46.07 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.58 0.705 . . . . 0.0 111.955 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 1.06 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -84.0 -31.37 25.53 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.688 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.401 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 9.0 m120 -156.21 -85.72 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.24 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.63 -18.15 11.23 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.561 ' HG3' ' HA2' ' A' ' 17' ' ' GLY . 25.3 mm100 -106.98 156.75 18.4 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.851 HG12 ' HG2' ' A' ' 9' ' ' ARG . 3.1 m -92.28 29.53 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.67 ' SG ' ' HB2' ' A' ' 23' ' ' CYS . 66.2 m -166.0 49.25 0.08 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.705 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 1.06 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 58.37 16.97 30.3 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 118.191 -1.957 . . . . 0.0 111.404 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.561 ' HA2' ' HG3' ' A' ' 13' ' ' GLN . . . 90.07 145.44 13.13 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 121.433 -0.413 . . . . 0.0 112.453 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.471 ' HD2' ' HG3' ' A' ' 13' ' ' GLN . 15.1 Cg_endo -57.37 -41.81 68.7 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.913 2.409 . . . . 0.0 112.628 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -45.38 -36.85 6.0 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.679 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.483 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 1.1 mpp_? -106.96 -22.82 12.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.721 -0.239 . . . . 0.0 111.098 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . 177.7 148.11 7.16 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.018 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.646 HD21 ' CD ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -140.19 143.62 36.17 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.194 0.521 . . . . 0.0 112.283 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.721 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 9.5 t -101.36 143.22 31.66 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.346 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -155.84 -108.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 118.753 -1.179 . . . . 0.0 113.255 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 43.6 t -72.26 68.41 0.74 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -177.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.426 ' HA2' HG21 ' A' ' 5' ' ' ILE . . . 114.93 -38.72 3.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.279 -0.962 . . . . 0.0 115.167 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.705 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -155.82 -165.98 2.09 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -177.172 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.721 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.7 m -83.09 -175.19 5.71 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.22 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.646 ' CD ' HD21 ' A' ' 22' ' ' LEU . 20.8 ttt180 -155.17 64.67 0.63 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -89.64 138.9 31.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.402 -178.488 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -80.65 162.9 58.82 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.692 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.71 117.16 3.81 Favored 'Trans proline' 0 CA--C 1.512 -0.606 0 C-N-CA 122.669 2.246 . . . . 0.0 112.738 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.18 46.98 0.97 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.75 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 20' ' ' ARG . 24.3 m-85 -146.04 147.49 31.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.691 0.282 . . . . 0.0 111.126 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 -87.25 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.48 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.684 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 50.85 -154.91 3.37 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.343 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.433 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 34.8 t -78.3 -20.46 51.47 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.63 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -127.86 -83.65 0.59 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.582 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 93.9 m -156.36 43.45 0.4 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.931 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.568 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 15.5 pm0 -102.92 -33.18 9.41 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.684 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.484 -0.77 . . . . 0.0 111.649 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.748 0.309 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.1 103.84 14.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.997 0.427 . . . . 0.0 110.368 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.449 ' O ' HD12 ' A' ' 5' ' ' ILE . 64.5 m-20 -158.2 -124.76 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.429 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.85 87.87 7.36 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.514 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -156.23 69.51 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-O 122.126 0.965 . . . . 0.0 108.787 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.55 153.86 23.0 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.963 -177.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.8 m -40.63 145.41 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.194 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 15' ' ' CYS . 76.0 mt-10 -87.76 179.15 6.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.671 178.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.867 ' HG2' HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -137.95 128.25 26.17 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.093 0.949 . . . . 0.0 112.251 178.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.798 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 1.0 OUTLIER -95.12 -147.09 0.27 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.572 178.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.452 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 3.0 t-20 -91.41 71.47 6.05 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.98 -24.83 2.25 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 119.673 -1.251 . . . . 0.0 115.216 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.752 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 9.5 mt-30 -155.56 -156.33 0.64 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.941 0.871 . . . . 0.0 110.386 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.867 HG12 ' HG2' ' A' ' 9' ' ' ARG . 32.9 m -107.23 115.01 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.195 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.642 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 1.2 m 68.87 47.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.71 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.798 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 54.47 29.77 48.19 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.19 -1.481 . . . . 0.0 111.227 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.14 150.69 0.27 Allowed Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.405 -0.398 . . . . 0.0 112.358 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 19.3 Cg_endo -59.0 -31.55 95.94 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.72 2.28 . . . . 0.0 112.672 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.28 -21.96 13.58 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.625 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -107.74 -33.49 7.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.358 . . . . 0.0 110.987 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 18' ' ' PRO . . . -177.32 161.54 29.06 Favored Glycine 0 CA--C 1.517 0.198 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.069 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.649 ' O ' ' N ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -125.93 -175.18 3.28 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 120.672 0.273 . . . . 0.0 110.41 179.387 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 14.6 p -137.42 148.24 46.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.386 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.601 ' CE2' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -156.61 -169.41 2.99 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.496 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.444 ' C ' ' O ' ' A' ' 24' ' ' PHE . 4.7 t -24.71 85.94 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.314 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . 120.39 -68.42 0.4 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.382 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.52 -163.69 1.5 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 3.6 t -84.34 169.5 14.58 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.679 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.649 ' N ' ' O ' ' A' ' 22' ' ' LEU . 2.0 tpp85 -145.47 94.55 2.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.98 ' SG ' ' HB2' ' A' ' 34' ' ' PHE . 30.5 t -85.61 157.12 20.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.842 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 20' ' ' ARG . 9.5 m-70 -77.88 158.21 78.15 Favored Pre-proline 0 C--O 1.231 0.124 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.348 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -64.71 113.54 2.37 Favored 'Trans proline' 0 CA--C 1.515 -0.434 0 C-N-CA 122.712 2.274 . . . . 0.0 112.665 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.91 -24.88 5.94 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.922 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.98 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.8 m-85 -85.53 164.68 17.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.719 0.295 . . . . 0.0 110.846 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -155.0 -90.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.134 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.74 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 49.23 -153.52 2.61 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.129 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.455 ' H ' ' NE2' ' A' ' 40' ' ' GLN . 0.3 OUTLIER -88.63 -0.11 56.94 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.642 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -154.92 -78.61 0.09 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.051 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.455 ' SG ' ' CB ' ' A' ' 34' ' ' PHE . 23.2 t -156.29 35.67 0.33 Allowed 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.858 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.62 ' NE2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -91.81 -35.28 14.19 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.74 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.659 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.804 0.335 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -109.28 -74.94 0.64 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.746 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.7 -170.59 0.14 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.032 0.444 . . . . 0.0 111.493 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.625 HG22 ' SG ' ' A' ' 23' ' ' CYS . 21.0 p -84.42 76.8 10.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.017 HG23 ' HA2' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -98.15 -20.21 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.387 -178.065 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.46 94.63 2.71 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.296 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.427 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 4.7 m -134.06 134.91 42.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.155 0.502 . . . . 0.0 111.145 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 15' ' ' CYS . 9.1 mm-40 -95.41 154.58 17.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.412 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 24.8 mtt180 -129.78 130.14 44.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.716 0.77 . . . . 0.0 111.209 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.868 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 1.5 p90 -96.28 -33.6 11.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.445 -1.252 . . . . 0.0 112.908 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -155.62 44.71 0.46 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.253 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.75 -13.4 56.36 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.285 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.72 ' HB2' ' HE1' ' A' ' 10' ' ' TYR . 32.4 mm-40 -84.59 -77.74 0.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 13' ' ' GLN . 3.7 p 145.72 108.29 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.553 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.696 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER 67.81 42.55 1.93 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 178.16 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.868 ' HA2' ' CG ' ' A' ' 10' ' ' TYR . . . 62.78 33.65 87.49 Favored Glycine 0 C--N 1.316 -0.554 0 C-N-CA 119.162 -1.495 . . . . 0.0 111.784 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.459 ' N ' ' CE1' ' A' ' 10' ' ' TYR . . . 73.52 163.39 8.36 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.434 -0.412 . . . . 0.0 112.742 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.597 ' HB3' HD11 ' A' ' 22' ' ' LEU . 57.3 Cg_endo -70.86 -42.36 2.32 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.774 2.316 . . . . 0.0 112.809 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -47.42 -27.95 4.44 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.858 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.481 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -106.11 -49.55 3.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.71 0.29 . . . . 0.0 110.925 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.19 132.91 3.47 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.342 -0.933 . . . . 0.0 113.018 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' ' 18' ' ' PRO . 2.6 mm? -96.21 170.98 8.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.21 0.529 . . . . 0.0 112.226 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -112.75 131.66 55.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.068 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -135.08 -173.25 3.27 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -31.74 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.464 -1.698 . . . . 0.0 111.446 179.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 1.017 ' HA2' HG23 ' A' ' 5' ' ' ILE . . . 56.56 4.87 1.0 Allowed Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.829 -0.623 . . . . 0.0 114.042 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' A' ' 24' ' ' PHE . 15.0 mttt -156.16 152.65 28.15 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 118.064 0.932 . . . . 0.0 112.995 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -84.45 175.76 9.11 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.004 178.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.421 ' CG ' ' HB2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -148.79 86.0 1.5 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.825 0.345 . . . . 0.0 111.421 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.938 ' SG ' ' HB2' ' A' ' 34' ' ' PHE . 19.2 t -85.03 154.79 21.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.368 . . . . 0.0 110.916 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 20' ' ' ARG . 2.9 m-70 -78.21 153.97 79.65 Favored Pre-proline 0 N--CA 1.455 -0.194 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.36 111.62 1.51 Allowed 'Trans proline' 0 CA--C 1.514 -0.524 0 C-N-CA 122.434 2.09 . . . . 0.0 112.743 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.08 31.67 2.01 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.349 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.938 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 6.3 m-85 -131.12 158.5 40.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -148.17 -88.22 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.036 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.659 ' H ' ' HB3' ' A' ' 41' ' ' ALA . . . 47.99 -154.85 1.37 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.118 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 m -79.31 -8.24 58.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.696 ' HB1' ' HA ' ' A' ' 15' ' ' CYS . . . -155.18 -74.67 0.11 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.377 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.449 ' SG ' ' CB ' ' A' ' 34' ' ' PHE . 45.3 t -155.74 33.54 0.36 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.21 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -97.55 -29.74 13.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.725 0.297 . . . . 0.0 111.742 -179.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.659 ' HB3' ' H ' ' A' ' 36' ' ' GLY . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.207 -0.901 . . . . 0.0 111.146 -179.852 . . . . . . . . 1 1 . 1 stop_ save_